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Abstract	  
Periventricular leucomalacia (PVL) is the most common brain injury in bilateral spastic 
cerebral palsy (BSCP). Cerebral palsy is a group of conditions that affect the 
development of the motor system, that are attributed to non-progressive lesions in the 
developing brain. In PVL, damage is caused by a primary arterial ischemic injury to the 
white matter in the posterior limb of the internal capsule, although other regions of the 
brain can also be affected including the spinal cord. Alterations in spinal cord 
development may lead to many of the clinical problems observed in BSCP, including 
altered motor control, co-contraction of agonist and antagonist muscle groups, 
progressive musculoskeletal deformities and weakness. Further to this, a heightened 
fracture risk of the long bones of the skeleton may be related to poor muscle 
development subsequent to the original brain injury.  
 
In the work contributing to this thesis, the fat content of five muscles and the volume of 
nine major muscles of the lower limbs of ambulant adolescents and young adults with 
and without BSCP are investigated using MRI. The relationship between bony 
geometry and muscle volume are also studied. Studies of spinal cord white matter 
organisation are also performed using diffusion tensor imaging (DTI) MRI techniques 
to investigate whether there are associations between spinal cord organisation and gross 
functional development in BSCP. 
 
Lower limb muscle volumes in BSCP were found to be smaller with increased 
intramuscular fat compared to their typically developing peers. Bone strength estimated 
from bony geometry was found to be significantly dependent on muscle volume 
independent of diagnosis. No differences were observed in spinal cord white matter 
microstructure between the subject groups, although a reduced white matter cross-
sectional area was observed in the BSCP group. The clinical implications of this work 
are discussed in detail. 
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Nomenclature	  
2PD   Two-point Dixon 
3PD   Three-point Dixon 
4PD   Four-point Dixon 
ACh   Acetylcholine 
ADC   Apparent diffusion coefficient 
ADP   Adenosine diphosphate 
AFO   Ankle-foot orthoses 
ATP   Adenosine triphosphate 
AMP   Adenosine monophosphate 
BMD   Bone mineral density 
BMI   Body mass index 
BSCP   Bilateral spastic cerebral palsy 
BTX   Botulinum toxin 
Br   Buckling ratio 
cAMP   Cyclic adenosine monophosphate 
CoA   Co-enzyme A 
COV   Coefficient of variation 
CP   Cerebral palsy 
CSA   Cross sectional area 
CT   Cortical bone thickness 
DTI   Diffusion tensor imaging 
DXA   Dual-energy X-ray absorption 
EMCL   Extramyocellular lipid 
EPI   Echo planar imaging 
FA   Fractional anisotropy 
FAD   Flavin adenine dinuclide 
FDRO   Femoral derotation osteotomy 
FG   Fast glycolytic 
FOG   Fast oxidative-glycolytic 
FOV   Field of view 
GMax   Gluteus maximus 
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GMFCS  Gross motor function classification system 
GMFM   Gross motor function measure 
GMH-IVH  Germal matrix haemorrhage – intraventricular haemorrhage 
GTP   Guanosine triphosphate 
GTPT   Greater trochanter prominence test 
GZLM   Generalized linear model 
HDL-C  High-density lipoprotein cholesterol 
ICC   Intra-class correlation 
IDEAL Iterative decomposition of water and fat with echo asymmetry 
and least squares approach 
IMAT   Intermuscular adipose tissue 
IMCL   Intramyocellular lipid 
IntraMF  Intramuscular fat 
IRS   Insulin receptor substrate 
J   Polar moment of inertia  
LG   Lateral gastrocnemius 
MEP   Motor evoked potential 
MG   Medial gastrocnemius 
MRI   Magnetic resonance imaging 
MRS    Magnetic resonance spectroscopy 
MTS   Modified Tardieu scale 
MTU   Musculo-tendinous unit 
NAD   Nicotinamide adenine dinuclide 
NSA   Number of signals averaged 
OVS   Outer volume suppression 
PCr   Phosphocreatine 
PCSA   Physiological cross-sectional area 
PCW   Post-conception weeks 
Pi   Inorganic phosphate 
PLIC   Posterior limb of the internal capsule 
pQCT   Peripheral quantitative computed tomography 
PRESS  Point resolved spectroscopy 
PVHI   Periventricular haemorrhage infarction 
PVL   Periventricular leucomalacia  
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RF   Rectus femoris 
ROI   Region of interest 
ROM   Range of movement 
SCALE  Selective control assessment of the lower extremity 
SCI   Spinal cord injury 
SCP   Spastic cerebral palsy 
SDD   Smallest detectable difference 
SDR   Selective dorsal rhizotomy 
SE   Spin echo 
SEM   Standard error of measurement 
SF/M   Subcutaneous fat to muscle volume ratio 
SM   Semimembranosus 
SNR   Signal-to-noise ratio 
SO   Slow oxidative 
SOL   Soleus 
SS-EPI  Single-shot echo planar imaging 
SSFP   Steady state free procession sequence 
ST   Semtiendinosus 
STEAM  Stimulated echo acquisition mode 
TA   Tibialis anterior 
TD   Typically developing 
TE   Echo time 
TMS   Transcranial magnetic stimulation 
TP   Tibialis posterior 
TR   Repetition time 
TSRT   Tonic stretch threshold 
VIF   Variance inflation factor 
VL+VI  Vastus lateralis and vastus intermedius complex 
WHO   Word Health Organisation 
ZOOM-EPI  Zonally magnified oblique multi-slice echo planar imaging 
Zp   Polar section modulus 	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1. Introduction	  
Cerebral palsy affects approximately 1 in 500 live births in the UK and is the most 
prevalent cause of motor disability in children1. Cerebral palsy recently has been 
defined as a group of disorders of the development of movement and posture, causing 
activity limitation, that are attributed to non-progressive disturbances that occurred in 
the developing fetal or infant brain. The motor disorders of cerebral palsy are often 
accompanied by disturbances of sensation, perception, cognition, communication, and, 
behaviour, by epilepsy, and by secondary musculoskeletal problems2.. Periventricular 
leucomalacia (PVL) is the most common brain injury in bilateral spastic cerebral palsy. 
The location of these lesions, in the posterior limb of the internal capsule, results in 
damage to the corticospinal tract with the destruction of a number of axons. Many other 
areas of the brain may also be affected by the injury, either directly or by mal-
development subsequent to the injury3.  Currently there is no cure for cerebral palsy and 
the primary aim of clinical interventions, including physiotherapy, orthoses and 
orthopaedic surgery, are to improve a patient’s functional capabilities and quality of 
life. 
 
Although cerebral palsy is considered neurologically non-progressive, cerebral palsy 
may affect the neurology of the developing child including the spinal cord and motor 
systems. As these children grow, many develop bony and muscular deformities, which 
are progressive, and may interfere with their mobility and function. Acquisition of early 
motor skills in children with cerebral palsy is variably delayed, and in more affected 
individuals, these motor skills may not be acquired, such as independent walking. 
 
Children with cerebral palsy are often categorised by the severity of their condition into 
one of five levels on the Gross Motor Function Classification System (GMFCS)4. This 
system categorises children into five levels based in their functional ability scored using 
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the Gross Motor Function Measure (GMFM)5. The GMFM is a clinical tool designed to 
evaluate change in gross motor function in children with cerebral palsy. Items on the 
GMFM span the spectrum from activities in lying and rolling up to walking, running 
and jumping skills. If a child is classified onto one of the levels at an early age, the 
trajectory of the functional development is predictable up to 21 years of age6. High 
functioning individuals with cerebral palsy (GMFCS levels I and II) typically remain 
stable into early adulthood6; however, lower functional individuals typically have a 
decline in functional ability from 8 years of age6. Into adulthood, individuals with 
cerebral palsy (GMFCS levels II-V) typically show a decline in their functional ability 
with increasing age7, culminating in the early loss of mobility7,8, with deterioration in 
motor ability associated with the level of neurological impairment and the timing of the 
acquisition of early motor mile-stones9.  
 
Adults with cerebral palsy have a life expectancy close to that of the general 
population8,10,11, with life expectancy related to the severity of condition10-12. The most 
common cause of death in older adults with cerebral palsy is disease of the circulatory 
system11. These individuals may have a two to three times greater risk of dying from 
ischemic heart disease compared to the general population13. Considering the relative 
long life expectancy of adults with cerebral palsy and its apparent relationship with 
mobility8,10,12, maximising an individual’s potential mobility is important. An 
individual’s mobility can be limited by muscle function, including reduced muscle 
volume and altered muscle composition. If present in this group, targeted interventions 
to improve muscle volume and composition may enable an individual to maximise their 
mobility, to improve both their quality of life and life expectancy. 
 
This programme of work utilises magnetic resonance imaging techniques to first 
examine muscle volume and composition in bilateral spastic cerebral palsy, and their 
impact on skeletal strength, compared to their typically developing peers, and secondly 
to investigate whether white matter organisation in the spinal cord is altered in subjects 
with bilateral spastic cerebral palsy compared to their typically developing peers. 
Relationships between any altered spinal cord white matter organisation and gross 
motor function, and selective motor control are also explored. Chapter 1 and Chapter 2 
provide an introduction to the neurological and musculoskeletal pathology associated 
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with cerebral palsy to enable an understanding of the condition to be developed before 
discussing the specific details of each study performed in this programme of work.  
1.1	  	   Thesis	  Aims	  
The aims of this programme of work are: 
• To compare lower limb muscle volumes of subjects with bilateral spastic 
cerebral palsy (BSCP) to their typically developing (TD) peers using MRI. 
• To investigate if there is a relationship between muscle volume and bone 
strength in the lower limb. 
• To compare intramuscular fat in the distal muscles of subjects with BSCP and 
compare with their TD peers. 
• To investigate white matter organisation in the cervical and thoracic spines of 
adolescents and young adults with BSCP and compare with their TD peers using 
diffusion tensor imaging (DTI) MRI. 
• To investigate any relationships between white matter organisation in the 
thoracic spine and gross motor function, selective motor control. 
 
1.2	  	   The	  adult	  motor	  system	  
The human motor system comprises three main components: the nervous system, the 
skeletal musculature, and the skeletal system. The nervous system is subdivided into the 
central nervous system (CNS), the brain and spinal cord, and the peripheral nervous 
system (PNS), the nerves that transmit signals to and from the CNS. Descending tracts 
of the spinal cord are grouped into two major pathways, the pyramidal and extra-
pyramidal tracts. The pyramidal tract, including the corticospinal tract, consists of 
motor neurons that conduct ionic signals from the motor region of the brain to the spinal 
cord where they form connections with the lower motor neurons either directly or 
through inter connecting neurons (interneurons) of the spinal cord, which in turn 
innervate skeletal muscles resulting in a muscular contraction. The extra-pyramidal tract 
controls posture and muscle tone via the brainstem. Ascending tracts of the spinal cord 
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transmit sensory signals from the peripheral receptors to the brain. Integration of 
sensory and motor systems enables the development of fine motor control. 	  
1.2.1	  	  Neurons	  
Nervous tissue is comprised of two types of cells: neurons and neuroglia. Neuroglia 
support, nourish and protect neurons and maintain homeostasis of the fluid surrounding 
the neurons. Neurons are formed of three parts as shown in Figure 1.1: cell body, 
dendrites, and axon. The cell body contains the nucleus surrounded by cytoplasm and 
typical cell organelles. The majority of the molecules required for the neuron’s 
operation are synthesised in the cell body. From the cell body two types of extensions 
are present: multiple dendrites that receive inputs and generally a single axon, glands 
and muscle fibres. The axon end divides into axon collaterals, which end by dividing 









Figure 1.1 Basic components of a neuron 
 
Neurons transmit information in the form of an electrical impulse along the axon – the 
action potential. The nerve action potential is a unidirectional, self-propagating reversal 
of the plasma membrane polarity. Initially there is an influx of sodium ions through 
voltage gated channels in the plasma membrane causing the membrane polarity to rise 
to +40 mV, follows by a rapid return to the resting membrane potential of -80 mV as 
potassium ions leave the axon. Action impulses are transmitted in only one direction, 
down the axon away from the original stimulation point. The axons of many neurons 
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are surrounded by a myelin sheath: a covering formed of lipid and protein. Myelin 
sheaths insulate the axon and increase the nerve impulse conduction velocity.  
 
Communication between a neuron and other neurons and effector cells (the muscle, 
gland or organ cell that responds to a stimulus at the terminal end of an efferent neuron 
or motor neuron) is possible through synapses. The ends of the axon terminals form 
synaptic end bulbs through which chemical neurotransmitters pass to enable 
communication since action potentials themselves cannot pass across the synapses. A 
neuron may concentrate all of there connections onto a single cell or post-synaptic 
neuron. However, neurons can also be divergent, where a neuron synapses with many 
cells, or convergent, where many neurons synapse onto a single target. Convergent 
connections enable the integration of information from many sources and divergent 
connections enable a neuron to exert a widespread effect. The junctions between 
neurones and muscle fibres are called the neuromuscular junction. At a neuromuscular 
junction the nerve action potential is passed from the axon synapse, across a synaptic 
cleft into the muscle fibre to set up a muscle action potential via neurotransmitters. 
 
Postsynaptic potentials can be excitatory or inhibitory. Postsynaptic excitation results in 
the depolarisation of the postsynaptic neuron at the cell body or dendrites, leading to an 
increase in the probability of initiating an action potential at the base of the second 
neuron’s axon resulting in an action impulse along the axon. Postsynaptic inhibition is 
the hyperpolarisation of the postsynaptic neuron at the cell body, dendrites, or at the 
base of the axon. This hyperpolarisation stops the formation of the action potential, 
preventing the transmission of the signal along the axon. In a more complex network of 
connections, multiple neurons may synapse with these neurons, for example at the pre-
synaptic terminal of the first axon to cause inhibition, preventing an excitation of the 
second neuron. It is through learning synaptic excitation and inhibition that motor and 
sensory systems interact to facilitate motor control. 
1.2.2	  	  The	  corticospinal	  system	  
The corticospinal system connects the motor cortex with the spinal cord grey matter, 
and is the principal motor system for controlling precise voluntary movements. The 
corticospinal tract conducts impulses from the brain down the spinal cord. The 
corticospinal tract is the last motor system to develop; brainstem motor systems are well 
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developed by birth, the corticospinal system continues to develop over a protracted 
postnatal period whilst key motor milestones are developed14. 
 
The corticospinal tract originates at the cerebral cortex, from the primary motor cortex, 
the supplementary motor area, and the pre-motor cortex. The axonal projections of the 
neurons in the motor cortex form the corticospinal tract that descends the spinal cord. 
The corticospinal tract descends at first through the posterior crus of the internal 
capsule, traverses the cerebral preduncle in the midbrain, the pons, and then form a 
discrete bundle, known as the pyramid, at the rostral level of the medulla oblongata15. 
About 70-90% of the corticospinal fibres cross the median plane in the pyramidal 
decussation to form the lateral corticospinal tract; of remaining, 10% continue 
uncrossed in the lateral corticospinal tract, and 10% continue to descend as the anterior 
corticospinal tract (Figure 1.2).  Since the corticospinal tracts traverse the medullary 
pyramids, they are often referred to as the pyramidal tracts, a term that also includes the 






Figure 1.2 Schematic diagram of cervical spinal cord showing the location of the 
lateral and anterior corticospinal tracts (red) in relation to the grey matter (grey) 
 
The lateral corticospinal tract descends in the lateral funiculus throughout most of the 
spinal cord, progressively diminishing in size and ending at the S4 spinal segment, as 
axons terminate onto the motor neurons in the ventral horn grey matter of spinal cord. 
This completes the connection, via the corticospinal tract, between the neurons in the 
motor cortex (known as the upper motor neurons) and the motor neurons in the spinal 
cord grey matter (known as lower motor neurons). The axons from the lower motor 
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neurons exit the spinal cord via anterior roots of spinal nerves and terminate at the 
motor end plate within a specific muscle providing motor innervation for voluntary 
muscles. The anterior corticospinal tract is typically much smaller than the lateral 
corticospinal tract. The anterior corticospinal tract descends in the anterior funiculus of 
the spinal cord and diminishes as it descends, ending at the mid-thoracic spine. As the 
anterior corticospinal tract descends, fibres cross the median plane and terminate with 
spinal motor neurons in the anterior white commissure15. Therefore, axons from the 
anterior corticospinal tract predominantly synapse with spinal motor neurons on the 
contralateral side compared to the tract, whereas axons from the lateral corticospinal 
tract predominantly synapse with the spinal motor neurons on the ipsilateral side. 
1.2.3	  	  Muscle	  tone:	  The	  vestibulospinal	  and	  reticulospinal	  tracts	  	  
Muscle tone is the resting resistance of a muscle to stretch due to a combination of 
muscle activity and the visco-elastic properties of muscle and connective tissue. 
Background muscle activity is controlled by brainstem nuclei, particularly the reticular 
and vestibular nuclei. The vestibulospinal nuclei produce two tracts, each functionally 
and topographically distinct: the medial and lateral vestibulospinal tracts. The lateral 
vestibulospinal tract descends ipsilaterally in the periphery of the antero-lateral 
funiculus and then shifts into the medial portion of the anterior funiculus at lower spinal 
cord levels. The medial vestibulospinal tract descends via the medial longitudinal 
funiculus into the anterior funiculus close to the midline of the spinal cord (see Figure 
1.2). Unlike, the lateral vestibulospinal tract, the medial vestibulospinal tract contains 
crossed and uncrossed axons and does not extend beyond the mid-thoracic spine level. 
The vestibulospinal nuclei are involved in balance and support with the vestibulospinal 
tracts exciting the motor neurons in the spinal cord causing contractions of the extensor 
muscles in the lower limbs. 
 
The reticulospinal tracts originate from the reticular nuclei and form three tracts: the 
medullary, pontine, and lateral reticulospinal tracts. The medullary axons originate from 
the gigantocellular reticular nucleus and descend bilaterally in the antero-lateral 
quadrant of the spinal cord. Pontine reticulospinal axons originate from the oral and 
caudal pontine nuclei and descend down the spinal cord together with the medullary 
reticulospinal the brain stem, collectively forming the medial reticulospinal tract. The 
lateral reticulospinal tract originates from the ventral-lateral tegmental field of the pons 
Introduction	  	  
J.J.	  Noble	   Musculoskeletal	  and	  spinal	  cord	  imaging	   22	  
and descends down the spinal cord in the lateral funiculus throughout the length of the 
spinal cord and synapses with muscle motor neurons in the spinal cord grey matter. The 
reticulospinal tracts are involved in locomotion and posture control and facilitation and 
inhibition of voluntary movement affecting muscle tone. The medial reticulospinal tract 
synapses with interneurons and lower motor neurons stimulating the extensor muscles 
and inhibiting the flexor muscles of the axial and proximal limb musculature. The 
lateral reticulospinal tract also synapses with lower motor neurons and interneurons but 
has the complementary effect to the medial reticulospinal tract: having an inhibitory 
effect on the extensors muscle and an excitatory effect on the flexor muscles of the axial 
and proximal limb musculature. Figure 1.3 summarises the location of the 















Figure 1.3 Schematic diagram of the cervical spinal cord showing the location of the 
vestibulospinal tracts (blue) and reticulospinal tracts (red) in relation to the grey matter (grey) 
1.3	  	   Corticospinal	  tract	  development	  
Once the corticospinal tract has descended through the internal capsule, traversed the 
cerebral preduncle in the midbrain, and brain stem, the growing corticospinal axons 
descend into the spinal white matter. A small number of “pioneer” corticospinal axons 
first enter the spinal cord between 17 and 29 post-conception weeks (PCW)16 followed 
by later waves of axons that further populate the corticospinal tract17,18, innervating the 
ventral horn of the spinal cord from 31 to 35 PCW16. The pioneer axons are guided by 
tissue molecular signals that are detected by the pioneer axon19,20. Longitudinal growth 
of the pioneer axon is followed by the formation of collateral branches that extend into 
the surrounding grey matter towards the spinal motor neurons. The innervation of the 
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spinal grey matter by these collateral axon branches is mediated by target-specific 
chemotropic factors from the target cell that induces branching18. This process controls 
each neuron’s function by controlling which spinal motor neuron and corticospinal 
neuron interact. 
 
The targeting of corticospinal axons to spinal motor neurons through diffuse chemical 
signals only enables the development of a coarse corticospinal network. However, a 
more refined mechanism is required to determine whether a corticospinal axon forms a 
functional connection with a particular segment or propriospinal circuit. This refined 
connectivity ultimately determines the specific functional network required to perform 
precise voluntary movements14. 
 
In the immature spinal cord, the transient corticospinal terminations are extensive in 
both the ipsilateral and contralateral grey matter. During the first year of postnatal life, 
there is growth of the spinal cord grey matter and elimination of transient terminations 
onto the cells of the grey matter, with the majority of the corticospinal tracts terminating 
in the contralateral grey matter to their origin in the motor cortex. Over the first few 
years of life, an adult pattern of termination emerges and axon myelination is largely 
complete. These refinements are augmented by stronger post-synaptic facilitation of the 
motor neurons, where the post-synaptic impulse potential (signal strength) is increased 
when the impulse closely follows a prior impulse. This results in stronger post-synaptic 
potentials leading to improved activation of muscle, encouraging muscle development. 
The refinement process is mediated by neuronal activity, with competition between 
terminals of the corticospinal tract. The more active the terminals are, the more 
competitive they are, increasing the probability they will not be eliminated14. However, 
the elimination of transient corticospinal terminations is only one aspect of the 
refinement process. The other refinement process is the growth of axon terminal 
branches and synaptic boutons21. This process begins during early development along 
side transient terminations but continues late into the postnatal period, and possibly into 
maturity21, resulting in the development of fine axon branches and dense clusters of 
synaptic boutons22. 
 
There is also evidence in that suggests there are interactions between the developing 
corticospinal and muscle systems23. The elimination of transient corticospinal terminals 
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may leave more space in the spinal grey matter reducing the competition and thereby 
reducing the pruning of muscle afferent fibre branches24. 
1.3.1	  	  Motor	  control	  and	  the	  developing	  corticospinal	  tract	  
As discussed above, during early postnatal development extensive anatomical changes 
occur in the morphology and topography of the corticospinal terminals in the grey 
matter of the spinal cord. This period coincides with a rapid improvement in an 
individual’s motor skills. These improvements in motor skills can be partly attributed to 
development of the cognitive, sensory, and motor systems, including the corticospinal 
system. The refinement of the corticospinal terminals and the generation of synaptic 
connections through synaptic bouton and synaptic vesicle development enables 
effective synaptic activation of spinal motor circuits and a larger post-synaptic response 
for a given descending control signal down the corticospinal tract25. The signal 
transition between corticospinal and motor control is also strengthened through 
temporal facilitation of the control system. If a second activation signal is received at 
the synapse a short time after an initial control signal, the response in the post-synaptic 
circuit is increased compared to the size of the response evoked by the first signal. This 
temporal strengthening of the post-synaptic response results in stronger muscle 
activation signals, and therefore a greater motor response, encouraging muscle 
development.	  	  
 
However, it is important to note that the development of motor control is not just 
dependent on the corticospinal tract, but also on the simultaneous development of the 
sensory systems, including the proprioceptive, visual, and vestibular systems. 
Reciprocal inhibition is a key example of this. In reciprocal inhibition, the antagonist 
muscle stretch reflex is inhibited when the agonist muscle is contracted. This is 
achieved through synapse inhibition of interneurons on the motor neurons of the 
antagonist muscle when the motor neuron for the agonist muscle group is selectively 
activated, thereby reducing the contraction of the antagonist muscle. Motor-sensory 
development in primates and the development of the corticospinal tract are highly 
correlated26. The rostral-caudal direction of the corticospinal tract growth in the spinal 
cord and the correlation between corticospinal tract maturation and motor sensory 
function suggest a particular sequence for the acquisition of motor skills. This is 
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supported by observations of the order of human motor development with head control, 
followed by upper limb control, sitting, crawling and finally standing and walking. 
1.4	  	   Cerebral	  Palsy	  
Recently, cerebral palsy has been defined as a group of permanent disorders of the 
development of movement and posture, causing activity limitations that are attributed to 
non-progressive disturbances that occurred in the developing foetal or infant brain. The 
motor disorders of cerebral palsy are often accompanied by disturbances of sensation, 
perception, cognition, communication and behaviour, by epilepsy and by secondary 
musculoskeletal problems2. 
 
Cerebral palsy is caused by an injury to the brain during the pre-natal or peri-natal 
periods. The most common injuries in pre-term babies are periventricular leucomalacia 
(PVL) and periventricular haemorrhagic infarction (PVHI). PVL is the most common 
brain injury in bilateral spastic CP (BSCP) and is caused by a primary arterial ischemic 
injury to the white matter. This infarction causes necrosis of all cell types and axonal 
pathways coursing adjacent to the ventricles in the region. This infarction is typically 
focal, bilateral, and located dorso-lateral to the external angle of the lateral ventricle27, 
in the posterior limb of the internal capsule (PLIC), resulting in damage to the 
corticospinal tract.  Diffuse white matter injuries around the infarction foci may also 
occur, with many other areas of the brain potentially affected by the injury, either 
directly or by mal-development subsequent to the injury (for review, see Volpe 
(2009)3). PVHI is caused by germinal matrix haemorrhage through the ependymal 
lining, resulting in an intraventricular haemorrhage (GMH-IVH). GMH-IVH impairs 
blood drainage through the terminal vein, causing venous stasis and ischemia through 
large areas of the hemisphere. PVHI is the most common brain injury in hemiplegia, 
tending to affect unilaterally more of the corticospinal tract than PVL, affecting one arm 
and one leg contralateral to the PVHI injury.  
 
In term births, the principal cerebro-vascular lesions result from global hypoxia-hypo-
perfusion insults to the entire brain, for example post-asphyxial encephalopathy, and 
focal infarction following embolic occlusions of a cerebral artery, arterio-occlusive 
strokes. Post-asphyxial encephalopathy, caused by birth trauma or intrauterine deficit, 
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results in a range of neuro-pathologies, with the most metabolically active regions of the 
brain typically affected. The patterns of the brain injuries are associated with different 
neuro-developmental outcomes28. Focal strokes may also further complicate peri-natal 
asphxia. 
1.4.1	  	  Classification	  of	  Cerebral	  Palsy	  
Cerebral palsy is a heterogeneous condition in aetiology, type, and severity of 
impairments. Therefore, children and adults with cerebral palsy exhibit a wide range of 
clinical presentations and functional abilities and are often subcategorised by the nature 
and severity of the condition. Traditionally, cerebral palsy is subcategorised by the 
distribution pattern of affected limbs (topographic) and the predominant type of tone or 
movement abnormality (physiological).  A commonly utilised classification system is 
shown in Table 1.1. Spastic cerebral palsy is the most common type, affecting 
approximately 85% of all individuals with cerebral palsy29.  This approach facilitates 
the comparison of a group of individuals with similar clinical presentation enabling a 
broad comparison of the natural histories and planning of future service needs. 
However, this traditional classification system is based upon clinical presentation and 
does not take into account the severity or location of damage in the brain, limiting the 
ability of the natural history and treatment efficacy to be investigated effectively. 
Individuals may have similar clinical presentation but may have different aetiologies, 
and may have a different natural history and response to a particular intervention. 
Instead, treatment and identification of individuals based on the specific patho-
physiology of the patient and not their clinical presentation is likely to produce more 
homogenous treatment groups that may result in improved patient outcome. 
 
A group chaired by Goldstein and Bax2 recently suggested a new classification 
framework. This framework has been developed to include recent developments in 
neuro-imaging and to improve the reliability of classification, with the ultimate aim of a 
standardised classification scheme to enable different clinicians to classify an individual 
in the same way. Bax et al. also recommend the discontinuation of the term ‘spastic 
diplegia’ due to the variable definitions currently in use. Currently the term can be used 
to describe an individual with both legs affected, or one arm and one leg of the 
individual are affected. Individuals may present with asymmetry, where one side is 
affected more than the other. In this report, the term ‘bilateral’ will be used to describe 
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individuals with both legs affected and minimal arm involvement, and ‘hemiplegia’ will 
be used to describe individuals with one arm and one leg involvement. 
 
Topographic Classification Explanation 
Monoplegia One lower limb involved 
Hemiplegia Unilateral involvement; usually arm more than leg 
Diplegia Bilateral involvement of the legs 
Minimal involvement of the upper limbs 
Quadriplegia All four limbs involved; lower more than upper 
Double Hemiplegia All four limbs involved; upper more than lower 
Physiological Classification  
Ataxic Exhibit hypotonia – reduced resistance to muscle stretch 
Spastic 
Exhibit hypertonia - an increased resistance to 
muscle stretch due to muscle spasticity (see section 
1.4.2) 
Athetoid Mixed muscle tone 
Table 1.1 Topographic and physiological classification of cerebral palsy 	  
1.4.2	  	  PVL	  and	  the	  developing	  motor	  system	  
PVL is the most common brain injury in bilateral spastic cerebral palsy and is caused by 
a primary arterial ischemic injury to the white matter. This infarction causes necrosis of 
all cell types and axonal pathways coursing adjacent to the ventricles in the region, 
resulting in damage to the corticospinal tract. PVL tends to occur between 24 and 33 
PCW, before the transient spinal terminations of the corticospinal tract in the spinal 
cord grey matter have been eliminated and mature projections onto the cells of the 
spinal grey matter have formed. As a result of the injury, intrinsic cord networks may 
not mature and muscle development may be delayed30. An injury to the developing 
corticospinal tract results in the loss of fine selective voluntary muscle control in distal 
limb muscles. Spinal cord and subsequent muscle development is likely to be affected 
by the extent, severity and timing of the original brain injury. 
 
An upper motor neuron lesion results in a combination of negative (reduced voluntary 
motor activity), and positive (increased involuntary muscle activity). Positive effects 
include increased tendon reflexes, clonus, spasticity, co-contractions, and 
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flexor/extensor spasms and negative effects include loss of selective motor control, 
muscle weakness, and fatigability. Spasticity is a common but not inevitable 
consequence of an upper motor neuron syndrome and is associated with damage to the 
corticospinal at the level of the cortex or internal capsule, and the reticulospinal and 
vestibulospinal tracts at the level of the spinal cord.  Currently, there is no set definition 
of spasticity in the literature. The most commonly used definition of spasticity is by 
Lance (1980): ‘spasticity is a motor disorder characterized by a velocity dependent 
increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting 
from hyper-excitability of the stretch reflexes, as one component of the upper 
motorneuron syndrome’31. However, the velocity dependence of a muscle to stretch is 
dependent on both muscle activity and the visco-elastic properties of the 
musculotendinous unit. Therefore, a review by Pandyan et al 2005 has suggested a new 
definition of spasticity: ‘disordered sensori-motor control, resulting from an upper 
motor neurone lesion, presenting as intermittent or sustained activation of muscles’32. 
 
Damage to the developing corticospinal tract may lead to spasticity. During normal 
corticospinal tract development the sensory neural pathways to the spinal cord are 
reduced and the effect of efferent motor neural pathways are strengthened. Damage to 
the developing corticospinal tract may alter the development of the intrinsic spinal 
networks, altering the excitatory and inhibitory connections between the upper motor 
neurons, interneurons, lower motor neurons and sensory neurons. This potential mal-
refinement of afferent connections and reduced development of inhibitory interneurons 
may explain the clinical findings of spasticity in this group. Furthermore, damage to the 
corticospinal tract may lead to abnormal development of the spinal reflexes including 
muscle stretch reflexes and flexion withdrawal, leading to persistence of a low threshold 
response and persistence of excitatory connections to antagonist muscle groups. 
Therefore, any structural changes to the spinal cord white matter following PVL may 
relate to the degree of spasticity in cerebral palsy. 
1.5	  	   Summary	  
Cerebral palsy is caused by an injury to the brain during the pre-natal or peri-natal 
periods, with PVL the most common brain injury in bilateral spastic cerebral palsy. 
Children with bilateral spastic cerebral palsy often present with reduced voluntary 
Introduction	  	  
J.J.	  Noble	   Musculoskeletal	  and	  spinal	  cord	  imaging	   29	  
selective motor control and muscle spasticity due to damage to the corticospinal tract 
and the vestibulospinal and reticulospinal tracts of the upper motor neurons. The 
corticospinal tract plays an important role in spinal cord development and the 
development of motor control. PVL tends to occur between 24 and 33 PCW, before the 
transient spinal terminations of the corticospinal tract in the spinal cord grey matter 
have been eliminated and mature projections onto the cells of the spinal grey matter 
have formed. As a result of the injury, intrinsic cord networks may not mature and 
muscle development may be delayed30. Spinal cord and subsequent muscle development 
is likely to be affected by the extent, severity and timing of the original brain injury. 
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2. Muscle	  and	  Bone	  
 
The upper and lower motor neurons enable the control of human movement, however, it 
is the musculoskeletal system that executes the movement. As discussed in Chapter 1, 
the motor neurones conduct ionic signals from the brain to the muscles to cause a 
muscular contraction. It is through contraction and relaxation of the muscles that the 
body can manipulate the relative positioning of the skeleton to produce a movement. 
Pathology of the motor neurone system can lead to mal-development of the 
musculoskeletal system. This chapter discusses healthy bone, muscle micro- and 
macrostructure, and muscle metabolism before introducing musculoskeletal impairment 
in cerebral palsy, including muscle structure, weakness, volume, and composition. 
2.1	  	   Skeletal	  muscle	  microstructure	  
Skeletal, cardiac and smooth muscles are the three types of muscle in the human body. 
The focus of this programme of work is on skeletal muscle, which is attached to bone 
and enables the body to move. A schematic representation of skeletal muscle structure 
is shown in Figure 2.1. Each skeletal muscle is a separate organ comprised of thousands 
of elongated cylindrical cells known as muscle fibres, which run parallel to each other. 
Skeletal muscle fibres are highly specialised cells that produce force and movement. 
Muscle fibres are cylindrical with a diameter of 10-100 µm but are of varying length 
depending on the muscle’s architecture and the number of fibres in series (see section 
2.2). A collagen mesh structure, the endomysium, surrounds the muscle fibres. This 
connective tissue structure supports the muscle fibres and may play a central role in 
transmission of tension between the muscle fibres and tendon and may influence the 
passive mechanical properties of the fibres33.  
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Figure 2.1 Skeletal muscle structure 
 
Each fibre is surrounded by a plasma membrane (sarcolemma). The muscle fibre’s 
cytoplasm (sarcoplasm) contains many mitochondria to enable production of large 
quantities of adenosine triphosphate (ATP) during a muscle contraction (muscle 
metabolism is described in section 2.3). The sarcoplasmic reticulum is a fluid filled 
membrane that extends throughout the sarcoplasm, which stores calcium ions required 
for muscle contractions. Transverse tubules (T-tubules) tunnel in from the surface to the 
centre of each muscle fibre along which muscle fibre action potentials travel. Along the 
entire length of each muscle fibre there is a cylindrical structure known as a myofibril. 
Each myofibril is composed of two types of protein filaments: thin filaments and thick 
filaments. The thin and thick filaments overlap in specific patterns to form 
compartments called sarcomeres, with sarcomeres separated by dense proteinous layers 
called Z discs.  
 
Thick filaments contain the protein myosin, within myosin tails that are arranged 
parallel to each other with the myosin heads projecting outward from the filament 
surface. Thin filaments are primarily formed of the protein actin and are anchored to the 
Z discs. Each individual actin molecule contains a myosin-binding site that enables the 
myosin heads of the thick filaments to attach. However, thin filaments also contain 
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tropomyosin and troponin. Tropomyosin, in a relaxed muscle, blocks the myosin 
binding sites on the actin preventing binding occurring between the thin and thick 
filaments. Troponin holds the tropomyosin molecules in place. It is through 
manipulation of the interactions between thin and thick filaments that muscle 
contractions can occur through the ‘sliding filament contraction mechanism’ as 
summarised below. 
1. Muscle action potential travels along transverse tubules opening Ca2+ channels 
in the sarcoplasmic reticulum membrane. 
2. Ca2+ flows into the sarcoplasm down its concentration gradient. 
3. Ca2+ binds to troponin on the thin filaments exposing the myosin binding sites. 
4. The actin-myosin bridge rapidly dissociates due to binding with ATP. 
5. The free myosin bridge moves into position to attach to actin, during which ATP 
is hydrolyzed. 
6. The free myosin bridge and its hydrolyzed products rebind to the actin filament. 
7. The-cross bridge generates force and actin replaces the reaction products (ADP 
and Pi) from the myosin cross-bridge ready for further ATP binding in step 4. 
8. Ca2+ channels in sarcoplasmic reticulum close and Ca2+ active transport pumps 
use ATP to restore low Ca2+ concentration in the sarcoplasmic reticulum. 
9. Troponin-tropomyosin complex slides back over actin binding sites blocking the 
myosin of the thick filaments. 
10. Muscle relaxes until another muscle action potential arrives. 
2.2	  	   Muscle	  macrostructure	  
2.2.1	  	  Muscle	  fibre	  types	  
In addition to the muscle microstructure discussed above, there are different fibre types 
with different morphological, contractile, and metabolic properties. Classically, muscle 
fibres are categorised into one of three types; Type 1 (SO), Type 2a (FOG), or Type 2b 
(FG). The morphological, contractile, and metabolic properties for each category is 
summarised in Table 2.1. Each fibre type is present in varying proportions within the 
different muscles in the body. However, this classification system is a simplification of 
the diverse variability between muscle fibres, with a spectrum of possible 
morphological, contractile, and metabolic properties. 
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2.2.2	  	  Skeletal	  Muscle	  Architecture 
Muscle fibre architecture is the arrangement of muscle fibres with respect to the force 
generation axis. Muscles have adopted different fibre alignments dependent on their 
function in the body. The maximum contraction force generated by a muscle is 
dependent on the muscle architecture. Muscle fibre architectures are broadly categorised 
into three categories. Muscles with fibres that extend parallel to the muscle force-
generating axis and extend along most of the muscle length have a parallel or 
longitudinal architecture. Muscles with fibres orientated over a narrow range of angles 
relative to the force-generating axis (the pennation angle) are termed to have uni-
pennate architecture. Muscles with fibres orientated at several pennation angles are 
termed to have a multi-pennate architecture. As well as pennation angle, muscle force is 
also dependent on muscle fibre length, fibre diameter, sarcomere length and muscle 
mass. The measurement of architectural parameters enables the calculation of the 
physiological cross sectional area (PCSA), which is directly proportional to the 
maximum force, generated by the muscle (Equation 2.1). Equation 2.1 can be further 
simplified since muscle volume (cm3) is equivalent to muscle mass divided by density 
(Equation 2.2). 
 
  Equation 2.1 
  Equation 2.2 
   
Where M = Muscle mass, θ = Pennation angle, L = fibre length,  
ρ = muscle density, V = Muscle volume 
 
Type 1 
Slow oxidative (SO) 
• Small in diameter. Contract slowest of the fibre types 
• Large amounts of myoglobin and mitochondria enabling 
ATP generation through aerobic respiration. 




• Contain large amounts of myoglobin 
• Generate ATP through aerobic respiration and glycolysis 
• Moderately high resistance to fatigue and are faster than 
SO fibres 
Type 2b 
Fast glycolytic (FG) 
• Largest in diameter. Generate the most powerful and 
fastest contractions 
• Low myoglobin and mitochondria content 
• Generate ATP predominately through glycolysis: fatigue 
quickly 
Table 2.1 The three muscle fibre types and their properties34 
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2.3	  	   Skeletal	  muscle	  development	  
Skeletal muscle development can be subdivided into four simultaneous processes: 
axonal outgrowth; myogenesis; synaptogenesis; and synapse elimination. In this section 
a brief overview of the four processes of muscle development are outlined, however, the 
detailed mechanisms within each process are not discussed. 
 
Axonal outgrowth is the process by which axons traverse from the ventral root of the 
spinal cord to the muscles. There is an approximate correspondence between the 
location of ventral root of the spinal cord with the muscles they innervate, for example 
the nerve root of biceps brachii is at the C5-C6 spinal level and the nerve root of the 
soleus is L5, S1-S2, however, this is variable between individuals. 
 
Myogenesis is the formation of muscle fibres. This process begins in the embryo where 
somites, the masses of tissue arranged in regular intervals along an embryos length, are 
differentiated and are destined to become skeletal muscle stem cells (myoblasts). This 
process of determination is controlled by two proteins, myoD and myf533. Myoblasts 
are the precursors of muscle fibers, whose development through differentiation and 
maturation is controlled by myogenic regulatory factors (mrf4 and myogenin)33. These 
regulatory factors cause the myoblasts to cluster and fuse forming multi-nucleated cells 
called myotubes that are 0.1 – 0.3 mm in length33. Myoblasts continue to fuse onto the 
ends of the myotubes enabling the myotubes to increase in length. These early 
myotubes are called primary myotubes. Primary myotubes and some less differentiated 
cells separate from the other primary myotubes to form clusters that are surrounded by a 
sheath – the basal lamina. Myoblasts then begin to cluster and aggregate beneath the 
basal lamina of the primary myotubes to form a secondary myotube. Unfused myoblasts 
also remain present beneath the basal lamina and are known as satellite cells. The 
primary and secondary myotubes contained within a single membrane then further 
differentiate towards becoming muscle fibres and become filled with contractile 
proteins. 
 
Synaptogenesis is the formation of the neuromuscular junction. As the muscle fibres 
develop acetylcholine (ACh) receptor proteins are integrated into the muscle membrane, 
the sarcolemma. As the outgrowing nerve from the spinal cord contacts the muscle 
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fibre, ACh receptors cluster around the site of the nerve, increasing the number of ACh 
receptors at the nerve junction and decreasing the number of ACh receptors elsewhere 
in the muscle. Once the ACh receptors are localised, the muscle fibre nuclei near the 
neuromuscular junction express the genes responsible for normal neuromuscular 
junction function. Once a neuromuscular junction has formed with a muscle fibre, due 
to neuromuscular junction activity it can no longer make new neuromuscular 
connections limiting the number of neuromuscular junctions on each muscle fibre to 
one33. However, once one neuromuscular junction has formed multiple other motor 
neurons may form a connection with the fibre through this neuromuscular junction. The 
number of motor neuron connections at the synapse is then subsequently reduced 
(synapse elimination) through inter-synaptic competition and synaptic withdrawal. In 
the maturing motor system, the number of motor neurons connecting to neuromuscular 
junction on a muscle fibre is reduced so that each muscle fibre is connected to only one 
motor neuron. 
2.4	  	   Muscle	  metabolism	  
Muscle cells, like all cells in the body, require energy to maintain cellular processes. 
However, muscle cells also additionally require energy to produce movement and force 
generation. Adenosine triphosphate (ATP) is the cellular energy molecule: a large 
amount of chemical energy is stored within each ATP molecule, which can then be 
transported around the cell to provide energy for example for muscle contraction, ion 
transport, and protein synthesis. The energy is acquired from ATP molecules by 
splitting it into adenosine diphosphate (ADP), an inorganic phosphate (Pi) (Equation 
2.3). 
 
 ATP ⟺ ADP + Pi + Energy Equation 2.3 
 Where ATP = Adenosine triphosphate, ADP= Adenosine diphosphate,  
Pi = inorganic phosphate  
 
ATP in muscle is primarily used in the contraction process (see section 2.1), where ATP 
enables the detaching of the myosin cross-bridges from the actin filaments, and to 
provide energy for metabolic pumps. The sodium-potassium pump (Na+-K+) maintains 
a resting potential difference across the muscle fibre membrane, and the calcium (Ca2+) 
pump returns Ca2+ to the sarcoplasmic reticulum after muscle activation. Energy is 
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generated within the muscle fibres through glucose and lipid oxidation, and stored in 
phosphocreatine, glycogen and lipid droplets within the sarcoplasm of the muscle 
fibres. 
2.4.1	  	  Phosphocreatine	  energy	  reserve	  
To enable muscle fibre activity to be sustained, a renewable supply of ATP is required. 
This is achieved in the short term through energy stores within the muscle fibres in the 
form of phosphocreatine (PCr). As ATP is expended, the enzyme creatine kinase 
replenishes ATP stores from PCr: 
 
 PCr + ADP ⟺ ATP + Cr Equation 2.4 
 Where Cr = Creatine 
 
However, PCr stores are not unlimited and become exhausted after 5-8 seconds of 
maximal contractions. For muscle activity to continue, the muscle fibres become reliant 
on glucose and lipid oxidation. The PCr stores are then replenished once the activity has 
been completed. 
2.4.2	  	  Glucose	  oxidation	  
Glycolysis is the breakdown of glucose into pyruvate producing a net gain of 2 ATP 
molecules. A simplified chemical reaction is shown in Equation 2.4. Additional 
intermediary molecules are produced between the start and end molecules that are not 
shown in Equation 3.4. This chemical reaction takes place in the muscle fibre cytosol 
and is anaerobic. 
 
 Glucose + 2ADP + 2Pi  ⇨ 2Pyruvate + 2ATP Equation 2.4 
 
Once glucose has been broken down to produce pyruvate (pyruvic acid), there are two 
different pathways for further oxidation depending on the availability of oxygen. In 
anaerobic conditions, for example during sustained strong contractions when the 
pressure inside the muscle becomes greater than the systolic blood pressure limiting 
oxygen perfusion into the muscle, pyruvate is oxidised to lactate (lactic acid) by 
nicotinamide adenine dinucleotide coenzyme (Equation 2.5). The anaerobic pathway 
results in a build up of lactate within the muscle. Since lactate is an acid molecule it 
alters the intracellular pH, which in turn alters subsequent cellular contraction and 
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metabolic activity. Furthermore, once the muscle activity intensity reduces, energy is 
required to transport the lactate in the blood to be further metabolised in the liver. 
Glycolysis is an inefficient process that does not produce enough energy to sustain 
muscle contractions in purely anaerobic conditions for much longer than 10-30 seconds. 
 
 Pyruvate + NADH ⇨ Lactate + NAD+ Equation 2.5 
 
The second pathway requires oxygen and is the preferential pathway for energy 
production as this pathway produces more ATP. When oxygen is present, pyruvate is 
rapidly taken up into the mitochondria to be oxidised to carbon dioxide and water 
(Equation 2.6). This pathway produces 15 ATP molecules for each pyruvate molecule 
oxidised, totalling 30 ATP for each glucose molecule initially broken down by 
glycolysis and is, therefore, the most efficient method for cells to manufacture ATP 
molecules from glucose. 
 
The oxidation of pyruvate begins with decarboxylation and combination with coenzyme 
A (CoA) to create acetyl CoA. Acetyl CoA then combines with oxaloacetic acid to 
make citric acid. Through a further series of reactions, two carbon atoms within the 
citric acid molecule are oxidised and removed to produce CO2, resulting in the eventual 
formation of oxaloacetic acid again. Therefore, the metabolism of axaloacetate forms a 
cycle known as the citric acid cycle (or Krebs cycle). Once Pyruvate has been combined 
with CoA to produce acetyl CoA, the energy is harnessed into ATP in two ways. One 
way is the creation of a high-energy phosphate bond within guanosine triphosphate 
(GTP), which in turn donates its phosphate to ADP forming ATP. The second way is 
the predominant producer of energy in the citric cycle, the electron transfer chain. 
Electrons are first received by the hydrogen receptor molecules, nicotinamide adenine 
dinuclide (NAD) and flavin adenine dinuclide (FAD) and are then passed to 
cytochromes on the inner mitochondrial membrane. As the electrons are passed along 
the cytochromes of the electron transfer chain, the electrons drop down their energy 
levels, with the released energy used to transport protons across the inner mitochondrial 
membrane against their concentration gradient. The energy generated by this proton 
gradient is sufficient to drive ATP synthesis, coupling oxidation to phosphorylation. 
The protons then diffuse back across the inner mitochondrial membrane through ATP 
 Pyruvate + 15ADP +15Pi  +4O2  ⇨ 3CO2 + H2O +15ATP Equation 2.6 
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synthase channels into the mitochondrial matrix. Figure 2.2 schematically shows the 






















Figure 2.2 Citric acid cycle. The orange circles represent the number of carbon molecules in each 
intermediate molecule. The carbon atoms are removed as CO2 and NAD+ and FAD (two carrier 
molecules in the electron transfer chain) take up the H atoms 
	  
2.4.3	  	  Glycogen	  degradation	  and	  synthesis	  
Muscle fibres can oxidise glucose directly from the blood stream, however, during 
muscle contractions the majority of the glucose oxidised to produce ATP is provided by 
the hydrolysis of glycogen stored in the muscle fibre sarcoplasm. Glycogen is 
synthesised by the enzyme glycogen synthase, which links thousands of glucose 
molecules together to form glycogen. The glycogen molecules are then broken down by 
the enzyme glycogen phosphorylase.  
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However, this is the final stage of the reactions that enable glycogen hydrolysis to 
occur. First, epinephrine (adrenaline) in the blood stream, released in response to stress, 
binds with G protein receptors on the muscle fibre sarcoplasm activating the membrane 
enzyme adenyll cyclise. This enzyme then produces a secondary messenger molecule, 
cyclic adenosine monophosphate (cAMP), which activates the enzyme protein kinase. 
Once activated, protein kinase activates the enzyme glycogen phosphorylase through 
phosphorylation, which can in turn then break down glycogen to produce glucose. 
Therefore, the amount of glucose available to the muscle fibre to produce ATP is 
controlled by epinephrine. 
2.4.4	  	  Lipid	  oxidation	  
As well as glucose, lipids (fatty acids) provide another source of energy to the muscle 
cells. Lipid metabolism is used to supply the energy for resting muscles and during 
exercise, particularly during low intensity exercise. However, during prolonged exercise 
such as long distance running, all the muscle glycogen stores are depleted and continued 
exercise is predominantly dependent on lipid metabolism35. The most abundant dietary 
lipids are triglycerides, which are composed of a glycerol backbone, to which three fatty 
acids are esterified. Triglycerides are also the form of lipid stored in lipid droplets 
within a cell’s sarcoplasm. 
 
The first step in lipid metabolism is the breakdown of the triglyceride lipid molecules 
into a glycerol and three fatty acid molecules. Fatty acid molecules vary in length. Short 
and medium chain fatty acids pass directly through the inner mitochondrial membrane 
into the inner matrix space of the mitochondria. Long chain fatty acids, for example 
palmitic acid (16 carbon atoms) and stearic acid (18 carbon atoms), require 
transportation into the mitochondria. At the outer mitochondrial membrane, long chain 
fatty acids are first activated by esterification with CoA and ATP to acyl-CoA by acyl-
CoA synthetase enzymes in two steps: first, the fatty acid molecule replaces the 
diphosphate group in ATP; second, CoA replaces the adenosine monophosphate (AMP) 
group in ATP to form acyl-CoA (Equation 2.7). Different acyl-CoA synthetase enzymes 
are present in the mitochondrial outer membrane for fatty acids of different lengths.  
 
                     Fatty acid + ATP + CoA ⇨ acylCoA +AMP + 2Pi Equation 2.7 
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No transport system is present for acyl-CoA to transport it into the inner mitochondrial 
matrix. Therefore, acyl-CoA enters the mitochondria via a shuttle system facilitated by 
the ammonium compound carnatine, which is biosynthesised from the amino acids 
lysine and methionine. The enzyme carnatine palmityl transferase I converts acyl-CoA 
to acetyl-carnatine at the outer surface of the inner mitochondrial membrane. Acetyl-
carnatine is then transported into the mitochondrial matrix by the enzyme acetyl-
carnatine translocase in exchange for carnatine molecules from the inner matrix space. 
 
Once in the mitochondrial matrix, acetyl-carnatine is converted back to acyl-CoA by the 
enzyme carnatine palmityl transferase II. The short and medium chain fatty acids are 
converted directly into acyl-CoA within the mitochondrial matrix by acyl-CoA 
synthetase enzymes, in the same process that takes place for the long chain fatty acids at 
the mitochondrial outer membrane (Equation 2.7).  The transfer of fatty acids into the 
mitochondria is summarised in Figure 2.3. Next, all acyl-CoA molecules are oxidatively 
phosphorylated in the β-oxidation pathway to produce acetyl-CoA: 1) Activation of 
acyl-CoA by ATP. 2) Oxidation by FAD. 3) Hydration (adding of a hydroxyl group and 
a hydrogen cation to the carbon-carbon double bond). 4) Oxidation by nicotinamide 
adenine dinucleotide (NAD+). 5) Thiolysis (splitting one molecule in two with an 
organic sulphur compound) to produce acetyl-CoA. 
 	  	  	  	  	  	  	  Palmitic	  acid	  +	  Acetyl	  CoA	  +	  7O2	  ⇨ 7CO2	  +	  4H2O	  +	  129ATP Equation 2.7 
 
Once the acyl-CoA molecules have been converted into acetyl-CoA, acetyl-CoA then 
enters the citric acid cycle and is oxidised to CO2 and H2O producing ATP (Figure 2.5). 
This is the same process that pyruvate enters in the aerobic glucose metabolism 
pathway. Equation 3.8 shows the overall reaction and ATP production for an example 
fatty acid palmitic acid, which has 16 carbon atoms. The transfer of fatty acids into the 
mitochondrial matrix is shown in Figure 2.4. A summary of the oxidative reactions in 
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Figure 2.3 Transfer of fatty acids into the mitochondrial matrix. ACS = Acyl-CoA synthase; Carn = 























Figure 2.4 Summary of the oxidative reactions in the mitochondria that produce energy in the 
form of ATP molecules by converting pyruvate and fatty acids to CO2 and H20 
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2.4.5	  	  Insulin,	  glucagon	  and	  skeletal	  muscle	  metabolism	  
Insulin and glucagon are peptide hormones produced by the beta and alpha cells in the 
pancreas respectively. Insulin and glucagon regulate blood glucose levels. Glucagon 
causes the liver to convert stored glycogen into glucose, which is released into the blood 
stream. Insulin reduces blood glucose levels by causing the uptake of glucose from 
blood in the liver, skeletal muscles, and adipocytes (fat cells) and causes the transition 
from lipid metabolism to glucose metabolism. Skeletal muscle is the most abundant 
insulin-sensitive tissue, 40-50% by body mass, is responsible for approximately 20-30% 
of resting oxygen consumption, and is responsible for 75-95% of all insulin mediated 
glucose disposal36-38. Therefore, skeletal muscle is not only responsible for force 
generation and movement facilitation, but also plays a significant role in metabolic 
health. 
 
Humans, and mammals in general, have the ability to switch metabolism between 
carbohydrates in times of abundance (decreased insulin) and lipids in times of calorific 
scarcity (decreased insulin), as the primary energy source is termed metabolic 
flexibility39,40. Insulin can also enhance lipid and glucose metabolism in periods of high 
metabolic demand due to exercise. The skeletal muscle insulin signalling pathways is 
summarised below. 
 
Insulin binds with α-subunits of insulin receptors on the sarcolemma. This causes 
increased intracellular β-subunit tyrosine kinase activity, which in turn causes 
autophosphorylation and phosphorylation of the insulin receptors and insulin receptor 
substrates (IRS-1, IRS-2), respectively. Tyrosine phosphorylation of IRS-1 and its 
association to the p85 regulatory subunit of phosphatidylinositol-3-kinase (PI3K) 
activates the p110 catalytic subunit, which increases phosphoinositides such as 
phosphatidylinositol 3,4,5-trisphosphate. This leads to the activation of 
phosphoinositide-dependent protein kinase (PDK) and downstream protein kinase B 
(Akt) and/or atypical protein kinase C (PKC). Phosphorylation of Akt substrate 160 
(AS160), which has a guanosine-5’-triphosphate (GTP)ase-activating domain (Rab4), 
allows translocation of an insulin sensitive glucose transporter (GLUT4) to the 
sarcolemma to facilitate glucose entry into the cell. Intracellular glucose is then rapidly 
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phosphorylated by hexokinase and directed to oxidative or non-oxidative (glycogen 
synthesis) pathways41. 
 
As well as the insulin signalling pathway summarised above, which increases glucose 
metabolism, insulin also suppresses fatty acid oxidation in skeletal muscle42. This 
mechanism is not as well understood. However, one possible mechanism is that at high 
physiological insulin concentrations there is a decrease in lipoprotein lipase and 
increased malonyl CoA levels43. 
2.4.6	  	  Intramuscular	  fat	  and	  muscle	  metabolism	  
There is a strong relationship between intramuscular fat content, insulin resistance and 
type-II diabetes44-46, with raised intramuscular fat levels potentially providing a marker 
of impaired mitochondrial content and/or function41. Within skeletal muscle, fat is 
stored in two separate compartments: Intramyocellular lipid (IMCL) and 
extramyocellular lipid (EMCL). EMCL is found within adipose cells adjacent to the 
muscle fibres, and IMCL is located within the muscle fibres along with enzymes 
involved in fatty acid esterification, hydrolysis, and transport into the mitochondria47. 
Enhanced storage of IMCL occurs due to the combined effects of high concentration of 
serum insulin and free fatty acids48.  In particular, greater IMCL in the soleus correlates 
with glucose-insulin-lipid metabolism and insulin sensitivity49-52, with soleus IMCL 
content being the only differentiating feature in a study of lean insulin-resistant subjects 
and their TD peers matched for BMI, body fat distribution, percentage body fat and 
physical fitness52.  
 
Adults with cerebral palsy have a life expectancy close to that of the general 
population8,10,11, with life expectancy related to the severity of condition10-12. The most 
common cause of death in older adults with cerebral palsy are diseases of the 
circulatory system11. These individuals may have a two to three times greater risk of 
dying from ischemic heart disease than their typically developing peers13. Further to the 
shorter life expectancy, individuals with cerebral palsy tend to show a decline in their 
functional ability with increasing age7, culminating in the early loss of mobility7,8. 
Weakness is a prevalent feature of individuals with cerebral palsy53-55. Weakness may 
be manifest in changes to intrinsic properties of the muscle itself, for example reduced 
muscle volume53,56-61, reduced non-contractile myofibrillar tissue, an inability to 
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optimally control the available muscle resources, for example reduced selective 
activation and co-activation of antagonist muscle groups.  Raised intramuscular fat 
corresponds to reduced contractile tissue content, resulting in a weaker muscle than 
predicted from muscle mass alone. Furthermore, inflammatory cytokines produced by 
intramuscular fat may interfere with the action of myofibrillar proteins reducing specific 
force production62. These secondary pathologies may contribute to a deficit in the 
“functional reserve” of adults with BSCP, and may expose these individuals to a 
heightened risk of immobility with increasing age60. 
 
Decreased physical activity is associated with increased intermuscular fat63-66. 
Intramuscular fat has also previously been correlated with deficits in central muscle 
activation67, increased risk of future mobility loss68,69, and insulin resistance70 in the 
elderly population. Considering the typically sedentary behaviour observed in cerebral 
palsy71,72 and similarities between muscles in the elderly and in cerebral palsy, including 
reduced muscle volume73, increased stiffness74 and reduced voluntary muscle 
activation75, individuals with cerebral palsy may have raised levels of intra- and 
intermuscular fat. However, it is important to note that the comparison of muscle in 
cerebral palsy with the elderly is limited due to the aetiology of the two groups. Muscle 
properties in the elderly are related to a degradation of muscle function with age, which 
is of different aetiology to muscle in cerebral palsy, which is abnormal as a result of 
altered muscle development including myogenesis and hypertrophy in this group. There 
are limited studies in the literature that have investigated body or muscle composition in 
this group. Since individuals with cerebral palsy have reduced muscle mass, even those 
with body mass index (BMI) in the normal range may have relatively increased levels 
of adipose tissue. Previous studies in children with cerebral palsy have suggested raised 
levels of fat76,77. In an MRI study of the lower limbs in children with quadriplegic 
cerebral palsy (GMFCS levels III-V), Johnson et al76 found increased levels of 
intermuscular and subcutaneous fat76.  To date, there have been no studies of 
intramuscular fat in adults or children with cerebral palsy. Therefore, a study 
investigating intramuscular fat in adults with cerebral palsy is required due to the multi 
factorial implications intramuscular fat may have on an individuals life, including: 
cardio-metabolic disease risk, muscle weakness, and the decline in mobility with 
increasing age reported in this group.  
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2.5	  	   Bone	  
The skeletal system provides several functions including support, protection, enabling 
movements, mineral homeostasis, blood cell production and triglyceride storage. The 
main focus of this programme of work is on the effect of cerebral palsy on an 
individual’s mobility, therefore, only aspects of bone morphology will be discussed. 
Bones are broadly classified into four categories based on their shape, long (e.g. femur), 
short (e.g. wrist and ankle bones), flat (e.g. scapulae, sternum), and irregular bones 
which do not fit into the other three categories. In this thesis, it is the long bones that are 
of primary interest as they form the main segments of the limbs on to which the muscles 
act to produce movement. The typical macroscopic structure of a long bone is shown in 














Figure 2.5 Schematic diagram of long bone structure 
 
The metaphyses are the regions in a mature bone where the diaphysis joins the 
epiphysis. However, in a growing bone each metaphyses contains an epiphyseal plate, a 
layer of hyaline cartilage that allows the diaphysis of the bone to grow in length through 
ossification. Articular cartilage is a thin layer of hyaline cartilage covering the parts of 
the epiphyses where the bone forms a joint with another bone. The role of articular 
cartilage is to reduce friction and absorb shock at freely moveable joints. Where the 
bone surface is not covered by articular cartilage it is covered by the periosteum. This is 
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a tough sheath of irregular connective tissue containing bone forming cells that enable 
bone to grow in diameter but not in length.  
2.5.1	  	  Bone	  development	  
Bone initially begins as a soft tissue model made from aggregated mesenchymal cells, 
to produce a hyaline cartilage model by bone78. The process of replacing this cartilage 
with bone is called osteogenesis. Osteogensis starts at the centre of the cartilage model, 
at an ossification centre during embryonic development in utero. The majority of bones 
have multiple ossification centres, the first ossification centre, or primary ossification 
centre, appears in late embryonic to early foetal life (7-16 weeks post-conception15) 
from which the bone diaphysis is formed. Secondary ossification sites form at birth at 
the ends of the long bones and at the extremities of flat bones where cartilaginous 
epiphyses ossify. Osteogenesis has a different mechanism depending on bone type: 
intramembranous (flat bones) and endochondral bones (long bones). The	   process	   of	  endochondral	   ossification	   can	   be	   divided	   into	   seven	   stages	   summarised	   below.	  Hyaline	  cartilage	  is	  left	  on	  the	  ends	  of	  the	  bones	  to	  form	  articular	  cartilage, and the 
epiphyseal plates (growth plates) are also formed to enable later increases in bone 
length. A brief overview of endochondral bone development is outlined below and in 
Figure 2.6. 
 
1. Periosteum formation: A hyaline cartilage model of the bone grows by a 
continuous division of chondrocytes accompanied by the secretion of an 
extracellular matrix, forming a layer of dense irregular connective tissue and 
undifferentiated stem cells (osteogenic cells) that surrounds the cartilage. The 
osteogenic cells then differentiate into osteoblasts. 
2. Bone collar formation: The osteoblasts secrete osteoid, a gelatinous substance 
consisting of collagen and mucopolysaccharide), onto the outside of the 
periosteum, resulting in the formation of a bony collar on the outside of the 
cartilage. 
3. Calcification of the matrix: Chondrocytes in the primary centre of ossification 
undergo hypertrophy and begin to secrete alkaline phosphatase instead of 
collagen. This enzyme removes the phosphate group from compounds enabling 
their calcification. 
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4. Cavity formation: The calcification of the primary centre makes the inner 
cartilage impermeable to the diffusion of nutrients. As a result the inner cartilage 
starts to deteriorate and cavities begin to form. 
5. Vascular invasion: The vessels that are within the periosteum will pass through 
the lamellar (compact bone) bony collar and invade the inner cavity of the 
cartilage model.  The remaining cartilage is broken down by osteoclasts and the 
osteoblasts secrete their osteoid forming trabaculae (spongy bone). 
6. Elongation: As blood vessels, osteoclasts, and osteocytes continue to invade the 
bone, endochondral ossification spreads outwards along the bone diaphysis 
causing the bone to elongate. At this time, blood vessels also invade the hyaline 
cartilage at the ends (the epiphyses) of the long bones forming secondary 
ossification centres. 
7. Epiphyseal ossification: This is similar to step 3, except instead of forming 















Figure 2.6 Summary of endochondral bone development 
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Increases in bone length occur at the epiphyseal plate where hyaline cartilage expansion 
and ossification continues until skeletal maturity when fusion of the diaphysis and 
epiphysis occurs.  In order for bones to increase in a width a new layer of compact bone 
is deposited into the outside of the bone. The peripheral edge of bone is lined by the 
periosteum in which osteoblasts secrete osteoid and become trapped in their secreted 
matrix directly beneath the periosteum, forming osteocytes. The bone cavity then 
increases in diameter through bone resorption by osteoclasts. This process is known as 
bone modelling: during growth, the skeleton is sculpted to achieve the desired shape 
and size by the removal of bone from one site by osteoclasts and deposition at a 
different site by osteoblasts. Once the skeleton has reached maturity, this process 
continues in the form of a periodic replacement of old bone with new at the same 
location, a process known as bone remodelling79. Bone remodelling enables micro-
fractures to be repaired and calcium homeostasis.   
2.5.2	  	  Bone	  strength	  
Bone strength is dependent on the ultimate strength of bone tissue, the spatial 
distribution of bone tissue (density, geometry), and the ability for bones to repair micro-
damage. Mechanical forces are a significant factor affecting bone strength and 
development. During growth, longitudinal growth increases lever arms and bending 
moments leading to greater forces experienced by the bone80. Greater muscle force also 
applies mechanical forces to the bones during muscle contraction. Body weight alone 
puts relatively small loads on bones, but the effect of weight is amplified by muscle 
action81, with bending and torsional forces being the predominant loading factors in 
long bone diaphysis82,83. There are two possible physiological adaptation processes 
influencing the relationship between bone and muscle strength; individual and 
evolutionary84. The evolutionary adaptation is evident from genetic factors influencing 
bone and muscle mass85. Bone strength is closely related to an individual’s height, as 
the bending forces experiences by the bones will increase with increasing length. The 
mechanism by which an individual increases bone strength to muscle strength mediated 
by strain is termed the Mechanostat Theory86,87. In this theory, the muscle-bone 
relationship, expressed as the “bone-muscle unit,” is modelled as a mechanical 
relationship modulated by the hormonal system.  
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Bone strength is determined predominantly by bone geometry and bone density,. The 
ability of a bone to resist torsional and bending forces (the polar section modulus, Zp) is 
inversely proportional to bone length to the third power and directly related to bone 
diameter to the third power88. Assuming a cylindrical bone shape, with circular cross-
section, the polar moment of inertia (J) is calculated using Equation 2.1289. The polar 
section modulus (Zp), which is a measure of torsional and bending strength, is 
calculated using Equation 2.1390.	  The stability of long bones to compressional forces 
can be estimated by the buckling ratio (BR), which is a ratio of the bone radius (r) to 
cortical bone thickness (t) given by Equation 2.14, with compressional bone strength 
related to the cortical-bone CSA. 
 
 Equation	  2.12 
 Equation	  2.13 
 Equation	  2.14 
                                                Where  T  = Anterior-posterior periosteal diameter 
M = Anterior-posterior medullary diameter 
R  = Bone radius 
T  = Cortical bone thickness 
In typically developing children, before puberty, overall bone strength is determined 
primarily by muscle area91. Following puberty, lower limb bone strength appears to be 
determined by a combination of weight- bearing and lean body mass91. With age, bone 
mass decreases: bending strength is maintained by a gradual increase in bone diameter 
by periosteal addition of bone, and endosteal resorption leading to a wider bone but a 
thinner cortex. This maintains bending strength but reduces the ability of the bone to 
cope with compressive loads. There is evidence in the literature that typically 
developing adult subjects have a limited potential to increase their bone mass84,92,93. 
However, immature bone in children and adolescents can increase their bone strength in 
response to increased loading93-95. 
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2.6	  	   Musculoskeletal	  impairment	  in	  cerebral	  Palsy	  
Individuals with cerebral palsy have musculoskeletal impairments. The most common 
impairments are muscle contractures72,73, muscle weakness53-55,96, altered muscle 
composition97-99, spasticity, poor selective motor control100-104, incomplete activation of 
the motor pool53,105,106,  and bony deformities.   
2.6.1	  	  Muscle	  contracture	  
Muscle contractures occur when the musculo-tendinous unit (MTU) becomes short 
relative to the adjacent long bone resulting in restricted range of movement at a joint. 
Although this is widely reported in the literature107,108, the causal mechanism of muscle 
contractures is not known. Altered muscle tissue stiffness109 and decreased muscle fibre 
length have previously been suggested as possible causes of contractures, however, this 
has not been established in the literature59,110-113. 
2.6.2	  	  Muscle	  weakness	  and	  reduced	  muscle	  volume	  
It is well known that individuals with cerebral palsy present with muscle morphological 
and structural differences compared to their typically developing peers. In cerebral 
palsy muscle strength is consistently reduced53-55,96, contributing to the overall 
functional deficit in this group60,114,115. This reduction in muscle strength has previously 
been attributed to an inability to optimally control the available muscle resources, for 
example reduced selective activation and co-activation of antagonist muscle groups105.  
However, these factors do not entirely explain the reduced muscle strength observed. 
Stackhouse et al.105 compared maximum voluntary and augmented voluntary activation 
(using electrical stimulation) contraction forces of individuals with cerebral palsy and 
their typically developing peers. The study found that the comparatively reduced 
voluntary activation in the cerebral palsy group could not fully explain the differences 
in muscle strength. A key factor affecting muscle strength is the physiological cross-
sectional area (PCSA). PCSA is a relationship between muscle volume, fascicle length, 
and pennation angle, representing the number of muscle fascicles working in parallel61. 
Therefore, the reduced muscle strength observed must also be due to changes in muscle 
morphology in addition to the neurological factors. 
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Lower limb muscles volumes have been shown to be greatly reduced in spastic cerebral 
palsy compared to typically developing individuals53,56-60 and compared to the non-
paretic limb in hemiplegia59,53,116, with muscle volumes ranging from 50% to 70% of 
their typically developing peers61. Predominantly, these studies have been investigating 
the muscle of older children.  However, Barber et al58 showed on average a 22% 
reduction in medial gastrocnemius muscle volume in children aged 2 to 5 years. As 
noted by Shortland117, this is a key finding as it indicates that since there is a large 
muscle volume reduction at a young age, this volume reduction may not be caused 
solely by abnormal usage of the muscles during motor skill development. The 
superposition of the cerebral injury on the developing motor system may have an 
important role in muscle development. As discussed in Chapter 1, as the corticospinal 
tract and motor skills develop, afferent sensory neural pathways to the spinal cord are 
reduced and the efferent motor neural pathways are strengthened. In cerebral palsy the 
corticospinal tract and intrinsic spinal cord network development may be altered by the 
cerebral injury, with the spinal cord organisation potentially affected distally from the 
level corresponding to the timing of the cerebral injury. This may play an important role 
in muscle size and development. If spinal organisation is more adversely affected 
distally along the spinal cord, this may explain the greater reduction of muscle volumes 
observed distally in the lower limb56,116. 
 
If the superposition of the cerebral injury on the developing motor system is related to 
muscle development, measuring white matter organisation in the corticospinal tract may 
provide a fundamental measure of the impact of the cerebral injury on the development 
of the motor system. 
2.6.3	  	  Muscle	  composition	  
The mechanical potential of muscle depends on gross morphology (cross sectional area, 
fibre length118), muscle fibre type, and muscle composition (fraction of intramuscular 
fat and connective tissue). Two recent reviews of the literature have suggested that 
structural and mechanical properties may be altered in spastic muscle, including 
evidence for alterations in fibre size and distribution, proliferation of extracellular tissue 
(connective and adipose tissue infiltration), and altered stiffness of muscle cells97,98. In 
the lower limb, biopsy studies have demonstrated increases in the connective tissue 
fraction, reduced muscle fibre diameter, and altered muscle fascicle stiffness119,120, as 
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well as increased fat content in the most affected muscles99.  Unlike muscle fibre size 
and cell stiffness, adipose tissue infiltration can be assessed non-invasively using MRI. 
 
Due to the typically sedentary behaviour observed in this group71,72, one aspect of 
muscle composition that may be altered in cerebral palsy is the level of intramuscular 
fat. Fatty infiltration into muscle results in a reduced proportion of contractile tissue per 
unit muscle volume and may alter muscle fibre orientation limiting the maximal 
contraction force of the muscle. Intramuscular fat also may secrete inflammatory 
cytokines that can reduce the myofibrillar force even in the absence of muscle 
atrophy62. If present in this group, raised intramuscular fat may have important 
consequences for physical performance, and implications for exercise regimes 
employed in their physical management.  
 
Adults with cerebral palsy have an increased risk of dying from diseases of their 
circulatory system than their typically developing peers11,13, and heightened levels of 
inter- and intra- muscular fat are associated with cardiovascular risk44,121. Therefore, if 
present in this group, raised levels intramuscular and intermuscular fat may contribute 
to the cardiovascular risk in this group. Since individuals with cerebral palsy have 
reduced muscle mass, even those with body mass index (BMI) in the normal range may 
have relatively increased levels of adipose tissue. Previous studies in children with 
cerebral palsy have suggested raised levels of fat76,77. In an MRI study of the lower 
limbs in children with quadriplegic cerebral palsy (Gross Motor Function Classification 
System (GMFCS) levels III-V), Johnson et al76 found increased levels of intermuscular 
and subcutaneous fat76.  To date, there have been no studies of intramuscular fat in 
adults or children with cerebral palsy even though this non-invasively quantified 
parameter appears to be one of those most associated with cardio-metabolic disease122.  
2.6.4	  	  The	  effect	  of	  intramuscular	  fat	  on	  muscle	  metabolism	  
The metabolic syndrome is a combination of medical disorders that, when occurring 
together, increase the risk of developing cardiovascular disease and type2 diabetes 
mellitus. The World Health Organisation (WHO) state that individual’s have the 
metabolic syndrome if they have any one of diabetes mellitus, impaired glucose 
tolerance, impaired fasting glucose or insulin resistance, and any two of the following: 
Blood pressure: ≥ 140/90 mmHg; Dyslipidemia: triglycerides: ≥ 1.695 mmol/L and 
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high-density lipoprotein cholesterol (HDL-C) ≤ 0.9 mmol/L (male), ≤ 1.0 mmol/L 
(female); Central obesity: waist: hip ratio > 0.90 (male); > 0.85 (female), or body mass 
index > 30 kg/m2; and Microalbuminuria: urinary albumin excretion ratio ≥ 20 µg/min 
or albumin:creatinine ratio ≥ 30 mg/g. Therefore, the WHO emphasises the role of 
insulin resistance as a risk factor for declining metabolic health and cardiovascular 
disease. 
 
The ability for insulin to increase skeletal muscle glucose transport is dependent on the 
cellular expression of insulin-sensitive glucose transporters, e.g. GLUT4, and the 
capacity for flux through the insulin signalling pathway41. Two of the potential 
mechanisms contributing to impaired insulin signalling and action is the accumulation 
of intramuscular lipids and lipid by-products123 and reduced physical activity. In 
particular, increased intramyocellular lipid (IMCL) is prevalent with aging, obesity, 
insulin resistance, diabetes mellitus, and the metabolic syndrome124-129, with skeletal 
muscle lipid accumulation associated with increased insulin resistance and loss of 
metabolic flexibility39,43,130,131. Intravenous lipid infusion inhibits the effect of insulin on 
muscle metabolism, reducing insulin-stimulated glucose transport, phophorylation, 
oxidation, and glycogen synthesis132. This inhibition may be due to the accumulation of 
intracellular fatty acyl CoA, diacylglycerol and ceramides133,134, which may impair steps 
in the insulin-signalling pathway. Alternatively, intramuscular lipid accumulation may 
not play a direct role in insulin inhibition, but may mark a chronic imbalance between 
the supply and oxidation of lipids, due to either a chronic dietary imbalance or due to 
reduced oxidative capacity of fatty acids caused by impaired mitochondrial 
number/density and/or function41. 
 
Despite links between skeletal muscle lipids and reductions in mitochondrial size, 
density and function135-137 and insulin resistance39,43,130,131, there are instances where 
raised IMCL content is concurrent with insulin sensitivity and high oxidative capacity 
in response to exercise and in endurance athletes43,138,139. However, it is likely that there 
are differences in the subcellular localisation, structure, and proximity to mitochondria 
between athletes and individuals with low levels of physical activity140,141. As noted in a 
recent review by Petersen et al.142, considering the degree of muscle atrophy and 
sedentary behaviour among individuals with cerebral palsy, combined with fatigability 
during physical activity, it may be possible that there are non-cerebral palsy specific 
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mechanistic defects occurring. Excess intramuscular lipid, decreased mitochondrial 
function, or chronic inflammation may further exaggerate the functional impairment in 
this patient group, and may lead to progressive metabolic disease risk142. Therefore, 
understanding any potential secondary mediators of muscle quality or metabolic 
abnormalities affecting muscle force production and fatigue-ability could have 
important implications for the life long mobility and physical management of patients 
with cerebral palsy. 
2.6.5	  	  Bony	  deformity	  and	  fracture	  risk	  
Bones adapt their mechanical strength to maintain the strain caused by physiological 
loads as close as possible to a set point86. Bone geometry and mineral density adapts to 
the forces and activity levels they experience143 and cortical bone cross-sectional area is 
significantly related to muscle cross-sectional area91,144,145.  Changes in bone mass lag 
behind changes in muscle strength by approximately 3 months146. 
 
Individuals with cerebral palsy can have delayed acquisition of the motor milestones 
(sitting, crawling, and walking) compared to their typically developing peers. As a 
result their bones are exposed to different forces and loading patterns resulting in 
adaptations of the bones to these altered forces. The cortical bone mineral content, 
thickness and strength have been shown to be reduced in individuals with cerebral 
palsy147. Furthermore, the bone geometries can also be altered causing some individuals 
with cerebral palsy to develop bony deformities. These deformities include acetabular 
malformations, increased tibial torsion and femoral anteversion, and equinovarus and 
planovalgus deformities of the foot. 
 
There is a high prevalence of fractures in individuals with cerebral palsy148-152, with 
lower limb fractures most prevalent149,150, commonly occurring in the distal femur and 
proximal tibia150. In ambulant children with cerebral palsy, high-energy fractures are the 
most common type, with fractures sustained through significant trauma. As discussed in 
section 2.5.1, bone strength is dependent on the ultimate strength of bone tissue, the 
spatial distribution of bone tissue (density, geometry), and the ability for bones to repair 
micro-damage. In typically developing children and adolescents, factors associated with 
bone fractures are bone mineral density (BMD), bone geometry, and bone size153. Poor 
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nutrition, lack of weight-bearing physical activity, obesity and high exposure to trauma 
may also influence fracture risks in the general paediatric population153.  
 
Although Dual-energy X-ray Absorption (DXA) is the most common method for 
measuring BMD in cerebral palsy, the technique suffers from systematic errors depend 
on skeletal site and body size154.  Since individuals with cerebral palsy often have a 
smaller body size than their TD peers155, an apparent low BMD score may be measured 
when assessed by DXA, thereby underestimating BMD in cerebral palsy. Gold standard 
assessments using peripheral quantitative computed tomography, pQCT, suggest that 
children with cerebral palsy do not have a deficit in BMD, but in fact have reduced 
cortical bone thickness147. Bone geometry can also be assessed using MRI, which also 
has shown reduced cortical bone thickness at the mid-femur of children with 
quadriplegic cerebral palsy156. 
 
Bones in non-ambulant children with cerebral palsy have reduced strength due to their 
reduced cortical thickness156. As discussed in section 2.6.2, muscle weakness in 
individuals with cerebral palsy is well documented, and is attributable to reduced 
muscle activation53,105,106, co-activation of agonist and antagonist groups105,106, and to 
reduced muscle volume53,56-61. Therefore, in individuals with cerebral palsy, the reduced 
bone strength and hence increased fracture rate may be due to the reduced mechanical 
loading applied to the bones by the local musculature. Bone geometry and the effects of 
reduced muscle strength and volume in ambulant individuals with cerebral palsy have 
not been assessed. 
2.6.6	  	  Treatment	  of	  musculoskeletal	  impairments	  in	  cerebral	  palsy	  
A wide range of interventions are utilised in the treatment of musculoskeletal 
deformities in cerebral palsy. Exercise interventions are commonly employed with the 
aim to improve joint ranges of motion (ROM), gait or mobility deficits, and muscle 
strength. Serial casting is commonly used, where a series of plaster casts are applied to 
the limb with the muscle of interest held in a stretched position, with the aim to increase 
joint ROM. Ankle foot orthoses (AFOs) are also commonly used with the aim to 
provide stability at the ankle during walking and to try and limit the development short 
plantarflexors by holding the ankle either in dorsiflexion or a neural position. 
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More invasive treatments are also employed. Botulinum toxin (BTX) injections may be 
given to patients with tight hamstrings and plantarflexors, although other muscles also 
can be injected. BTX is a protein exotoxin that binds with high affinity and specificity 
to the pre-synaptic membranes of cholinergic motor neurones, and is then 
internalised157. Once inside the cell, one of its two subunits specifically cleaves 
components of the cell’s exocytotic machinery so that the discharge of acetylcholine-
containing vesicles, and hence neurotransmission at the neuromuscular junction, is 
prevented158. Injection of BTX into selected muscles therefore produces dose-dependent 
chemical denervation resulting in reduced muscular activity159. As well as the injection 
of BTX, a variety of soft tissue and bony surgeries are often utilised. Intramuscular and 
tendinous lengthening can be used to lengthen short musculo-tendinous units, and bones 
can be de-rotated, lengthened, or shortened by bony surgery. All of these interventions 
treat the secondary and tertiary effects of the initial primary injury to the brain. 
Although these interventions are performed to improve a patient’s clinical presentation, 
these interventions may in turn have negative consequences on muscle and bone. 
2.8	  	   Summary	  
Muscles play an important role in the execution of a movement initiated through the 
motor system. However, muscle also has an important role in bone development and 
metabolic health. In cerebral palsy, the secondary muscle weakness to the initial insult 
to the motor control system may have further consequences on the individual’s 
metabolic and bone health.  
 
There are limited studies investigating lower limb muscle volume in the literature and 
no studies have been published to date investigating the relationship between muscle 
size and bone strength in ambulant individuals with cerebral palsy. Considering the high 
fracture rate in this group148-152, muscle size may prove to be a valuable target for 
intervention to reduce an individual’s fracture risk. Muscle strength in cerebral palsy 
may also be affected by a potentially greater intramuscular fat content compared to their 
typically developing peers. As well as affecting muscle strength, increased 
intramuscular fat can also affect an individual’s metabolic health39,43,130,131. Therefore, 
investigating intramuscular fat levels in cerebral palsy may not only have implications 
for muscle function, but also for the life long health in this patient group.
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3. Assessment	  Techniques	  
In this chapter the techniques employed in the literature for investigating selective 
motor control, spasticity, functional ability, and spinal cord pathology in this 
programme of work are reviewed. Magnetic resonance imaging (MRI) provides the best 
soft tissue detail of all imaging modalities and provides a unique method for 
investigating tissue structure in vivo. In this chapter only the specific techniques relating 
to the programme of work are discussed. The underlying working principles of MRI are 
described in Appendix A. 
3.1	  	   GMFCS	  and	  functional	  outcome	  measures	  
Functional outcome measures are important for the assessment of treatments given to 
individuals with mobility disabilities and measure the combined effect of the both the 
musculoskeletal and neurological impairment on an individual’s functional ability. For 
cerebral palsy, various measures have been developed including the Gross Motor 
Function Measure (GMFM)5, the Gross Motor Performance Measure (GMPM)160, the 
Functional Independence Measure for Children (WeeFIM), the Gillette Functional 
Assessment Questionnaire (GFAQ)161 and the Timed Up and Go test (TUG)162. It is 
important to use a functional outcome measure in this study to investigate a potential 
relationship between measured whiter matter organisation using DTI and the 
individual’s functional capacity. In order to select a functional outcome measure it is 
important to consider the group it is to be applied to. The range of functional abilities of 
the group must be accounted for in the scale of the outcome measure, i.e. the measure 
can successfully differentiate functional ability within the study group. In this section 
the most widely used outcome measure in the literature, the GMFM, is discussed in 
detail together with the Gross Motor Function Classification System (GMFCS)4 that is 
based on the GMFM. 
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3.1.1	  	  Gross	  Motor	  Function	  Classification	  System	  (GMFCS)	  
The GMFCS was first developed in 1997 and is a five level classification system that 
describes the gross motor function of children and youths with cerebral palsy based on 
their self-initiated movement with particular emphasis on sitting, walking, and wheeled 
mobility4.  
 
The aim of the GMFCS is to determine an individual’s present abilities and limitations 
in gross motor function, focusing on their typical performance in home, school, and 
community settings (i.e., what they do), rather than their full capability. A summary of 
the five GMFCS levels is given in Table 3.1. For each functional level in the scale 
descriptions of motor function are given for different age groups in the following 
ranges: before age 2, 2 to 4 years, 4 to 6 years, and 6 to 12 years of age. Descriptions for 
youths aged 12 to 18 years have been added in an expanded and revised version of the 
GMFCS in 2008163. GMFCS has good inter-rater reliability4,163 and has been used for 
clinical practice and research164,165 166. Children who have motor problems similar to 
those classified in Level I can generally walk without restrictions but tend to be limited 
in some of the more advanced motor skills. Children whose motor function has been 
classified at "Level V" are generally very limited in their ability to move themselves 
around even with the use of assistive technology. Therefore, the scale encompasses the 
very wide ranges in functional ability observed in cerebral palsy but only differentiates 
this range into five categories. When investigating relationships with functional ability 
using GMFCS level, the limited resolution of the system to differentiate between 
individuals should be accounted for. Therefore, utilising a measure with greater 
discrimination of functional ability is advisable. 
 
GMFCS Level Description 
I Walks without limitations 
II Walks with limitations 
III Walks using a hand-held mobility device 
IV Self-mobility with limitations, may use powered mobility 
V Transported in a manual wheelchair 
Table 3.1 Summary of the Gross Motor Function Classification System 
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3.1.2	  	  Gross	  Motor	  Function	  Measure	  
The Gross Motor Function Measure (GMFM) was developed in the 1980’s as a clinical 
tool for evaluating change in gross motor function of children with cerebral palsy5.  The 
initial GMFM consisted of 85 parts as used in a validation performed by Russel et al5. 
However, in response to feedback during this initial validation study the authors added 
three additional measures to form the GMFM-88167. The GMFM-88 is separated into 
four main dimensions: lying and rolling; sitting; crawling and kneeling; standing; and 
walking, running, and jumping. Scores for each dimension are expressed as a 
percentage score of the maximum score possible in that dimension, with the total score 
calculated as an average of the percentage scores across the five dimensions. 
Administering the GMFM-88 takes approximately 45-60 minutes for an experienced 
assessor. 
 
The GMFM-88 has been validated in the literature for children aged 5 months to 16 
years with cerebral palsy5,168,169 and has been used as a functional outcome measures in 
studies investigating various interventions including selective dorsal rhizotomy170-179, 
intrathecal baclofen180, physical therapy181, strength training182, and muscle tendon 
surgery183. Despite the extensive use of the GMFM-88 in the literature, it is important to 
note that there are limitations in design and how the GMFM-88 has been used in the 
literature. Due to the wide range of functional abilities examined in the GMFM-88 and 
the time required to perform the measure, some researchers have utilised only the 
dimensions that are most relevant to their study as restricting the number of dimensions 
increases the measures sensitivity to changes in the functions of interest. There are two 
main limitations of the GMFM-88: 1) the potential for two individuals with different 
functional abilities producing the same total score. Two individuals can achieve the 
same score despite the individuals having different functional abilities within each 
dimension as the scores are combined to produce the total score. 2) Children with total 
scores in the middle range have a greater potential to change their score compare to 
those with low or high scores.  
 
A shortened version of the GMFM has also been developed, the GMFM-66184. The 
GMFM-66 was developed in response to the limitations of GMFM-88 highlighted in the 
literature, with the ordering of items according to difficulty, altered interval scale 
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properties for improved interpretability, and a decrease in administration time. GMFM-
66 has been shown to have comparable reliability scores as the GMFM-88. However, 
many items in the lower dimensions of functional ability have been removed causing 
the measure to be less descriptive and less sensitive to change in children with low 
functional abilities. Of the 22 items removed from the GMFM-88 13 were from the 
lying and rolling dimension, five from the sitting dimension, and four from the kneeling 
and crawling dimension.  
 
Selective Dorsal Rhizotomy (SDR) is a neurosurgical procedure that can be used in 
children with cerebral palsy with the aim to relieve the effects of spasticity and 
improving motor function. SDR involves the incomplete transection of the posterior 
lumbosacral rootlets in the lumbar spinal cord, reducing the excitatory sensory input 
from the lower limbs entering the spinal cord. The results of the studies performed in 
this thesis on white matter organisation in the spinal cord may be applicable for aiding 
SDR treatment planning and decision-making. The common use of the GMFM as a 
functional outcome measure in SDR studies in the literature makes the measure 
appropriate for use in this study; SDR studies have shown that a functional difference 
can be detected following SDR (i.e. surgically altering the white matter organisation in 
the spinal cord) using this tool172,174-179,184-186. 
3.2	  	   Assessing	  selective	  voluntary	  motor	  control	  
Selective muscle control has been defined as the ability to isolate the activation of 
muscles in a selected pattern in response to demands of a voluntary movement or 
posture187. Selective voluntary motor control describes the performance of specific 
isolated joint movements upon request, rather than the activation of selected muscles 
during functional tasks188. Voluntary muscle control is produced through the 
corticospinal tract, controlling both directionality and force production189. An injury to 
the corticospinal tracts affects the force, speed, timing, and patterns of voluntary 
movements. In cerebral palsy, damage commonly occurs to the corticospinal tracts in 
the periventricular area of the brain190. 
 
In the literature, selective motor voluntary control impairment has been reported 
indirectly in cerebral palsy through muscle recruitment timing errors during maximum 
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voluntary contractions100, simultaneous associated movements at contra-lateral joints, 
mass patterns of flexion and extension (synergies) during movements101, and coupled 
hip, knee and ankle movements during gait and voluntary movements101-104. However, 
in cerebral palsy the patho-physiology of impaired selective voluntary motor control is 
not well understood with several potential causes including a loss of inhibition, the 
persistence of low threshold stretch reflexes and primitive flexor/extensor patterns, a 
loss of connections with the corticospinal tract, or a combination of these factors. Due 
to the reduced selective voluntary motor control capabilities in cerebral palsy, 
investigating a potential relationship with selective voluntary motor control is an 
important factor of a study investigating spinal cord white matter organisation.  
 
Importantly for this study, a relationship has been reported in the literature for spinal 
white matter organisation (determined by diffusion tensor imaging) in the cervical spine 
with precision grip force control in 24 healthy volunteers. Fractional Anisotropy (see 
Chapter 3) was found to be higher in subjects with low error in force tracking tasks191. 
This result infers a higher white matter organisation in subjects with better force control 
and is indicative that a reduced axon organisation may be observed in individuals with 
cerebral palsy who have reduced selective voluntary muscle control compared to their 
typically developing peers.  
 
Clinical assessment of selective voluntary motor control have been described and used 
as outcome measures in the literature192-194. Recently a clinical tool been developed 
which evaluates the entire lower limb: Selective Control Assessment of the Lower 
Extremity (SCALE)188. SCALE involves the scoring of the hip, knee, ankle, subtalar 
joints, and toes, and summing to produce an assessment of the entire lower limb. The 
authors have demonstrated content and construct validity, good reliability between 
assessors and a strong relationship to gross motor classification. SCALE has been used 
in the literature to show increased distal motor impairment in spastic cerebral palsy195, 
and that the independence of knee and hip joint motion in the swing phase of gait is 
positively related to selective voluntary motor control 196. However, SCALE is a 
qualitative measure that involves subjective scoring selective voluntary motor control 
from zero to two: normal (2); impaired (1); or unable (0).  Quantitative evaluation of 
selective voluntary motor control requires instrumentation. This could be achieved 
through electromyography or utilising a device similar to that proposed by Lindberg et 
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al197 for the lower limb, for example a pedal-force control system. Defining a task that 
subjects with CP could successfully perform across a range of functional abilities is 
difficult due to the large variation in joint ranges of movement and selective motor 
control within this group. Therefore, despite the qualitative nature of SCALE it is 
currently the only non-instrumented clinical assessment technique that assesses the 
entire lower limb. Therefore, SCALE will be used in this study to assess selective 
voluntary motor control due to the number of tests to be performed in this study and the 
time constraints this imposes on the study. 
3.3	  	   Assessing	  spasticity	  
Spasticity is a complex phenomenon that currently has no set definition in the literature. 
As a result a range of measurement techniques have been developed and utilised in the 
literature that measure different components of spasticity. These techniques range of 
clinical non-instrumented tests to instrumented isokinetic tests with electromyography 
and dynamometers.  
 
Non-instrumented techniques commonly used for the clinical assessment of spasticity 
can be categorised into three main groups; Ashworth-like scales, Tardieu-like scales, 
and other clinical grading scales198. The Ashworth-like scales are based on scoring the 
resistance encountered in a specific muscle group by passively moving a limb at one 
non-specified velocity through its range of movement on a 5 point scale initially 
described by Ashworth199. The Tardieu-like scales are based on the description by 
Tardieu200 involving the measurement of joint-angle measured at different velocities of 
muscle stretch. Derived clinical assessments (the Tardieu Scale201) involves passive 
movement of the joints at three specified velocities and the intensity and duration of the 
muscle reaction to stretch (X) is rated on a 5 point scale, with the joint-angle (Y) at 
which this muscle reaction is first felt. A simplified scoring system, the Modified 
Tardieu Scale (MTS)193. The MTS only defines the moment of the ‘catch’, seen in the 
ROM at a particular joint angle at a fast passive stretch. In a review by Scholtes et al198 
the authors state that only the Tardieu-like scales are suitable instruments for the clinical 
measurement of spasticity since the Ashworth-like scales only grade muscle tone 
intensity at one velocity of passive stretch. However, these descriptive clinical measures 
do not strictly measure spasticity, but are a grading of a joint’s resistance to stretch. In 
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these tests the cause of this stretch resistance cannot be elucidated and can be caused by 
altered stretch reflexes, persistent muscle activation, altered elasticity of the musculo-
tendinous unit, or a combination of these factors. 
 
Instrumented quantitative measures have been developed, including quantifying muscle 
activity to measure the response to stretching of muscles, tendon tap, or electrical 
stimulation and can be acquired simultaneously with the clinical non-instrumented 
techniques including the modified Ashworth scale202-205. The resistance to stretch can be 
quantified at a joint using isokinetic dynamometry, during which the peak passive toque 
of a joint to passive movements can be measured206-209. Muscle reflexes can also be 
measured in conjunction with isokinetic dynamometry using electromyography. This 
enables the contribution of an increased muscle reflex on the muscle stretch resistance 
to be investigated. This enables patients with increased stretch resistance to be 
categorised by the contribution of muscle reflexes to the stretch resistance depending on 
EMG activity210 
 
Conclusion: Currently there are no non-instrumented clinical tests for grading the 
degree of muscle spasticity. Although these techniques assess muscle resistance to 
stretch, they require additional neurophysiological measurements to enable the 
contribution of muscle reflexes to stretch resistance to be identified. Isokinetic 
dynamometry combined with electromyography currently enables both the passive 
stretch resistance and degree of muscle activation to be quantified; however the relative 
contributions of altered muscle reflexes and muscle tissue structure cannot be 
elucidated. In this study, due to the limited time scale to perform the spasticity tests, and 
that the primary outcome measures for altered corticospinal tract development are 
altered selective motor control and subsequent muscle development only non-
instrumented trials have been employed. Therefore, despite having limitations, the 
modified Ashworth will be performed in this study for grading spasticity due to its short 
acquisition time and large usage in the literature. 
3.4	  	   In	  vivo	  methods	  for	  assessing	  intramuscular	  fat	  
Ultrasound is a common non-invasive method used to assess adipose tissue infiltration 
in muscles. Khoury et al.211 assessed the fatty infiltration and pennation pattern in the 
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supraspinatus shoulder muscle of individuals with rotator cuff disease. The fatty 
infiltration was evaluated by assessing the echogenicity of the supraspinatus muscle 
compared to normal trapezius muscles of the same individuals. Khoury et al.211 
compared the ultrasound results with MRI images. The MRI images were evaluated 
subjectively by examining the proportion of fat within the muscle on the sagittal and 
coronal T1-weighted images using a grading method by Goutallier et al.212. In this 
method normal muscle with no fatty streak is grade 0; mild fatty muscle has a few 
streaks is grade 1; moderately fatty muscle is grade 2; and approximately equal amounts 
of fat and muscle, i.e. severe fatty infiltration, is grade 3. Grading methods, such as the 
Goutallier technique212,  enable intramuscular fat assessment but are only a qualitative 
technique.  
 
T1-weighted image segmentation is commonly used to quantify intermuscular adipose 
tissue (IMAT) using MRI. IMAT defined as the visible fat within the muscles 
(intramuscular fat) and between the muscles beneath the fascia (intermuscular fat). This 
is typically achieved by drawing regions around adipose tissue on T1-weighted images. 
The adipose tissue is separated into inter-muscular, subfascial or subcutaneous and the 
percentage of adipose tissue calculated. Although this method is effective for assessing 
intermuscular and subcutaneous fat volumes, it is not an accurate method for measuring 
fat within individual muscles (intramuscular fat) due to the mixed tissue and therefore 
signal intensities within muscle. Alternative quantitative methods for intramuscular fat 
are magnetic resonance spectroscopy (MRS) and chemical shift imaging techniques. 
3.4.1	  	  Magnetic	  Resonance	  Spectroscopy	  (MRS)	  
MRS produces a spectrum of signal intensity vs. frequency that shows the chemical 
shift of 1-H within different molecules. These differences arise due to the differing 
electron shielding of specific atoms, which creates a difference in magnetic field 
strength and, therefore, frequency. This means that the spectrum contains the 
information as to the metabolites present.  
 
Due to the very large quantities of water molecules compared to metabolites in the body 
water suppression techniques are required to suppress the spectral peak of water so that 
it does not dominate the spectra. This also enables the analogue to digital converter to 
have increased dynamic range over the small signals of interest. Water suppression is 
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achieved by applying a narrow-bandwidth radio frequency pulse that excites only the 
water molecules. A spoiler gradient is then applied which dephases these excited spins. 
This is carried out before the main MRS sequence, although the sequence is often run 
first without water suppression to obtain reference spectra. There are two main 
sequences for single voxel MRS:  PRESS and STEAM. Point Resolved Spectroscopy 
(PRESS) uses a 90o excitation pulse followed by two refocusing 180o pulses, with a 
slice selection gradient applied during each pulse such that the echo originates only 
from the required voxel of interest defined by the overlapping region of each slice select 
gradient (Figure 3.1). STimulated Echo Acquisition Mode (STEAM) uses a stimulated 
echo rather than a double spin echo to localize the signal from a single voxel, with three 






















Figure 3.2 STimulated Echo Acquisition Mode (STEAM) sequence. TM denotes the 
time between the second and third 90° RF pulses, known as the mixing time. 
 
Assessment	  Techniques	  	  
J.J.	  Noble	   Musculoskeletal	  and	  spinal	  cord	  imaging	   66	  
1H Spectroscopy can be used to assess the fat content of muscles and is considered to be 
the ‘Gold Standard’ for intramuscular fat quantification. As well as quantifying fat, 
MRS can be used to measure a wide range of metabolites in tissues using 1H and 31P 
spectroscopy. In the literature, MRS has been used in the assessment of lipid content of 
the supraspinatus muscle in asymptomatic volunteers and patients with supraspinatus 
tendon lesions and compared with qualitative fat infiltration assessment of T1-weighted 
images213. Comparable results were obtained between the quantitative MRS results and 
the qualitative grading of the T1-weighted images. The authors conclude that routine 
assessment of the apparent lipid content is feasible with proton MR spectroscopy and 
provides the possibility to quantify fatty atrophy of the supraspinatus muscle. However, 
MRS has limited spatial resolution and, therefore, is not suitable if the entire muscle 
cross-section or volume is of interest. 
 
3.4.2	  	  Dixon	  Imaging	  
As discussed above, in the literature fat-water fraction measurements are predominantly 
obtained using localized proton (1-H) MR spectroscopy (MRS)213-216. However, MRS 
has a limited spatial resolution compared to imaging techniques. Consequently MRI 
techniques for the measurement of fat-water ratios are desirable, particularly in spatially 
heterogeneous tissue.  
 
Chemical shift imaging methods based on the Dixon technique217 utilise the predictable 
phase evolution between water and fat signal constituents due to their chemical shift 
difference to enable the calculation of separate water and fat images, permitting the 
calculation of the fat fraction. The fat fraction is the signal intensity attributable to fat, 
normalised by the total signal from all mobile proton species. Recent advancements in 
image processing techniques, such as IDEAL (iterative decomposition of water and fat 
with echo asymmetry and least-squares approach)218,219, have further helped to separate 
fat and water signals in inhomogeneous magnetic field regions and Dixon sequences are 
now becoming more widely available on clinical MRI systems (Philips –mDixon, 
Siemens – Dixon, Hitachi – FatSep, GE –IDEAL).  
 
These techniques have been widely used in studies quantifying the degree of liver fat in 
hepatic steatosis (for review see Reeder220). Dixon imaging is increasingly being 
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utilised for clinical intramuscular fat quantification121,221, including in Duchenne 
Muscular Dystrophy222,223. To date no studies having been published in the literature 
investigated intramuscular fat in cerebral palsy using Dixon imaging techniques. The 
increasing use of Dixon techniques for in vivo intramuscular fat quantification 
demonstrates a need for an in vivo comparison evaluation of these techniques with MRS 
that is currently considered the gold standard for in vivo intramuscular fat 
quantification. However, to effectively test the validity of these imaging techniques a 
study comparing intramuscular fat measured using Dixon techniques with muscle 
biopsy is required. 
Dixon	  imaging	  technique	  
The Dixon imaging technique217 discriminates between fat and water spins based on the 
difference between their resonant frequencies to produce separate fat and water images. 
The original two-point Dixon (2PD) technique acquired two spin-echo images: one 
image is acquired with water and fat in phase, and the second image is acquired with the 
water and fat signals out of phase, with 180o water-fat phase difference (Figure 3.3A-B). 
These images then undergo complex addition or subtraction to produce water only and 
fat only images respectively, from which a fat-water ratio image can be calculated. 
Therefore, a fat-water fraction measurement can be made for a much larger region of 
interest and with much higher spatial resolution using Dixon techniques compared to 
MRS.  
 
The three-point Dixon (3PD) technique224 was developed to reduce sensitivity to 
magnetic field inhomogeneities, and, therefore, phase errors, that are associated with 
2PD225 by utilising a combination of multipoint acquisition and image processing 
techniques. Phase errors are different in each voxel and typically result in swapped 
water and fat assignment for the voxels affected225. Figure 3.3 C shows the effect of a 
phase error on the relative phases of the water and fat signals. Equations 3.1 to 3.4 show 
how the phase error and water (W) and fat (F) images are calculated from three point 
acquisitions (So, S1 and S-1). A four-point Dixon (4PD) technique has also been 
developed226, in which the extra acquisition enables a more accurate correction of the 
phase error, increasing the image acquisition time.  
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Figure 3.3 Schematic	  diagram	  showing	  the	  relative	  phases	  of	  water	  (blue)	  and	  fat	  (red)	  in	  Dixon	  imaging,	  where	  α	  =	  phase	  difference	  between	  water	  and	  fat	  signals	  and	  Φ	  =	  phase	  error 
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   Equation 3.4 
Where So, S1 and S-1 are the signals from the three acquisitions 
W = Water signal, F = fat signal, Φ = Phase error 
3.5	  	   Transcranial	  magnetic	  stimulation	  
Transcranial magnetic stimulation (TMS) is a non-invasive method for depolarising or 
hyperpolarising neurons in the brain though electromagnetic induction. TMS induces 
electric currents in the brain, causing either general or location specific activation of the 
brain, enabling the study of brain functions and the treatment of a range of psychiatric 
disorders.  
 
TMS of the sensory-motor cortex is often utilised to infer anatomical connections 
between the cortex and musculature by invoking a motor response. TMS studies have 
been performed in children to investigate the development of the motor systems, and are 
considered to be sensitive to corticospinal functional connectivity evoked by 
stimulation227,228. There are four TMS measures that are typically made when 
investigating the motor system connectivity: Motor evoked potential (MEP) threshold is 
the minimum potential applied to the brain that stimulates the motor cortex, evoking a 
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motor response; MEP latency is the latency of a TMS evoked MEP is an estimate of the 
central motor conduction time; Cortical maps: by stimulating a number of different 
areas of the scalp, different regions of the motor cortex are stimulated enabling an 
estimate of the somatotopic representations of muscles within the motor cortex; 
Ipsilateral MEP: Stimulation of the motor cortex may evoke an MEP in the 
homologous target muscle ipsilateral to the stimulation. This indicates the presence of 
an ipsilateral corticofugal motor projection. 
 
TMS has been utilised in the literature to investigate the cerebral damage and motor 
system connectivity in cerebral palsy. TMS has detected enhanced plasticity of the 
developing brain, altered cortical maps, and transcallosal inhibition in children with 
cerebral palsy. Enhanced plasticity of the developing brain has been shown in children 
with hemiplegia, with some children exhibiting prominent mirror movements of the 
paretic hand when the non-paretic hand is voluntarily controlled. TMS evoked 
ipsilateral projections that appear to originate from branched corticospinal tract neurons 
in the primary motor cortex of the contra-lesional hemisphere are associated with 
prominent mirror movements. Conversely, projections that appear to arise from areas 
other than the primary motor cortex have been found to not be associated with mirror 
movements229-231. Cortical maps detected using TMS have suggested that the cortical 
map of the lower extremity muscles are laterally displaced in children with bilateral 
spastic cerebral palsy caused by PVL232.  TMS has also detected that children with PVL 
may have structural deficits in the corpus callosum. The ipsilateral silent period (a	  marker	   of	   transcallosal	  motor	   inhibition) is a measure of myelination state of the 
mid-body of the corpus callosum where axons connecting the motor areas in both 
hemispheres meet233. In children with spastic diplegia, the ipsilateral silent period is 
absent, suggesting demyelination of the callosal structure234. 	  
TMS is a valuable tool for assessing connectivity of the motor system to be 
investigated, however, it does not quantify the underlying neural structure.  TMS is also 
limited by the stimulation method. The stimulating coils placed onto the scalp are of a 
finite size, and therefore have limitations in the precision of the area of stimulation. This 
can prevent the electrode from stimulating the area of interest alone without collateral 
stimulation of the surround neurons. Also, since the technique is transcranial, the area of 
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the motor cortex that is stimulated is superficial. The region of the motor cortex 
responsible for lower limb motor control is deep within the motor cortex, limiting the 
ability of TMS to stimulate the lower limb motor neurons, especially without co-
stimulation of other motor areas. Due to the difficulty in selectively stimulating the 
region of the motor cortex related to lower limb motor control together with the 
practicalities of utilising TMS including subject recruitment, TMS will not be used in 
this programme of work.  
3.6	  	   Diffusion	  tensor	  imaging	  
Anatomical MRI is routinely used to evaluate a range of neurological conditions. In 
cerebral palsy, MRI can reveal anatomic abnormalities, for example signal and volume 
abnormalities or white matter abnormalities. These abnormalities have been shown to 
correlate well with type and severity of neurologic sequelae235 and long-term motor 
outcome measures236,237. However, studies have shown that not all patients diagnosed 
with cerebral palsy exhibit neurological abnormalities in MRI images; a recent 
European study of 351 patients with CP found that 11.7% had normal MRI results238. 
Therefore, the high sensitivity of diffusion tensor imaging (DTI) to tissue structure may 
not only complement the clinical assessment of those patients exhibiting neurological 
abnormalities, but also enable the detection of abnormalities in the white matter 
microstructure of patients with insignificant findings on anatomical imaging techniques. 
This section discusses the application of DTI for quantifying spinal cord white matter 
organisation. For a detailed explanation of the principles of MRI and DTI sequences see 
Appendix A.  
 
In the literature, DTI has been used successfully in the brain to investigate white matter 
injuries in CP. The majority of the published studies involve the investigation of 
specific white matter structures in the brain, often correlating their findings with motor 
function239-245.  Children with bilateral spastic cerebral palsy often present with reduced 
voluntary selective motor control and muscle spasticity due to damage to the 
corticospinal tract and the vestibulospinal and reticulospinal tracts of the upper motor 
neurons. The corticospinal tract plays an important role in spinal cord development and 
the development of motor control. As a result of the brain injury, intrinsic spinal cord 
networks may not mature and muscle development may be delayed30.  Therefore, the 
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application of spinal cord DTI may reveal further abnormalities in the development of 
the central nervous system and may further explain a range of pathologies associated 
with cerebral palsy including reduced selective motor control and spasticity. 
 
Histological studies have been performed comparing diffusion parameters with 
measured axon dimensions, density, area fraction, and average axon size in rats246 and 
on excised human cervical spine247. These studies observed that ADC and FA were 
related to axon packing parameters. However, despite these results showing that a 
relationship exists between the DTI parameters and the underlying axon microstructure, 
it is important to note that a measured change in FA or ADC does not differentiate 
between changes in axon dimensions or packing parameters. 
 
To date, the majority of DTI studies of the spinal cord have been animal studies. The 
results of these studies have demonstrated the application of DTI for spinal cord 
compressions248, inflammatory diseases249,250 and arteriovenous malformations251. 
Despite the use of MRI anatomical imaging, and recently DTI, in neurological imaging, 
no studies in the literature to date have investigated abnormalities in the spinal cord of 
patients with CP. However, DTI has not been widely used in the literature to investigate 
the spinal cord. Artefacts caused by the surrounding flowing cerebrospinal fluid and 
bone, respiratory and cardiac motion, and low signal-to-noise-ratio (SNR) due to its 
small size represents a challenge for sequence design. This is particularly true in the 
transverse plane as precise anatomical localisation, small in-plane voxel size, and 
insensitivity to motion and susceptibility artefact is required. These factors make spinal 
cord diffusion imaging a challenge for sequence design.  
3.6.1	  	  Spinal	  cord	  DTI	  techniques	  
DTI of the brain is usually performed using single-shot echo-planar imaging (SS-EPI) 
sequences. SS-EPI benefits from a high signal-to-noise ratio (SNR) and is relatively 
robust to movement ghosting artefacts252. However, these sequences are not directly 
transferable to the spinal cord due to susceptibility artefacts caused by the magnetic 
field inhomogeneities around the spinal column253 and motion artefact from bulk 
motion of the spinal cord due to respiratory and cardiac motion, pulsating cerebrospinal 
fluid and swallowing. This bulk physiological motion causes non-linear phase errors 
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and shifts in k-space if the motion occurs during application of the diffusion encoding 
gradients254. 
 
The first diffusion weighted study of the human spinal cord in vivo was first published 
in 1999 by Clark et al.255. This study utilised a navigated, cardiac-gated pulsed-gradient 
spin echo diffusion imaging technique to produce ADC maps of the spinal cord in the 
sagittal plane255. The one-dimensional navigator echo was employed to correct the 
phase error accumulated in each line of k-space256,254. Single-shot techniques are 
sensitive to susceptibility artefact. This sensitivity can be reduced by employing a 
multi-shot EPI read out, which reduces the readout train length, and thus reducing the 
sensitivity to susceptibility artefacts257. This technique also enabled a greater spatial 
resolution through multiple shots258. This interleaved EPI technique results in superior 
image quality with reduced ghosting artefacts compared to fast spin echo techniques259. 
This motion artefact can be further reduced by employing a velocity-compensated 
diffusion gradients in tandem with a navigator echo260.  
 
Since the first diffusion weighted sequences for imaging the spinal cord were developed 
there has been a continual development of MRI machines, sequence design, and 
analysis techniques with the aim of generating increasingly robust and reliable DTI 
images for clinical applications.  
 
As discussed above, DTI-EPI techniques in the brain are commonly performed using 
single shot spin-echo EPI sequences. Considering the strong susceptibility gradients 
around the spinal cord, alternative sequence designs have been produced using multiple 
spin-echo read out schemes. Spin echo read-out sequences have a major advantage 
compared to gradient echo read-out techniques as susceptibility artefacts caused by the 
bone are greatly reduced. However, spin echo techniques are susceptible to image 
artefacts caused by the diffusion gradients altering the spin phases during the echo train 
acquisition258 and requires a longer read out time. Less common DTI techniques have 
also been used in the literature including a steady-state free procession sequence 
(SSFP)261, and a radial k-space trajectory spin echo sequence with each line of acquired 
data passing through the k-space origin262.  Single-shot techniques are advantageous due 
to dephasing caused by patient motion and increased scan time associated with multi-
shot techniques. However, the relatively long readout time of a single-shot technique 
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results in increased T2* decay resulting in sometimes significant blurring in the phase 
encoding direction. Therefore, current techniques attempt to reduce the magnetic 
susceptibility of these data sets by reducing the readout duration, which reduces the off-
resonance related artefacts263. Of these techniques, reduced field-of-view single-shot 
EPI and ZOOM EPI have been shown to be feasible in a clinical population and will be 
discussed in detail below.   
 
Reduced Field-of-view single shot EPI (reduced FOV SS-EPI) 
Reduced FOV SS-EPI techniques have been recently been developed that reduce 
magnetic susceptibility artefacts of SS-EPI by implementing non co-planar SE 
selection264-266, two-dimensional selective pulses267,268, outer volume suppression252 or a 
combination of these269. A reduced field of view reduces the number of k-space lines 
acquired, thus shortening the read out time and, therefore, reducing susceptibility 
artefacts. Saritas et al. presented a reduced FOV technique that utilised a two-
dimensional spatially selective echo-planar RF excitation pulse followed by a 180° 
refocusing RF pulse to select a rectangular FOV270. This reduces the read-out duration 
in the phase encoding direction to enable a higher in-plane resolution to be acquired 
without increasing read-out time270. This technique also allows for contiguous multi-
slice imaging without the need for inter-slice gaps271. Furthermore, the signal-to-noise 
ratio (SNR) is independent of the number of slices acquired266. An alternative approach 
is to use non co-planar SE selection to reduce the read-out duration in the phase 
encoding direction, however, this does not produce a rectangular field of view and 
aliasing from the outer volume is significant and alias reduction techniques, such as 
outer volume suppression (OVS)) are required. This is not true for the Saritas et al 
approach and represents an advantage over non-coplanar SE selection approaches. 
Wilm et al recently developed a reduced FOV technique with non-coplanar SE SS-EPI 
combined with OVS272, as shown in Figure 3.4.  The advantage of the Saritas et al 
technique compared to that proposed by Wilm et al is that OVS is not required.  
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Figure 3.4 Schematic representation of the reduced field of view sequence (ZOOM). The SPIR fat 
saturation pulse precedes the outer volume suppression. Tilting of the π/2 pulse is achieved by an 
additional gradient in the phase-encoding direction during the π/2 slice selection272 
 
Compared to traditional SS-EPI techniques reduced FOV SS EPI techniques do have a 
lower SNR. The SNR is reduced to only a square root of the signal to noise ratio of the 
full field of view due to the reduced number of k-space lines acquired. Despite this, a 
recent clinical study comparing reduced FOV SS-EPI with traditional SS-EPI showed 
improved image quality and other radiological metrics in a clinical population, and the 
reduced FOV SS-EPI images were rated as superior by a team of neuro-radiologists273.  
 
ZOOM-EPI 
The higher resolution achieved with the reduced FOV SS-EPI approach, by reducing the 
k-space matrix size, results in potential aliasing from outside the FOV, particularly in 
the phase encoding direction. Zonally magnified oblique multi-slice echo planar 
imaging (ZOOM-EPI) was developed to correct this aliasing artefact for optic nerve 
imaging265, and was subsequently successfully employed in the spinal cord271. ZOOM-
EPI is a reduced FOV SE-EPI technique that uses a tilted 180° refocusing RF pulse to 
reduce the FOV. However, unlike the reduced FOV techniques discussed above, the 
read-out FOV can be freely chosen to obtain the desired resolution as aliasing artefacts 
are avoided by using standard receiver bandwidth limiting filters, enabling a zoomed 
image to be reconstructed271. This initial approach required a two-slice thick inter-slice 
gap, making contiguous slices unobtainable. However, ZOOM-EPI has since been 
further developed to enable the acquisition of contiguous slices. Contiguous slice 
ZOOM EPI (CO-ZOOM-EPI) selectively excites and refocuses only a narrow FOV 
while simultaneously suppressing the signal from regions outside the desired FOV 
through the application of a slice-selective 90° RF pulse followed by a dual spin echo 
refocusing RF pulse consisting of two 180° RF pulses that are slice selective in the 
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phase encoding direction274. This enables the excitation and refocusing of only a narrow 
cross-section of the image volume. Out-of-phase protons within the refocusing slice 
undergoing two 180° RF pulses resulting in the restoration of magnetisation and 
minimal saturation of protons274.  
 
 
3.7	  	   Summary	  
The functional ability of individuals with cerebral palsy can be assessed clinically and 
reliably using the GMFM. However, clinical selective motor control and spasticity 
measures are not well developed in the literature. Spasticity in particular is difficult to 
assess and measure clinically and all currently available clinical tests have significant 
limitations. Although instrumented testing such as EMG and isokinetic testing could be 
used, the limited time scale available to assess selective motor control and spasticity 
measures in this study restricts their use. Due to their relatively wide use in the 
literature, SCALE and Modified Ashworth tests will be utilised to investigate selective 
motor control and joint stiffness respectively in this programme of work.   
 
Dixon based imaging techniques are an important tool for assessing the distribution of 
fat in the body that can be implemented to assess intramuscular fat accumulation in 
cerebral palsy. However, to date, there are no studies in the literature evaluating the 
Dixon techniques for in vivo intramuscular fat quantification.  Considering the 
increasing use of Dixon techniques for in vivo intramuscular fat quantification, an in 
vivo evaluation is required to investigate the accuracy of the technique for intramuscular 
fat quantification. 
 
DTI MRI techniques provide a valuable tool for the characterisation of tissue 
microstructure in vivo, and are sensitive to the spinal cord microstructure, including 
axon dimensions, density, area fraction, and average axon size246,247. However, it is 
important to note that DTI parameters cannot differentiate between changes in axon 
dimensions, packing parameters, or myelination. Although DTI MRI has multiple 
technical limitations, the development of reduced field of view approaches that 
addresses some of the limitations enables the microstructure and pathology of the spinal 
cord to be investigated. In particular, reduced FOV SS-EPI has been shown to produce 
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improved image quality compared to traditional SS-EPI approaches in a clinical 
population and therefore is applicable for use in this programme of work. The approach 
developed by Wilm et al252 is implemented for clinical use on the 3.0 T Phillips 
Achieva system (Philips Medical Systems, Best, The Netherlands) installed at the 
teaching hospital where all MRI scans in this programme of work will be performed. 
Therefore, the reduced FOV SS-EPI with outer volume suppression proposed by Wilm 
et al will be utilised for spinal cord DTI in this programme of work. 
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4. Programme	  of	  Work	  
As discussed in Chapters 1 and 2, individuals with cerebral palsy develop progressive 
musculoskeletal deformities secondary to an insult to the brain in utero or in early 
childhood that results in the development of a motor disorder275. These individuals also 
often suffer from a combination of altered sensation, cognition, communication, and 
perception and develop progressive musculoskeletal deformities275. Currently there is 
no cure for cerebral palsy and the primary aim of clinical interventions in children and 
adults are to improve a patient’s functional capabilities. The primary interventions 
utilised to address these acquired musculoskeletal deformities are physiotherapy, 
botulinum toxin injections, soft tissue and bony orthopaedic surgery. The aim of the 
first four studies in this programme of work are to investigate the extent that lower limb 
abnormalities, including muscle size and composition, are altered in ambulant 
individuals with bilateral spastic cerebral palsy (BSCP). This is important as identifying 
the muscle groups most adversely affected in this population may enable improved 
targeted of interventions to enable to maximise an individual’s functional ability with 
the aim of improving quality of life and reducing the decline in mobility7 culminating in 
the early loss of mobility7,8 in this group. Furthermore, altered intramuscular fat may 
have cardio-metabolic consequences38,42,129,130 that may have important implications for 
an individual’s general health, potentially contributing to the early mortality8,10,11 in this 
patient group.  
 
Periventricular leucomalacia (PVL) is the most common cause of BSCP, with lesions 
located in the posterior limb of the internal capsule bilaterally with damage to the 
corticospinal tract at this time. Many other areas of the brain may also be affected by the 
injury, either directly or by mal-development subsequent to the injury3. Although the 
extent of the damage and subsequent mal-development in the brain following PVL has 
been widely investigated in the literature, to date no studies have been published 
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investigating potential mal-development of the spinal cord following PVL. PVL occurs 
while the corticospinal system is developing. An injury to the developing corticospinal 
system may alter the refinement and elimination of afferent and efferent terminations in 
the spinal cord and the development of interneurons and intrinsic spinal cord networks. 
The aim of the fifth study in this programme of work is to investigate whether any 
potential disturbances to spinal cord development in PVL may explain alterations to 
functional ability, selective motor control, and muscle spasticity commonly observed in 
this patient group. 
 
In this chapter, overviews of each of the five studies in this programme of work are 
outlined, including subject recruitment and ethical approval. The full details of each 
study are given in each of the result chapters (Chapters 5-9) that follow. 
4.1	  	   Subjects	  
All studies in this thesis, with the exception of study three, are case-control studies 
investigating aspects of bilateral spastic cerebral palsy and comparing to their typically 
developing peers. Local research ethics committees granted ethical approval for each 
study in thesis.  
4.1.1	  	  Case	  subjects	  
Individuals aged 10 – 24 years, with a diagnosis of bilateral spastic CP, Gross Motor 
Function Classification System (GMFCS) levels I-III, who met the safety requirements 
of MRI were included in this study. Patients who had undergone surgery, serial casting 
or botulinum toxin injections to the lower limbs within the previous year were excluded 
from the study. Case subjects were recruited as a convenience sample of individuals 
attending our hospital department, including physiotherapy, orthopaedic consultations 
and clinical gait analysis appointments. Consecutive patients that met the inclusion 
criteria invited to participate in the study. The inclusion criteria for case subjects in all 
studies were:  
• Diagnosis of bilateral spastic cerebral palsy. 
• No surgery, serial casting or botulinum toxin injections to the lower limbs 
within the previous year. 
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• All individuals must meet the safety requirements of MRI. 
• Be able to understand what is being asked of them, and agree to take part in the 
study. 
4.1.2	  	  Control	  subjects	  	  
Controls subjects were recruited from students and staff at Guy’s & St Thomas’ NHS 
Foundation Trust and King’s College London, and through individual’s known to the 
local research team. The inclusion criteria for control subjects were: 
• Have no diagnosis of any musculoskeletal or neurological conditions. 
• Have never undergone surgery to their lower limbs. 
• All individuals must meet the safety requirements of MRI. 
• Be able to understand what is being asked of them, and agree to take part in the 
study. 
4.2	  	   Overview	  of	  studies	  
4.2.1	  	  Study	  1:	  Lower	  limb	  muscle	  volumes	  in	  bilateral	  spastic	  cerebral	  
palsy	  
Muscle weakness is a feature of individuals with spastic cerebral palsy53-55,96, however, in 
the literature there are few studies of muscle volume in this group. These limited studies 
have found reduced muscle volumes in individuals with cerebral palsy volume53,56-61. This 
study compares the volumes of nine major muscles in the lower limb in ambulant 
adolescents and young adults with BSCP with those of their typically developing peers. 
Nineteen independently ambulant subjects with bilateral spastic cerebral palsy (mean 
age 14.2 ± 2.7 years; 11 male; GMFCS levels I (n=5) and II (n=14)), and nineteen 
typically developing subjects (mean age 16.5 years (standard deviation 3.0), 11 male) 
took part in this study. This study is discussed in more detail in Chapter 5.  
 
This study combines data from two studies examining muscles in cerebral palsy. All 
MRI data was collected on a 1.5 T Phillips Achieva system (Philips Medical Systems, 
Best, The Netherlands).  I designed the MRI protocol used to collect data from twelve 
BSCP and ten TD subjects using a three point Dixon sequence (TE/TR = 4.6/13 ms, 
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echo time shift = 1.53 ms (120° echo phase shift), 20° flip angle, 0.9 x 0.9 mm in-plane 
voxel size, number of averages = 2, 5 mm slice thickness) with a quadrature body coil. 
Each scan took approximately 30 min. The MRI images of the lower legs of seven 
individuals with BSCP and nine TD subjects were collected as part of another PhD 
project (Nicola Fry, 2009). These subjects were scanned using a T1 weighted turbo spin 
echo sequence (TE/ TR = 18/1104.4 ms, number of averages = 2, echo train length = 3, 
1.8 x 1.8 mm in-plane voxel size) with a quadrature body coil. Slices were collected 
contiguously with a slice thickness of 2 mm over the hip, knee and ankle joints and 
every 4 mm over the remainder of the lower limb. Image acquisition took 
approximately 20 min for each subject.  Data processing was performed with another 
PhD student (Andrew Lewis, 2013). I performed the data analysis and manuscript 
preparation. This study is published in Brain & Development 36 (2014) 294-300. This 
paper is included in Chapter 5.  
4.2.2	  	  Study	  2:	  Bone	  strength	  and	  muscle	  volume	  in	  bilateral	  spastic	  
cerebral	  palsy	  
The Mechanostat Theory86,87 states that bone remodelling, and therefore strength, is 
mediated by strain induced by muscle action, modulated by the hormonal system. 
Considering the prevalence of muscle weakness in cerebral palsy53-­‐55, the high fracture 
rate reported in this patient group148-152 may be attributable to their reduced muscle 
strength. The objective of this study is to measure bony geometry, cortical bone cross-
sectional area, and local muscle volume, and from these to estimate the relationship of 
bone bending and compressional strength to local muscle volume in individuals with 
bilateral spastic cerebral palsy. 
 
Twenty-seven participants with BSCP (mean age: 14.6 ± 2.9 years; GMFCS levels I-III) 
and twenty-two typically developing peers (mean age: 16.7 ± 3.3 years) took part in this 
study. Periosteal and medullary diameter in the distal femur, cortical bone CSA in the 
femur and tibia along with nine lower limb muscle volumes were measured using MRI. 
The polar section modulus, cortical bone CSA and buckling ratio were calculated to 
estimate bone bending and compressional strength in the distal femur. This study is 
discussed in more detail in Chapter 6. 
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4.2.3	  	  Study	  3:	  In	  vitro	  and	  in	  vivo	  comparison	  of	  mDixon	  techniques	  
The objective of this study is to compare Dixon-based MRI techniques for fat 
quantification at 3T with magnetic resonance spectroscopy (MRS) in vitro and in vivo. 
In vitro, two- three- and four-point mDixon sequences, with 10°, 20° and 30° flip angles 
were acquired from seven test phantoms with sunflower oil-water percentages of 0-60% 
sunflower oil and calculated fat-water ratios compared with MRS. In-vivo, two- three- 
and four-point mDixon sequences with 10° flip angle were acquired and compared with 
MRS in the vastus medialis of nine typically developing subjects (aged 30.6 ± 5.3, BMI 
22.2 ± 2.6). This study is published in The British Journal of Radiology, 87 (1036), 
2014. This paper is included in Chapter 7.  
4.2.4	  	  Study	  4:	  Intramuscular	  fat	  in	  ambulant	  young	  adults	  with	  bilateral	  
spastic	  cerebral	  palsy	  
It is known that individuals with BSCP have small and weak muscles. However, no 
studies to date have investigated intramuscular fat infiltration in this group. The 
objective of this study is to determine whether adults with BSCP have greater inter- and 
intramuscular fat than their typically developing peers.  
 
Ethical approval for this study was granted by Hampstead Research Ethics Committee 
London (09/H0720/120). The ethical approval letter and subject information sheets are 
given in Appendix B. 10 young adults with BSCP (7 male, mean age 22.5 years, 
GMFCS levels I-III), and 10 typically developing young adults (6 male, mean age 22.8 
years) took part in this study. 11 cm sections of the left leg of all subjects were imaged 
using multi-echo gradient echo chemical shift imaging (mDixon). Percentage 
intermuscular fat, intramuscular fat, and a subcutaneous fat to muscle volume ratio 
(SF/M) were calculated. This study is discussed in more detail in Chapter 8. 
4.2.5	  	  Study	  5:	  Spinal	  cord	  development	  in	  bilateral	  spastic	  cerebral	  palsy	  
The most common cause of BSCP, PVL, tends to occur between 24 and 33 PCW, 
before the transient spinal terminations of the corticospinal tract in the spinal cord grey 
matter have been eliminated and mature projections onto the cells of the spinal grey 
matter have formed. As a result of the injury, intrinsic cord networks may not mature 
and muscle development may be delayed30. Therefore, spinal cord and subsequent 
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muscle development is likely to be affected by the extent, severity and timing of the 
original brain injury. The objective of this study is to investigate the organisation of 
white matter in the spinal cord at the thoracic (T10-11) and cervical (C6-7) in 
individuals with BSCP using DTI MRI.  
 
National Research Ethics committee West London (11/LO/1520) granted ethical 
approval for this study. The ethical approval letter and subject information sheets are 
given in Appendix C. 11 participants with BSCP were recruited to the study (mean age: 
16.4 years ± 4.2; age range: 12.1 – 25.5 years; GMFCS level I: n=1, level II: n=4, level 
III n=5, level IV: n=1; 11 male) from clinics in our university hospital. Ten TD subjects 
were included in this study (mean age: 16.9 years ± 3.9; age range: 12.3 – 23.2 years, 12 
male). The TD subjects had no previous surgery to their lower limbs and had no known 
neurological or musculoskeletal conditions. The T10/11 data from one TD subject was 
excluded from analysis due to significant subject movement during image acquisition. 
Diffusion measures of microstructure including fractional anisotropy and apparent 
diffusion coefficients will be compared between spinal levels and subject groups. 
Relationships between DTI measures and lower limb muscle volume and measures of 
selective motor control (SCALE) and functional ability (GMFM) in the case subjects 
will also be investigated. This study is discussed in more detail in Chapter 9. 
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5. Lower	  limb	  muscle	  
volumes	  in	  bilateral	  spastic	  
cerebral	  palsy	  
Abstract	  
Muscle weakness is a feature of individuals with bilateral spastic cerebral palsy (SCP) 
but there are few reports in the literature of muscle volume in this group. This study 
compares muscle volumes in adolescents and young adults with SCP with those of their 
typically developing (TD) peers. Measurements of the volumes of nine major lower 
limb muscles in 19 independently ambulant subjects with SCP (mean age 14.2 ± 2.7 
years, 11 male, GMFCS I (n=5); GMFCS II (n=14)), 19 TD subjects (mean age 16.5 ±  
3.0 years, 11 male) were made using magnetic resonance imaging.  Muscle volumes 
were normalised to body mass to minimise the non-pathological variance in muscle 
size. 
 
Lower limb muscles were smaller in the SCP group (p≤0.023 in all muscles) than the 
TD group with the exception of the vastii (lateralis + intermedius; p=0.868) and gluteus 
maximus (p=0.056). Average muscle volume deficit was 27.9%. Muscle volume 
deficits were significantly greater for distal muscles than proximal muscles (p<0.001). 
Reduced muscle size in adolescence and the natural history of sarcopenia in adulthood 
may contribute to the early loss of mobility of adults with SCP. 
 
This chapter is the published manuscript in Brain & Development 36 (2014) 294-300. 
Additional information including tables of results and example images are given in 
Appendix D. 
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Abstract
Aim: Muscle weakness is a feature of individuals with spastic cerebral palsy (SCP) but there are few reports in the literature of
muscle volume in this group. This study compares muscle volumes in adolescents and young adults with SCP with those of their
typically developing (TD) peers. Design:Measurements of the volumes of nine major lower limb muscles in 19 independently ambu-
lant subjects with SCP (mean age 14.2 years (sd 2.7), 11 male, GMFCS I (n = 5); GMFCS II (n = 14)), 19 TD subjects (mean age
16.5 years (sd 3.0), 11 male) were made using magnetic resonance imaging. Results: Lower limb muscles were smaller in the SCP
group (p 6 0.023 in all muscles) than the TD group with the exception of the vastii (lateralis + intermedius; p = 0.868) and gluteus
maximus (p = 0.056). Average muscle volume deficit was 27.9%. Muscle volume deficits were significantly greater for distal muscles
than proximal muscles (p < 0.001). Conclusions: Reduced muscle size in adolescence and the natural history of sarcopenia in adult-
hood may contribute to the early loss of mobility of adults with SCP.
! 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Keywords: Cerebral palsy; Independently ambulant; Lower limb; Muscle volume; Magnetic resonance imaging
Muscle weakness in individuals with spastic cerebral
palsy (SCP) is well documented [1] and is in part attrib-
utable to reduced activation of the muscles in SCP [2–4]
and to co-activation of agonists and antagonists [2,3].
Wiley and Damiano [1] demonstrated that during max-
imum voluntary contractions the muscle groups of chil-
dren with SCP may produce only between 30% and 75%
of the force of their typically-developing (TD) peers.
Stackhouse et al. [2] compared forces from the quadri-
ceps and plantarflexors during maximum voluntary con-
traction and augmented voluntary activation using
electrical stimulation in groups of children with SCP
and TD children. In both groups muscles could produce
substantially greater forces when electrically stimulated.
However, data from the subjects with SCP implied that
lack of voluntary activation of the musculature alone
could not explain muscle weakness. Elder et al. [4]
attempted to quantify the agonist–antagonist co-activa-
tion and cross-sectional area of the triceps surae in chil-
dren with SCP and found that both contributed
significantly to weakness during voluntary activation.
Their study investigated the triceps surae only and was
limited to a small number of children.
Investigations of gross muscle morphology in SCP
have largely been confined to the medial gastrocnemius.
Volume deficits have been reported in children and
young adults of between 22% and more than 50% [5–
0387-7604/$ - see front matter ! 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
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7]. Fewer studies include measurements of muscle size
for the whole lower limb. Lampe et al. [8] studied muscle
volumes and lengths in a group of young adults with
unilateral SCP using MRI. They found significant
reductions in muscle volumes for nearly all the muscles
in the lower limb when compared to the non-paretic
limb and noted that the proximal musculature was less
aﬀected than the distal musculature. Riad et al. [9] also
reported significantly reduced muscle volume for the
majority of the muscles in the lower limb compared to
the non-paretic limb in adolescents and young adults
with unilateral SCP. However, these studies did not
include TD adults as controls and was limited to unilat-
eral subjects. Oberhofer et al. [10] published MRI data
from a young group of six children with SCP (four bilat-
erally aﬀected) and a matched group of TD children.
They found significant diﬀerences in muscle volumes
(normalised to body mass) for the quadriceps and the
hamstrings in the children with CP, but not for the calf
muscles. Their results are in contrast to Fry et al. [7] who
found very large diﬀerences in muscle volume in the gas-
trocnemius muscles, and to Lampe et al. [8] who found
the distal muscles to be more aﬀected. A recent review of
muscle morphology in SCP by Barret and Lichtwark
[11] highlights the limited volume data studies published
to date.
In this paper we measured the volume of nine major
muscles of the lower limbs in adolescent and young
adult subjects with bilateral SCP and in TD subjects.
We hypothesised that we would find large reductions
in muscle volumes in the individuals with SCP, and that
the distal muscles would be more aﬀected than the prox-
imal ones due to increased distal motor impairment in
this group [12].
1. Materials and methods
1.1. Participants
The local research ethics committee granted ethical
approval for this study. SCP group inclusion criteria:
age 10–24 years, diagnosis of bilateral SCP, Gross
Motor Function Classification System (GMFCS) levels
I–III and met the safety requirements of MRI. Patients
were excluded from the study that had undergone sur-
gery, serial casting or botulinum toxin injections to the
lower limbs within the previous year. This is a conve-
nience sample of individuals attending our hospital
department, with consecutive patients that met the
inclusion criteria were invited to participate in the study.
Nineteen participants with bilateral SCP were recruited
to the study (mean age: 14.4 years; age range: 10.2–
19.7 years, GMFCS level I: n = 5, level II: n = 14, 11
male) from clinics in our university hospital. Nineteen
TD subjects were included in this study (mean age:
16.5 years; age range: 10.6–22.3 years, 11 male, 8
female). The TD subjects had not had no previous sur-
gery to their lower limbs and had no known neurologi-
cal or musculoskeletal condition.
1.2. Data collection and analysis
Both lower limbs of all subjects were acquired with
contiguous transverse slices from above the iliac crest
to below the calcaneum. All subjects lay supine on the
scanner bed and went feet first into the scanner with
their feet resting against a wooden footplate giving an
approximate plantarflexion angle of 25!.
All MRI data was collected on a 1.5 T Phillips Achi-
eva system (Philips Medical Systems, Best, The Nether-
lands). Seven SCP and nine TD subjects were scanned
using a T1 weighted turbo spin echo sequence (TE/
TR = 18/1104.4 ms, number of averages = 2, echo train
length = 3, 1.8 ! 1.8 mm in-plane voxel size) with a
quadrature body coil. Slices were collected contiguously
with a slice thickness of 2 mm over the hip, knee and
ankle joints and every 4 mm over the remainder of the
lower limb. Image acquisition took approximately
20 min for each subject. Data was also collected from
twelve SCP and ten TD subjects using a three point
Dixon sequence (TE/TR = 4.6/13 ms, echo time
shift = 1.53 ms (120! echo phase shift), 20! flip angle,
0.9 ! 0.9 mm in-plane voxel size, number of aver-
ages = 2, 5 mm slice thickness) with a quadrature body
coil. Each scan took approximately 30 min.
Volume measurements were performed using Osirix
[13] (version 3.7.1). Visually, the proximal and distal
endpoints of each muscle belly were identified and
regions of interest were outlined on every image slice
with the exception of T1 weighted scans with 2 mm slice
thickness where regions were drawn on every other slice
(eﬀective slice thickness = 4 mm). The total volume was
calculated within the software as the sum of the outlined
cross sectional areas multiplied by slice thickness. The
volumes of the medial gastrocnemius (MG), lateral gas-
trocnemius (LG), soleus (SOL), tibialis anterior (TA),
rectus femoris (RF), vastus intermedius and lateralis
composite (VI + VL), semimembranosus (SM), semtien-
dinosus (ST), and gluteus maximus (GMax) were mea-
sured. Sections of the boundary between VL and VI
are diﬃcult to identify in MRI. Therefore, to remove
potential boundary inaccuracies, VL and VI were mea-
sured as a group VL + VI.
Individuals with SCP tend to be shorter and lighter
than TD children of similar age [14]. To account for dif-
ferences in body size across the age range and between
groups, muscle volumes were normalised to body mass
[6,7]. In general, the volumes of each muscle were aver-
aged across legs of individual subjects prior to statistical
analysis of normalised muscle volume between the two
groups. When data was not available from a particular
muscle due to image artefacts or subject compliance,
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volume data for that muscle was taken from a single
limb.
Shapiro–Wilks tests of normality found that the mea-
sured volume data was not normally distributed for all
muscles (p > 0.05), and required non-parametric statis-
tics. Therefore, independent sample median test were
used to test for diﬀerences in normalised muscle volume
between the two subject groups for each muscle investi-
gated. Percentage muscle deficits (PMD) were calculated
for the SCP group using Equation 1 and related samples
Wilcoxon signed rank test was used to investigate
whether the proximal (GMax, RF, VL + VI, SM, ST)
or distal (MG, LG, SOL, TA) muscles were more
aﬀected. Since multiple statistical tests (10) were per-
formed on the same subjects, the Benjamini [15] method
to correct for false discovery rate was used. All statisti-
cal tests were performed using SPSS (Version 20.0; IBM
SPSS, Chicago, USA).
PMD ¼ 100" ðmeancontrol $ valuecaseÞ
meancontrol
ð1Þ
where PMD = percentage muscle deficit,
meancontrol = mean normalised value for TD subjects,
valuecase = normalised value for a subject with SCP.
2. Results
The physical characteristics of subjects in the SCP
and TD groups are summarised in Table 1. There was
no significant diﬀerence in age (p = 0.052), height
(p = 0.052), or BMI (p = 0.052) between the groups:
however, body mass (p < 0.001) was significantly smaller
in the SCP group (Independent samples median test).
The subjects had undergone a range of previous inter-
ventions (see Table 2) but none within the previous year.
Three of the subjects with SCP had previously had
undergone femoral de-rotation osteotomies. These sub-
jects had internal fixation devices on the lateral aspect
of their proximal femurs that distorted the MRI images
around this area preventing accurate assessment of RF,
VI + VL, SM, ST and GMax. Persistent muscle activa-
tion or subject movement in 4 SCP subjects and 3 TD
subjects prevented accurate delineation of various mus-
cles for each of these subjects. One SCP subject became
unwell during the MRI scan, which meant that images
of the thigh region could not be collected. In the other
eleven SCP and sixteen TD subjects all the muscles
could be measured. The total number of muscles mea-
sured for each muscle is given in Fig. 1a.
Muscle volumes were normalised to body mass
because of the strong and significant correlation
between MG muscle volumes and body mass shown in
our previous work [6]. Significant linear relationships
were also found between muscle volume and body mass
amongst the TD subjects for all muscles in this study
with the exception of ST, as shown in Table 3. When
normalised to body mass, muscle volumes did not vary
significantly with either height or subject age.
Fig. 1a shows a histogram of normalised muscle vol-
ume for each muscle measured. A significant diﬀerence
(Independent samples median tests with correction for
multiple tests, Benjamini [13]) in normalised muscle vol-
ume was found between the SCP and TD subject groups
for all muscles with the exception of the GMax and
VI + VL composite (individual p-values are given in
Fig. 1a. The mean PMD of all muscles combined was
27.9%, with the mean PMD ranging between 8.2% for
VI + VL and 38.4% for MG (see Fig. 1b). In the individ-
uals with SCP, distal muscles were more aﬀected than
proximal muscles and (p < 0.001, see Fig. 1b).
3. Discussion
Individuals with SCP have profound muscle weak-
ness that compromises their physical performance [16–
18]. However, the sizes of the muscles throughout the
lower limb in this group have been elucidated in very
few studies [8,10]. Here, we measured the volume of nine
of the largest muscles in the lower limb and found them
all (with the exception of VI + VL and GMax) to be sig-
nificantly smaller in a group of ambulant adolescents
and adults with SCP than in a group of TD young peo-
ple of comparable age and sex, even when muscle vol-
ume was normalised to body mass (Fig. 1a). Average
muscle volume deficits ranged from 8.2% for the
VI + VL to 38.3% for MG. We found that distal mus-
cles had greater deficits in volume than proximal mus-
cles (Fig. 1b).
The deficits in muscle volume of the plantarflexors in
this study were similar to those we have previously
reported for the medial gastrocnemius in children with
bilateral SCP awaiting surgery [7]. Overall, the reduc-
tions in muscle volume recorded throughout the limb
were larger than those reported in a study of young
adults with unilateral SCP [8]. These authors did not
Table 1
Physical characteristics (mean ± standard deviation) of SCP and
control groups and number of SCP subjects in each GMFCS levels
(I–II).
SCP group TD group
Number of subjects 19 19
Age (years) 14.4 ± 2.7 16.5 ± 2.0
Sex (m, f) 11, 8 11, 8
Body mass (kg) * 44.3 ± 11.5 67.2 ± 18.3
Height (m) 1.55 ± 0.13 1.72 ± 0.12
BMI (kg/m2) 18.2 ± 2.8 22.5 ± 4.0
GMFCS level I 5 –
GMFCS level II 14 –
* Denotes significant diﬀerence between groups (p = 0.001).
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have an independent control group but rather used the
non-paretic limb as a control. In which case, they may
have underestimated the deficits in muscle volume in
the paretic limb. The statistically insignificant deficit of
the quadriceps and gluteus maximus muscle volumes
in our study suggests that these muscles may be utilised
more than the other muscle groups in functional tasks
and, therefore, a larger muscle volume is maintained.
Muscle weakness is not caused by reduced muscle size
alone, but also by reduced muscle activation [2–4] and
increased co-activation [2,3]. Stackhouse et al. [2] mea-
sured the torques produced by maximum voluntary con-
traction (MVC) and by MVCs augmented by electrical
stimulation, from the plantarflexor and quadriceps mus-
cle groups in ambulant children with bilateral SCP
(n = 12, age range: 7–13 years) as well as TD subjects
(n = 10, age range: 8–12 years). They found that the
force (normalised to body mass) that could be generated
by MVC alone was 56% lower for the quadriceps and
73% lower for the plantarflexors in those with bilateral
SCP compared to control children. In addition, those
with SCP were able to activate 33% and 49% less of
the available mechanical potential of their quadriceps
and plantarflexors respectively than control subjects.
Barber et al. [19] found 33% lower active ankle plantar-
flexion torque across the available range of ankle joint
motion in SCP compared to their TD peers. This
reduced ankle platarflexion torque was partially
explained by 37% smaller medial gastrocnemius muscle
and 4% greater antagonistic co-contraction. The Achil-
les tendon slack length was also 10% longer in the
SCP group. A relationship between reduced muscle acti-
vation and muscle volume is plausible: those with SCP
may not develop suﬃcient tension frequently enough
to encourage normal muscular growth [2,19].
3.1. Clinical implications
In previous studies, significant relationships have
been found between muscle morphological parameters,
strength and function in individuals with SCP. Ohata
et al. [20] found a significant relationship between quad-
riceps muscle thickness and GMFCS level. Moreau et al.
[21] demonstrated a strong relationship between VL
thickness and knee extensor voluntary strength. We
have previously shown that intense exercise may
increase muscle volume in the plantarflexors of children
with SCP [22], and two other studies have shown that
neuromuscular electrical stimulation may also result in
increases in muscle volume [23] and cross-sectional area
[24]. It is possible that training exercises that produce
increases in muscle volume may also increase muscle
strength and improve function in this group, though
perhaps, the more significant problem of reduced muscle
growth, in these young people, is the eﬀect on their long-
term function. Their limited muscular reserve may
expose them to the deleterious eﬀects of aging on muscle
earlier than their typically developing peers, and result
Table 2
Previous interventions in the group of adolescents and adults with SCP.
Subject Surgery Botulinum toxin injection
1 Bilateral Achilles tendon lengthening (x3) None
Right hamstring lengthening
2 Bilateral gastrocnemius lengthening None
Left calcaneal osteotomy
3 None None
4 Bilateral psoas release, medial hamstring lengthening and rectus femoris transfer Bilateral gastrocnemius (x2)
Bilateral to hamstrings (x1)
5 None None
6 Bilateral psoas release and gastrocnemius lengthening, and femoral derotation None
7 Right femoral derotation None
Bilateral hamstring and gastrocnemius lengthening
8 Left tibialis posterior recession and gastrocnemius lengthening Left gastrocnemius (x1)
Left tibialis posterior (x1)
9 Left hamstring lengthening Left gastrocnemius (x2)
10 None None
11 None None
12 Right tibialis posterior, Achilles tendon, flexor digitorum longus, and flexor hallucis longus lengthening Right gastrocnemius (x1)
13 Bilateral hamstring lengthening Right gastrocnemius (x1)
Right Achilles tendon, gastrocnemius and soleus lengthening Right hamstrings (x1)
14 Hamstring lengthening bilaterally Bilateral gastrocnemius (x4)
Left Achilles tendon lengthening
15 Left hamstring and gastrocnemius lengthening None
16 Right femoral derotation osteotomy and gastrocnemius lengthening None
17 Bilateral hamstring lengthening None
18 None None
19 None None
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in an early loss of mobility [25]. Preserving muscle vol-
ume may enhance long-term mobility in SCP.
There was much greater variation in normalised mus-
cle volume for the young people with SCP than for their
typically developing peers. Some of this variability in
normalised muscle volume appears to be related to
GMFCS level (see Fig. 2). However, the unequal group
sizes (GMFCS level I [n = 5] and II n = 14]) limits
power of this study to determine the contribution of
GMFCS level on muscle volume. Volume imaging
may have a role in tailoring individual treatment. For
example, smaller muscles may benefit most from resis-
Fig. 1. (a). Normalised muscle volumes in the SCP group (white) and TD group (grey) for all muscles investigated. Where N = number of subjects
(TD, SCP), p = p-value and *denotes a significant result (Benjamini corrected [13]). (b). Group averaged percentage muscle volume deficits for each
muscle separately and for muscles grouped by anatomical location (distal, proximal) for the SCP group compared to the TD group mean. Error bars
represent the standard error for each category.
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tance training, and knowledge of muscle size may be
useful in dose optimisation for improving the eﬃcacy
of botulinum toxin injections.
3.2. Limitations
The number of subjects recruited may limit the scope
and power of this study to investigate the relationship
between muscle volumes and other variables such as
gross motor function. Voluntary muscle strength
depends on many factors, including age, sex and levels
of voluntary muscle activation, as well as muscle size,
architecture and composition. A future more sophisti-
cated study is required to enable the muscular and neu-
rological components of muscle weakness in SCP to be
separated out. However, the diﬀerences in normalised
muscle volume between the TD and SCP groups were
large (see Fig. 1a) and we found the aﬀected muscles
to be significantly smaller for all muscles except
VI + VL and GMax. Muscle volume deficits will con-
tribute to the weakness observed in the lower limbs of
individuals with CP [1], during voluntary activation as
well as more automatic activities such as walking.
It is possible that the diverse histories of surgical
intervention, serial casting, botulinum toxin injections
and physiotherapy received by the individuals with
SCP in this study may have influenced the development
of particular muscles. Unfortunately, it is not possible to
recruit a representative group of young adults and ado-
lescents with SCP who have not had significant interven-
tion during their lifetime. Longitudinal studies of the
natural history of muscle impairments in SCP, as well
as the eﬀect of intervention, are required to improve
the selection of treatments in this group and preserve
muscle mass.
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Error bars represent the standard error of each group.
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6. Bone	  strength	  and	  muscle	  
volume	  in	  bilateral	  spastic	  
cerebral	  palsy	  
Abstract	  
There is a high prevalence of fractures in individuals with cerebral palsy148-152, 
commonly occurring in the distal femur and proximal tibia150.	   The objective of this 
chapter is to investigate whether bone strength in the distal femur and proximal tibia is 
related to local muscle volume in ambulant individuals with bilateral spastic cerebral 
palsy (BSCP). Twenty-seven participants with CP (mean age: 14.6 ± 2.9 years; Gross 
Motor Function Classification System (GMFCS) levels I-III) and twenty-two typically 
developing (TD) peers (mean age: 16.7 ± 3.3 years) took part in this study. Periosteal 
and medullary diameter in the distal femur and cortical bone cross-sectional area (CSA) 
and thickness (CT) in the distal femur and proximal tibia were measured along with 
nine lower limb muscle volumes using MRI. Additionally, the polar section modulus 
(Zp) and buckling ratio (BR) were calculated to estimate bone bending strength and 
compressional bone stability respectively in the distal femur. The relationships of all 
measured parameters with muscle volume, height, age, body mass, gender, and subject 
group were investigated using a generalized linear model (GZLM). 
 
In the distal femur, Zp was significantly positively related to thigh muscle volume 
(p=0.007), and height (p=0.026) but not significantly related to subject group (p=0.076) 
or body mass (p=0.098). BR was not significantly different between groups and was not 
related to any of the variables tested. Cortical bone CSA was significantly lower in the 
BSCP group at both the distal femur (p=0.002) and proximal tibia (p=0.009).  It was 
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also positively associated with thigh muscle volume (p<0.001) at the distal femur, and 
with subject height (p=0.005) at the proximal tibia. 
 
Conclusions: Bending and compressional strength of the femur, estimated from Zp and 
cortical bone CSA respectively, is associated with reduced thigh muscle volume. 
Increasing muscle volume by strength training may have a positive effect on bone 
mechanics in individuals with BSCP. 
 
The work in this chapter has been published in Bone (Noble et al. Bone 2014 Sep; 
66:251-5). 
6.1	  	   Introduction	  
There is a high prevalence of fractures in individuals with cerebral palsy148-152, with 
lower limb fractures most prevalent149,150, commonly occurring in the distal femur and 
proximal tibia150. In ambulant children with cerebral palsy, fractures are most 
commonly sustained through significant trauma. In typically developing children and 
adolescents, factors associated with bone fractures are bone mineral density (BMD), 
bone geometry, and bone size153,276. Poor nutrition, lack of weight-bearing physical 
activity, obesity and high exposure to trauma may also influence fracture risks in the 
general paediatric population153.  	  
Although Dual-energy X-ray Absorption (DXA) is the most common method for 
measuring BMD in cerebral palsy, the technique suffers from systematic errors that 
depend on skeletal site and body size154.  Since individuals with cerebral palsy often 
have a smaller body size than their TD peers155, an apparent low BMD score may be 
measured when assessed by DXA. Gold standard assessments using peripheral 
quantitative computed tomography, pQCT, suggest that children with cerebral palsy do 
not have a deficit in BMD, but in fact have reduced cortical bone thickness (CT)147. 
Bone geometry can also be assessed using MRI277, which has shown reduced cortical 
bone thickness at the mid-femur of children with quadriplegic cerebral palsy156. 
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Bone strength is related to BMD, however it is determined predominantly by bone 
geometry. The ability of a bone to resist bending and torsional forces (estimated using 
the polar section modulus, Zp) is inversely proportional to bone length to the third 
power and directly related to bone diameter to the third power88. The stability of a bone 
to compressional forces can be estimated by the buckling ratio (BR), which is a ratio of 
the bone radius to cortical bone thickness. In typically developing children, before and 
after puberty, bone strength and geometry is determined primarily by bone length and 
muscle CSA, modulated by physical activity and dietary calcium91. 
 
In adults, bone mass decreases with age: bending strength is maintained by a gradual 
increase in bone diameter by periosteal addition of bone, and endosteal resorption 
leading to a wider bone and a relatively thinner cortex. This maintains bending strength 
but reduces the ability of the bone to remain stable in the presence of larger compressive 
loads. In non-ambulant children with cerebral palsy, femoral bone bending and torsional 
strength, estimated from geometric measures, is lower than their typically developing 
peers156. Bone geometry in ambulant young adults with cerebral palsy has not been 
assessed.  
 
Mechanical forces are a significant factor affecting bone strength and development. 
Longitudinal growth increases the length of lever arms and bending moments leading to 
greater forces experienced by the bone80, with bending and torsional forces being the 
predominant loading factors in the long bone diaphysis82,83. Muscle weakness55 and 
reduced muscle volumes53,56-61,278 in individuals with cerebral palsy is well documented. 
Therefore, in individuals with cerebral palsy, the reduced bone strength and increased 
fracture rate may be due to the reduced mechanical loading applied to the bones by the 
local musculature. If there is relationship between bone strength and muscle size, this 
may provide an alternative treatment option to clinicians for reducing the fracture rate in 
this group.  
  
In this study we investigate bone strength at the most common fracture sites in cerebral 
palsy: the distal femur and proximal tibia150. Cortical bone cross-sectional area (CSA) 
and cortical bone thickness (CT) in the distal femur and proximal tibia, femoral cross-
sectional geometry, and the volume of nine major muscles of the lower limbs were 
measured in adolescent and young adults with bilateral spastic cerebral palsy (BSCP) 
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and their typically developing (TD) peers. Bone strength in the distal femur was 
estimated through calculation of Zp and BR. We hypothesised that cortical bone CSA, 
CT, BR and Zp are significantly related to the local muscle volume, independently of 
diagnosis and body mass.  
6.2	  	   Materials	  &	  Methods 
6.2.1	  	  Participants	  
The local research ethics committee granted ethical approval for this study. Individuals 
aged 10 – 24 years, with a diagnosis of bilateral spastic CP, Gross Motor Function 
Classification System (GMFCS) levels I-III, who met the safety requirements of MRI 
were included in this study. Patients who had undergone surgery, serial casting or 
botulinum toxin injections to the lower limbs within the previous year were excluded 
from the study. None of the subjects had had previous osteotomies of the long bones. 
This was a convenience sample of individuals attending our hospital department, with 
consecutive patients that met the inclusion criteria invited to participate in the study. 27 
participants with bilateral spastic CP were recruited to the study (mean age: 14.6 years; 
age range: 10.2 – 23.1 years, GMFCS level I: n=5, level II: n=17, level III n =5, 19 
male, 8 female) from clinics in our university hospital. 25 TD subjects were included in 
this study (mean age: 16.7 years; age range: 10.6 – 23.2 years, 17 male, 5 female). The 
TD subjects had no previous surgery to their lower limbs and had no known 
neurological or musculoskeletal condition. Z-scores for height-to-age and BMI-to-age 
were calculated based on the World Health Organization (WHO) growth reference 
data279. For individuals 20 years of age and older, the age-19 height and BMI z-score 
reference have been used in order to have a consistent metric of relative height and BMI 
for all subjects. 
6.2.2	  	  Data	  collection	  and	  analysis	  
MRI images of both lower limbs of all subjects were acquired with contiguous 
transverse slices from above the iliac crest to below the calcaneum. All subjects lay 
supine on the scanner bed with their feet resting against a wooden footplate giving an 
approximate plantarflexion angle of 25 degrees. 
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MRI data was collected on 1.5 T and 3.0 T Phillips Achieva systems (Philips Medical 
Systems, Best, The Netherlands). On the 1.5 T MRI system, seven BSCP and nine TD 
subjects were scanned using a T1-weighted turbo spin echo sequence 
(TE/TR=18/1104.4 ms, number of averages = 2, echo train length = 3, 1.8 x 1.8 mm in-
plane voxel size) with a quadrature body coil. Slices were collected contiguously with a 
slice thickness of 2 mm over the hip, knee and ankle joints and every 4 mm over the 
remainder of the lower limb. Image acquisition took approximately 20 minutes for each 
subject. On the 3.0T system, 12 BSCP and 10 TD subjects using a three point Dixon 
sequence (TE/TR=4.6/13 ms, echo time shift = 1.53 ms (120 o echo phase shift), 20o flip 
angle, 0.9 x 0.9 mm in-plane voxel size, number of averages = 2, 5 mm slice thickness) 
with a quadrature body coil. Each scan took approximately 30 minutes. On the 3.0T 
MRI system, data was collected from eight CP and six TD subjects using a three point 
Dixon sequence (TE/TR=2.11/5.2 ms, echo time shift = 0.76 ms (120 o echo phase 
shift), 10o flip angle, 1.2 x 1.2 mm in-plane voxel size, number of averages = 2, 5 mm 
slice thickness) with a quadrature body coil. Image acquisition took approximately 15 
minutes for each subject. 
 
The proximal and distal endpoints of the femur and tibia were identified in the MRI 
images and the length of the bones calculated as the distance between the end points for 
each bone. The distal femur and proximal tibia were defined as 70% and 30% along the 
length of the bone from the proximal ends respectively. Cortical CSA was measured at 
the distal femur and proximal tibia by drawing regions of interest around the inner and 
outer cortical bone boundaries. Periosteal (T) and medullary diameter (M) were 
measured in the anterior-posterior direction at the distal femur and medio-laterally in 
the proximal tibia. CT was calculated using Equation 6.1. In the distal femur, assuming 
a cylindrical bone shape with circular cross-section, the polar moment of inertia (J) is 
calculated using Equation 6.289. The polar section modulus (Zp), which is a measure of 
torsional and bending strength, is calculated using Equation 6.390. Stability to 
compressional force was estimated by using the buckling ratio (BR), which is a ratio of 
the bone radius (r) to cortical bone thickness (CT) given by Equation 6.4.  
 
The proximal and distal endpoints of each muscle belly were identified and regions of 
interest around the muscle cross-sections were manually outlined on every image slice 
with the exception of T1-weighted scans with 2 mm slice thickness where regions were 
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drawn on every other slice (effective slice thickness = 4 mm). The total volume was 
calculated within the software as the sum of the outlined cross sectional areas multiplied 
by slice thickness. The volumes of the medial gastrocnemius (MG), lateral 
gastrocnemius (LG), soleus (SOL), tibialis anterior (TA), rectus femoris (RF), vastus 
intermedius and lateralis composite (VI+VL), semimembranosus (SM), semtiendinosus 
(ST), and gluteus maximus (GMax) were measured. Sections of the boundary between 
VL and VI are difficult to identify in MRI. Therefore, to remove potential boundary 
inaccuracies, VL and VI were measured as a group VL+VI. The total thigh and shank 
muscle volumes were calculated from the addition of RF, VI+VL, SM, ST, GMax, and 
MG, LG, SOL, TA respectively. All MRI image measurements were performed 
manually using Osirix (version 3.7.1; Pixmeo, Geneva, Switzerland)280.  
 







Where  T = Periosteal diameter 
M = Medullary diameter 
        r = Bone radius 
 
Data from the left or right limb of each subject was selected at random. When data was 
not available from a particular limb due to image artefacts or lack of subject 
compliance, muscle volume and bone geometric data were taken from the other limb. 
Shapiro-Wilks tests of normality found that the measured cortical bone CSA and CT in 
the femur and tibia, and Zp and BR in the femur were normally distributed (p>0.05). A 
generalized linear model (GZLM) was employed to investigate relationships between 
cortical bone CSA, Zp, and BR with muscle volume. Subject group and gender were set 
as fixed factors, with shank and thigh muscle volume, height, age, and body mass as 
covariates. Multiple linear regression analysis was subsequently performed to assess 
linearity of the significant factors from the GZLM with each of the dependent variables 
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for cortical bone (CSA, CT, Zp, and BR). Co-linearity of the covariates was assessed by 
calculating the variance inflation factor (VIF) with the VIF co-linearity threshold set to 
10281. All statistical tests were performed using SPSS (Version 20.0; IBM SPSS, 
Chicago, USA). 
6.3	  	   Results	  
The physical characteristics of the CP and TD subject groups are summarised in Table 
6.1. The CP group was significantly younger (p=0.02), shorter (p<0.001) and lighter 
(p<0.001) than the TD group. There was no significant difference in BMI (p=0.392). 
Height-for-age and BMI-for-age Z-scores were significantly lower in the CP group 
(p<0.001 and p=0.013 respectively). VIF scores for co-linearity between the 
independent variables (age, height, body mass, and shank and thigh muscle volume) are 
summarised in Table 6.2. All VIF scores were less than 10, and therefore, all 
independent variables were included in the GZLM analysis. Example MRI images of 
the thigh and tibia of one CP subject and one TD subject along with the corresponding 
cortical bone CSA regions of interest are given in Figure 6.1. Group comparisons of 
thigh and shank muscle volume normalised to body weight are shown in Figure 6.2 and 
Table 6.3. Group comparisons of cortical bone CSA, CT, Zp, and BR are given in 
Figure 6.3 and Table  6.3.   
 
 CP Group TD Group 
Number of subjects 27 25 
Age (years)* 14.6 ± 2.9 16.7  ± 3.3 
Gender (m,f) 19, 8 17, 8 
Body mass (kg)* 48.2  ± 14.8 66.9  ± 17.0 
Height (m)* 1.56  ± 0.13 1.72 ± 0.12 
Height Z-score for age -0.72  ± 0.87 0.70  ± 0.92 
BMI (kg/m2) 19.3  ± 3.9 22.3 ± 3.5 
BMI Z-score for age -0.29  ± 1.32 0.54  ± 0.95 
GMFCS level I 5 - 
GMFCS level II 17 - 
GMFCS level III 5 - 
Table 6.1 Physical characteristics (mean ± standard deviation) 
of CP and control groups and number of SCP subjects in each 
GMFCS levels (I-III). * Denotes significant difference between 
groups (p<0.05) 
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Age	   Body	  




Thigh	  muscle	  volume	   2.07	   4.001	   5.361	   	  
Age	   	   4.349	   4.961	   7.513	  
Body	  Mass	   	   	   4.152	   6.29	  
Height	   	   	   	   7.523	  








Figure 6.1 Example MRI images of the proximal femur (A-B,E-F) and 
tibia (C-D, G-H) for a age and sex matched TD subject (A-D) and CP 
subject (E-H). Regions of interest (green) are shown in B,D,F, and H 
identifying the inner and outer cortical bone boundaries for cortical bone 
CSA calculation. 
 
Tibial cortical bone CSA was dependent on subject group, being lower in the BSCP 
group (p=0.009), and positively related to height (p=0.005), but was not related to shank 
muscle volume (p=0.166), body mass (p=0.492), gender (p=0.335), or age (p=0.151).. 
In the GZLM, a diagnosis of BSCP explained a reduction in tibial cortical bone CSA of 
0.413 cm2, accounting for 43.2% of the difference between the groups. Tibial cortical 
bone CSA increased by 0.024 cm2 and 0.028 cm2 per cm height in the BSCP and TD 
groups respectively. Within the multiple linear regression analysis, height explained 
39.3% and 46.5% of the variance in tibial cortical bone CSA in the BSCP and TD 
subject groups respectively. A plot of proximal tibial cortical bone CSA versus the 
predicted tibial cortical bone CSA by subject height in each group is shown in Figure 
6.4. CT in the proximal tibia is not significantly related to subject group (p=0.751), 
shank muscle volume (p=0.064), height (p=0.713), body mass (p=0.437), age 
(p=0.905), and gender (p=0.916).  
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Figure 6.2 Thigh and shank muscle volume 
normalized to body mass in the CP group 
(white) and TD group (grey). Error bars 
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Figure 6.3 Cortical bone CSA in the proximal tibia and 
distal femur, and calculated Zp and BR in the femur for 
the CP group (white) and TD group (grey). Error bars 
represent the standard error in each group. 
 
	   	   	   95%	  Confidence	  Interval	   	   	  









CP	   49.60	   42.22	   56.98	   16.22	   3.54	  
Body	  Mass	  (kg)	  
TD	   66.51	   59.40	   73.62	   16.04	   3.42	  
CP	   1.56	   1.51	   1.62	   0.13	   0.03	  
Height	  (m)	  
TD	   1.71	   1.65	   1.77	   0.13	   0.03	  
CP	   0.40	   0.32	   0.48	   0.18	   0.04	  Shank	  normalised	  
muscle	  volume	  (cm3/kg)	   TD	   0.85	   0.75	   0.96	   0.24	   0.05	  
CP	   1.40	   1.17	   1.62	   0.50	   0.11	  Thigh	  normalised	  
muscle	  volume	  (cm3/kg)	   TD	   2.37	   2.01	   2.73	   0.81	   0.17	  
CP	   2.40	   2.18	   2.61	   0.47	   0.10	  
Tibia	  CT	  (mm)	  
TD	   2.94	   2.72	   3.17	   0.51	   0.11	  
CP	   3.55	   3.21	   3.89	   0.74	   0.16	  
Femur	  CT	  (mm)	  
TD	   4.53	   4.18	   4.87	   0.77	   0.16	  
CP	   1.88	   1.65	   2.11	   0.51	   0.11	  
Tibia	  CSA	  (cm2)	  
TD	   2.81	   2.59	   3.03	   0.50	   0.11	  
CP	   1.99	   1.77	   2.22	   0.49	   0.11	  
Femur	  CSA	  	  (cm2)	  
TD	   3.02	   2.75	   3.29	   0.61	   0.13	  
CP	   3.47	   3.21	   3.74	   0.58	   0.13	  
BR	  (femur)	  
TD	   3.15	   2.93	   3.37	   0.50	   0.11	  
CP	   2.12	   1.76	   2.49	   0.81	   0.18	  
Zp	  (femur)	  (cm3)	  
TD	   3.48	   3.01	   3.95	   1.06	   0.23	  
Table 6.3 Mean, 95% confidence interval of the mean, standard deviation and standard error for the CP 
and TD groups. CT = cortical bone thickness; CSA = cortical bone cross-sectional area; BR = buckling 
ratio; Zp = polar section modulus. 
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Distal femoral cortical bone CSA was significantly related to subject group (p=0.002) 
and thigh muscle volume (p<0.001), but was not significantly related to height 
(p=0.120), body mass (p=0.299), age (p=0.279), or gender (p=0.602). In the GZLM, 
BSCP explained an overall reduction in femoral cortical bone CSA of 0.412 cm2, 
accounting for 38.6% of the difference between the groups. Femoral cortical bone CSA 
was increased by 0.871 cm2 and 0.525 cm2 per 1000 cm3 of thigh muscle volume in the 
BSCP and TD groups respectively. Thigh muscle volume explained 74.7% and 48.4% 
of the variance in femoral cortical bone CSA in the BSCP and TD subject groups 
respectively. A plot of distal femoral cortical bone CSA versus the predicted femoral 
cortical bone CSA from thigh muscle volume in each group is shown in Figure 6.5. CT 
in the distal femur is significantly related to thigh muscle volume (p=0.01) and subject 
group (p=0.05), but is not related to height (p=0.559), body mass (p=0.408), age 
(p=0.117), and gender (p=0.129). In the GZLM, BSCP explained an overall reduction in 
femoral CT of 0.444 mm, accounting for 41.7% of the difference between groups. 
Femoral CT was increased by 0.571 mm and 0.758 mm per 1000 cm3 of thigh muscle 
volume in the BSCP and TD groups respectively. A plot of distal femoral CT versus the 
predicted CT from thigh muscle volume in each group is shown in Figure 6.6.  
 
The circularity assumption for Zp and BR is valid in the distal femur with the mean 
anterior-posterior and medial-lateral periosteal diameter ratio normally distributed about 
a mean of 0.98, standard deviation 0.09. In the GZLM, Zp is significantly related to 
thigh muscle volume (p=0.007) and height (p=0.026), but is not significantly related to 
subject group (p=0.117), body mass (p=0.145), age (p=0.407), or gender (p=0.427). Zp 
increased by 0.592 cm3 per 1000 cm3 of thigh muscle volume, and by 0.038 cm3 per cm 
height. Thigh muscle volume and height explained 75.4% of the variance in Zp across 
all subjects. A plot of Zp versus the predicted Zp from thigh muscle volume and height 
is shown in Figure 6.7. BR was not significantly related to subject group (p=0.06), thigh 
muscle volume (p=0.446), height (p=0.671), body mass (p=0.670), age (p=0.197), or 
gender (p=0.095).  
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Figure	  6.7	  Thigh	  muscle	  volume	  and	  height	  predicted	  Zp	  in	  the	  distal	  femur	  versus	  measured	  Zp	  for	  both	  groups	  (R2	  =	  0.754). 
 
6.4	  	   Discussion	  
As hypothesised, this study has found that distal femoral cortical bone CSA, CT, and 
bone-bending strength (measured by Zp) is significantly related to the local muscle 
volume in ambulant individuals with BSCP.  The significantly reduced lower limb 
muscle volume in this group53,56-61,278 means that there is reduced mechanical loading 
experienced by the bones, therefore, stimulating bone growth less than in their TD 
peers. However, contrary to the hypothesis, tibial cortical bone CSA and CT were not 
significantly related to muscle volume. 
 
Femoral bone-bending strength estimated from bony geometry (Zp) is related to thigh 
muscle volume and height, together accounting for 75.4% of the variation in Zp across 
groups. This result is consistent with the Mechanostat Theory86,87. In this theory, the 
muscle-bone relationship, expressed as the “muscle-bone unit,” is modelled as a 
mechanical relationship in which bone remodelling is mediated by strain induced by 
muscle action and modulated by the hormonal system. Height is also an important 
factor influencing bending strength, with longer bones experiencing greater bending 
moments. Stability to buckling, (Buckling ratio BR) estimated as a ratio of the bone 
radius and CT, is not reduced in ambulant individuals with BSCP and is not related to 
gender, age, height, body mass, or muscle volume across the subject groups. The 
consistent BR (the ratio of bone radius to CT) across subject groups suggests that the 
overall radial geometry of the femoral diaphysis is maintained. Although BR is similar 
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between subject groups, the reduced cortical bone CSA in BSCP suggests that these 
individuals have reduced compressional bone strength.  
 
This study found that proximal tibial cortical bone CSA is related to diagnosis and 
height but not to local muscle volume. The reduced tibial cortical bone CSA suggests 
that compressional bone strength may be reduced in BSCP. The lack of a relationship 
between cortical bone CSA and local muscle volume may also be due to the irregular 
cross-section of the proximal tibia and the uneven distribution of muscle around the 
tibia. Activity level, which was not measured in this study, may further explain the 
variability of tibial cortical bone CSA in both subject groups. Forces experienced in 
high impact activities such as running and jumping are not necessarily related to the size 
and strength of the surrounding muscle. The sedentary behaviour typically observed in 
CP71,72 coupled with their reduced ability to run and jump may explain the diagnosis 
dependent reduced tibial cortical bone CSA in this study. This is an important finding 
that suggests that exercise interventions for bone strength development that utilise 
muscle-mediated loading of the long bones may have a greater impact on bone strength 
compared to traditional weight bearing therapies. However, a longitudinal study is 
required to investigate whether increasing muscle size leads to increased bone strength 
in this patient group. 
6.4.1	  	  Study	  limitations	  
The use of muscle volume as a surrogate of muscle strength is a limitation of this study 
However, measurements of muscle strength in CP are unreliable and may underestimate 
the maximum force generating capacity of muscle due to poor selective voluntary motor 
control and coactivation of antagonists53,105,106. However, muscle volume is reflective of 
the total number of sarcomeres and is linearly related to muscle power118. Therefore, it 
is reasonable to use muscle volume as a surrogate measure of maximal muscle force 
potential in CP.   
 
The CP and TD groups were convenience samples, resulting in the CP group being 
younger (p=0.02), shorter (p<0.001) and lighter (p<0.001) than the TD group. Pubertal 
stage was not assessed in this study. To accommodate difference between the groups 
age, height and body mass were covariates in our statistical analysis. 
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Zp, Br, and cortical bone CSA are not direct measurements of bone strength. Zp and Br 
are parameters that are used in the field of civil engineering for geometrically uniform 
cylinders. The material properties of bone, including cortical bone density, have not 
been measured in this study and may be altered in individuals with CP. 
 
MRI data was collected using three different MRI protocols on two scanners. The 
different protocols resulted in different images, particularly between the T1-weighted 
and Dixon sequences. This may have resulted in a systematic difference between the 
muscle and bony geometries measured between the different acquisition protocols, as an 
observer may indentify the boundaries between the tissues at slightly different locations 
depending on the image contrast. However, this systematic error is likely to be small 
due to the good image contrast between muscle, bone, and fat for all acquisition 
protocols enabling the bone and muscle boundaries to be easily identified. The 
repeatability of the image analysis technique employed was investigated for the 
measurement of muscle volume by a single rater and was found to be ‘almost perfect’ 
(Appendix D). However, this only reflects the reliability of the analysis technique 
employed. A second repeatability study is required that assesses the repeatability of the 
entire acquisition and analysis protocol, acquiring repeat images of a single subject 
using all image acquisition protocols and scanners. 
6.4.2	  	  Clinical	  implications	  
This study indicates that increased fracture risk in ambulant individuals with CP is 
related to reduced muscle volume and diagnosis, and is independent of body mass.  
Bones in adolescents and young adults with CP show the same adaptation to mechanical 
loading due to muscle contractions as their TD peers282. The results of the present study 
suggest that strength training to increase muscle size may increase bone strength and 
cortical bone CSA, decreasing the risk of fractures in this patient group.  
6.5	  	   Conclusion	  
Reduced bone bending and torsional strength and cortical bone CSA are related to thigh 
muscle volume in ambulant individuals with CP. Therefore, strength training exercises 
to increase muscle size and strength may improve bone strength and reduce the risk of 
bone fractures in CP. 
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7. In	  vitro	  and	  in	  vivo	  
comparison	  of	  mDixon	  
techniques	  	  
Abstract	  
The objective of this study is to compare Dixon-based MRI techniques for 
intramuscular fat quantification at 3T with MR spectroscopy (MRS) in vitro and in vivo. 
In vitro, two- three- and four-point mDixon sequences with 10°, 20° and 30° flip angles 
were acquired from seven test phantoms with sunflower oil–water percentages of 0–
60% sunflower oil and calculated fat–water ratios compared with MRS. In vivo, two- 
three- and four-point mDixon sequences with 10° flip angle were acquired and 
compared with MRS in the vastus medialis of 9 healthy volunteers (aged 30.6±5.3 
years; body mass index 22.2±2.6). Results: In vitro, all mDixon sequences correlated 
significantly with MRS (r =0.97, p< 0.002) with the measured percentage fat dependent 
on flip angle (p<0.001) and mDixon sequence (p= 0.005). In vivo, a significant 
difference was observed between sequences (p<0.001), with all mDixon sequences 
overestimating the intramuscular fat content of the vastus medialis muscle compared 
with MRS. This study demonstrates that mDixon techniques have good linearity and 
low variability for use in intramuscular fat quantification. To avoid significant fat 
overestimation with short repetition time, a low flip angle should be used to reduce T1 
effects. 
 
This chapter is the published manuscript in The British Journal of Radiology 87:1036 
(2014).  A supplementary table of results is given in Appendix E. 
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Objective: To compare Dixon-based MRI techniques
for intramuscular fat quantification at 3T with MR
spectroscopy (MRS) in vitro and in vivo.
Methods: In vitro, two- three- and four-point mDixon
(Philips Medical Systems, Best, Netherlands) sequences
with 10°, 20° and 30° flip angles were acquired from seven
test phantoms with sunflower oil–water percentages of
0–60% sunflower oil and calculated fat–water ratios com-
pared with MRS. In vivo, two- three- and four-point mDixon
sequences with 10° flip angle were acquired and compared
with MRS in the vastus medialis of nine healthy volunteers
(aged 30.665.3 years; body mass index 22.262.6).
Results: In vitro, all mDixon sequences correlated
significantly with MRS (r.0.97, p,0.002). The mea-
sured phantom percentage fat depended significantly
on the flip angle (p#0.001) and mDixon sequence
(p50.005). Flip angle was the dominant factor
influencing agreement with MRS. Increasing the flip
angle significantly increased the overestimation of the
mDixon sequences compared with MRS. In vivo, a sig-
nificant difference was observed between sequences
(p,0.001), with all mDixon sequences overestimating
the intramuscular fat content of the vastus medialis
muscle compared with MRS. Two-point mDixon agreed
best with MRS and had comparable variability with the
other mDixon sequences.
Conclusion: This study demonstrates that mDixon tech-
niques have good linearity and low variability for use in
intramuscular fat quantification. To avoid significant fat
overestimation with short repetition time, a low flip angle
should be used to reduce T1 effects.
Advances in knowledge: This is the first study investi-
gating the optimal mDixon parameters for intramuscular
fat quantification compared with MRS in vivo and in vitro.
Chronic diseases associated with obesity are strongly related
to the amount of adipose tissue in and around skeletal
muscle tissue.1,2 Furthermore, many pathology exists, in-
cluding cerebral palsy, where the patients exhibit reduced
fat-free mass3,4 but have increased fat inﬁltration into
skeletal muscle.5 Therefore, an effective method for quan-
tiﬁcation of intramuscular fat is required to determine
which patients may develop obesity-related chronic diseases.
In the literature,6–9 fat–water fraction measurements are
predominantly obtained using localized proton (1-H) MR
spectroscopy (MRS). However, MRS has a limited spatial
resolution compared with imaging techniques. Conse-
quently, MRI techniques for the measurement of fat–water
ratios are desirable, particularly in spatially heterogeneous
tissue. Chemical shift imaging methods established on the
Dixon technique10 that discriminate between fat and water
spins based on their different resonance frequencies are
now available on the majority of clinical MRI systems and
are increasingly applied in clinical settings (mDixon, Phi-
lips Medical Systems, Best, Netherlands; Dixon, Siemens
Healthcare, Erlangen, Germany; FatSep, Hitachi, Tokyo,
Japan; and IDEAL, GE Healthcare, Waukesha, MI).
The original two-point Dixon (2PD) technique10 acquired
two images using a modiﬁed spin-echo pulse sequence.
One image is a conventional spin-echo image with water
and fat in phase, the second is acquired with the read out
gradient shifted to produce an image with 180° water–fat
phase difference. These images then undergo complex
addition or subtraction to produce water only and fat only
images, respectively, from which a fat–water ratio image
can be calculated. Therefore, a fat–water fraction mea-
surement can be made for a much larger region of interest
and with much higher spatial resolution using Dixon
techniques than MRS. The three-point Dixon (3PD)
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technique11 was developed to reduce sensitivity to magnetic ﬁeld
inhomogeneities and, therefore, phase errors associated with
2PD12 by utilizing a combination of multipoint acquisition and
image processing techniques. A four-point Dixon (4PD) tech-
nique has also been developed,13 in which the extra acquisition
enables a more accurate correction of the phase error. Recent
advancements in image processing techniques, such as iterative
decomposition of water and fat with echo asymmetry and least-
squares approach (IDEAL)14,15 have further helped to separate
fat and water signals in inhomogeneous magnetic ﬁeld regions.
Dixon imaging techniques have been widely used in the
literature16–23 for hepatic fat quantiﬁcation hepatic steatosis (for
a review see Reeder and Sirlin16) and are increasingly utilized for
intramuscular fat quantiﬁcation. However, limited validation
studies comparing Dixon and MRS techniques for intramuscular
fat quantiﬁcation have been reported.24 The purpose of this
study was to perform such a validation at 3.0 T, as well as in-
vestigating optimal strategies by comparing two-, three- and
four-point mDixon each with a range of ﬂip angles.
METHODS AND MATERIALS
All MR data were acquired on a 3.0T Achieva® system (Philips
Medical Systems) running software v. 2.6.3, using an eight-channel
receive-only phased array knee coil.
In vitro
Seven 50-ml test phantoms were produced consisting of 0%, 10%,
20%, 30%, 40%, 50% and 60%, respectively, sunﬂower oil mixed
with water, to cover the range of intramuscular percentage fat
observed in vivo.19 These phantoms were made following a method
described previously,25 where 15mmol of an anionic surfactant
sodium dodecyl sulphate was added to 0.5 l of deionized water and
2.5 g of gelatine dissolved in the solution using a magnetic stirrer
hotplate heated to 50 °C. The solution was poured into seven 50-ml
plastic tubes along with the corresponding amount of sunﬂower oil,
homogenized and placed on a roller overnight to set at room
temperature (21 °C). All seven phantoms were placed within the
knee coil to enable images of each phantom to be made within
a single axial image acquisition. The scanner room temperature
was set to 21 °C during image acquisition.
Localized MRS data were acquired of a voxel 403403 5mm at
the centre of each phantom using a Point RESolved Spectroscopy
(PRESS) sequence with echo time (TE)/repetition time (TR)5 35/
5000ms, 16 signals averaged (NSA), and with and without water
suppression. Four axial gradient-echo mDixon imaging strategies
were employed (see below) with three different ﬂip angles (10°, 20°
and 30°), slice thickness5 5mm, 4803480 matrix size,
0.9430.94mm in plane resolution and 2 NSA.
1. two-point mDixon with water and fat signal phase sampling
strategy (0, 180°); TE/TR5 2.3/5.0ms, echo time shift
(∆TE)5 1.14ms
2. three-point mDixon optimized for phase estimation (3PDP)
with (0, a, 2a) sampling strategy, where a5120°,11 TE/TR5
2.11/5.2 and ∆TE50.76ms
3. three-point mDixon optimized for magnitude estimation
(3PDM) with (2a, 0, a) sampling strategy, where
a5 180°,11,26,27 TE/TR5 2.3/5.4 ms and ∆TE5 0.76ms
Figure 1. Examples of mDixon (a) water and (b) fat images of
the phantoms acquired with two-point Dixon with 10° flip
angle.
Figure 2. An example of in vitro MR spectroscopy spectrum of
40% sunflower oil phantomwith water suppression. ppm, parts
per million.
Figure 3. Average route mean square (RMS) difference between
MR spectroscopy and mDixon measurements of phantom
percentage fat. Error bars represent the standard error of the
RMS difference. PD, point Dixon; PDM, mDixon optimized for
magnitude estimation; PDP, mDixon optimized for phase
estimation.
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4. four-point mDixon with phase sampling strategy (0, a, 2a,
3a), where a5 90°, TE/TR5 2.3/5.6ms and ∆TE5 0.57ms.
Seven repeated acquisitions were acquired using each mDixon
technique to assess reproducibility. Between each repeated scan,
the phantoms were removed from the scanner and repositioned.
To enable T2 correction to be applied to the MRS data, the T2 of
the lipid and water in the 60% sunﬂower oil phantom was
measured using stimulated echo acquisition mode MRS,
TR5 10,000ms, voxel size5 303 83 8mm, NSA5 16 and
TE5 40, 45, 50, 55, 60, 65, 70, 80, 90, 100 and 120ms.
Data analysis
All MRS data were processed using the AMARES algorithm28 in
magnetic resonance user interface java version (jMRUI).29 The
percentage fat was measured according to Equation (1), with the
lipid signal deﬁned as the peak at 1.3 parts per million (ppm).
The T2 values of the 60% sunﬂower oil phantom were calculated
by ﬁtting an exponential to the water and lipid amplitudes over
increasing TE. The ﬁtted lipid and water peaks were T2 corrected
using T2 values measured in the 60% sunﬂower oil phantom. All
mDixon images were processed on the scanner using the manu-
facturers in-built mDixon algorithm that calculates four image
series: water signal, fat signal, in-phase and out-of-phase images.
Volumes of interest (VOIs) were drawn over the volume of the
phantoms ﬁlled by the water–fat emulsions using OsiriX (Pixmeo,
Geneva, Switzerland).30 From these VOIs, the mean signal in-
tensities from the fat and water images were measured to create
a mDixon-based fat percentage [Equation (2)], and averaged
across the seven repeated acquisitions. The mean percentage fat
measured for each phantom using each technique was assessed for
linearity using Pearson’s correlations, and the route mean square
(RMS) difference and Bland–Altman plots were calculated to as-
sess the agreement with MRS. The RMS difference was not nor-
mally distributed (Kolmogorov–Smirnov test, p5 0.023), therefore,
related-samples Friedman’s two-way analysis of variance (ANOVA)
Figure 4. Bland–Altman plots of agreement between MR spectroscopy (MRS) and mDixon sequences with (a) 10° flip angle;
(b) 20° flip angle; and (c) 30° flip angle. Mag, magnitude; PD, point Dixon.
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by ranks test was employed to test for signiﬁcant differences in
agreement with MRS between the four mDixon sequences tested
and by ﬂip angle. The reproducibility of the sequences was deﬁned
as the standard deviation of the measured percentage during each















Nine healthy adult volunteers (ﬁve males; mean age, 30.66 5.3
years; body mass index, 22.26 2.6 kgm2) took part in the study.
All volunteer scanning was approved by local research ethics
committee (study number 01/11/12). Localized MRS data were
acquired of the vastus medialis, PRESS, TE/TR5 35/2000ms,
153 203 25mm voxel and 32 NSA. mDixon images were
also acquired with the same imaging parameters as in vitro with
10° ﬂip angle and 10 NSA. Data acquisition times were 2:36,
4:03, 4:11 and 4:18min for the 2PD, 3PDP, 3PDM and 4PD
sequences, respectively.
Data analysis
All MRS data were processed using the AMARES algorithm28
in jMRUI.29 Water, intramyocellular (IMCL) and extra-
myocellular (EMCL) lipid peaks were quantiﬁed (with prior
knowledge of peaks at 1.3 and 1.2 ppm, after removal of the
residual water) and percentage fat calculated using Equation
(1). The measured water, EMCL and IMCL signals were T2
corrected using T2 values for water (31.3ms), EMCL fat
(77.6ms) and IMCL fat (89.4ms) previously measured at 3 T
in muscle.31
Figure 5. Reproducibility represented by percentage fat
standard deviation over seven separate acquisitions averaged
across phantoms. PD, point Dixon; PDM, mDixon optimized for
magnitude estimation; PDP, mDixon optimized for phase
estimation.
Figure 6. Examples of (a) water and (b) fat images of the same
volunteer acquired with two-point Dixon (2PD) sequence. This
subject had 3.15% fat measured by 2PD.
Figure 7. Example of (a) MR spectroscopy (MRS) spectrum of
the vastus medialis from the same volunteer in Figure 5. This
volunteer had 0.93% intramuscular fat measured by MRS.
(b) Estimated intramyocellular (IMCL) and extramyocellular
(EMCL) peaks. (c) Residual spectrum after fitting of IMCL and
EMCL peaks. ppm, parts per million.
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All mDixon images were analysed using OsiriX.30 VOIs were
drawn to match the corresponding MRS voxel locations for fat and
water, with the fat voxel shifted in the x, y and z directions cal-
culated using a 3.4 ppm chemical shift between water and lipid at
3.0T. From these VOIs, the mean signal intensities from the fat and
water images were measured to create an mDixon-based fat–water
ratio [Equation (2)]. The percentage fat measured by MRS and
mDixon were compared for agreement using Bland–Altman
plots,32 one-way ANOVA and Tukey post hoc test. All statistical
analyses were performed using SPSS® v. 20.0 (SPSS, Chicago, IL).
RESULTS
In vitro
Figure 1a,b shows an example of water and fat images of the
phantoms, respectively. An example in vitro spectrum with water
suppression is shown in Figure 2. There were strong positive and
signiﬁcant correlations between MRS-derived and Dixon-based
percentage fat measurement ratios for all Dixon sequences and
ﬂip angles (r. 0.97, p, 0.002). Figure 3 shows the average
RMS difference between MRS and mDixon calculated phantom
percentage fat by each technique and ﬂip angle. A signiﬁcant
difference in the RMS difference was observed between ﬂip
angles (p# 0.001) and between mDixon sequences (p5 0.005).
Compared with MRS, all four mDixon sequences exhibited
greater average RMS difference with larger ﬂip angles. Bland–
Altman plots comparing Dixon- and MRS-based measures of
percentage fat are shown in Figure 4. As the ﬂip angle of the
mDixon sequences is increased, mDixon increasingly over-
estimates the fat content of the phantoms for all sequences in-
vestigated. Figure 5 summarizes the mean, standard deviation
and reproducibility (average standard deviation) for each
phantom and mDixon technique investigated.
In vivo
Figure 6 shows example water and fat images of one volunteer.
Figure 7 shows an example MRS spectrum of one volunteer and
the ﬁtted IMCL and EMCL peaks. Figure 8 shows a histogram of
the group mean percentage intramuscular fat measured by all
techniques investigated. A signiﬁcant difference was observed
between the measurement techniques (ANOVA, p, 0.001). The
Tukey post-hoc tests found a signiﬁcant difference between all
measurements (p# 0.001) with the exception of 4PD and 3PDM
(p5 0.998). In the Bland–Altman plot in Figure 9, comparing
each mDixon technique investigated with MRS, it can be seen
that all mDixon techniques overestimated the percentage in-
tramuscular fat in the vastus medialis compared with MRS. 2PD
exhibited the closest agreement with MRS and 4PD the worst
agreement with MRS.
DISCUSSION
In vitro, all mDixon techniques correlated very strongly with the
MRS measured percentage fat (r. 0.97, p, 0.002). As shown
in Figures 3 and 4, increasing the ﬂip angle signiﬁcantly
overestimated the measured percentage fat using all mDixon
techniques investigated compared with MRS, and this was found
to have a much larger effect on the agreement between the Dixon
and MRS than Dixon sequence type (2PD, 3PDP, 3PDM or 4PD).
This overestimation of the phantom fat content with increasing
ﬂip angle occurs owing to T1 effects.
33 The T1 of water is much
longer than that of lipid; with the short TR and increasing ﬂip
angle, the water signal becomes increasingly more suppressed than
the lipid signal, resulting in a higher measured percentage fat. This
means that when the sequence TR is reduced to shorten scan time,
the ﬂip angle must also be reduced to prevent overestimation of
the fat content due to T1 weighting. The closest agreement be-
tween MRS and mDixon and a smaller average RMS difference
than the other sequences investigated was observed for the 2PD
sequence with a 10° ﬂip angle. This is a surprising result. This may
be owing to the recent development of the two-point mDixon
algorithm to include the static magnetic ﬁeld strength (B0) in-
homogeneity correction. Previously, two-point techniques have
not included B0 inhomogeneity correction
34 and, therefore, would
Figure 8. Group mean intramuscular percentage fat in vastus
medialis. Error bars represent the standard error of the group.
MRS, MR spectroscopy; PD, point Dixon; PDM, mDixon
optimized for magnitude estimation; PDP, mDixon optimized
for phase estimation.
Figure 9. Bland–Altman plot showing the agreement between
intramuscular percentage fat measured using MR spectros-
copy (MRS) and the four mDixon sequences tested in vivo.
Mag, magnitude; PD, point Dixon.
Full paper: Comparison of Dixon techniques for intramuscular fat quantification BJR
5 of 7 birpublications.org/bjr Br J Radiol;87:20130761
In	  vitro	  and	  in	  vivo	  comparison	  of	  mDixon	  techniques	  
J.J.	  Noble	   Musculoskeletal	  and	  spinal	  cord	  imaging	   111	   
be likely to agree the least with MRS 2PD acquires only two signal
acquisitions, one with the fat and water signals in phase and one
out of phase. The better agreement of 2PD with MRS compared
with the 3PD and 4PD sequences suggests that a different algo-
rithmmay be used by the mDixon implementation on the scanner
when in 2PD. The 3PD (phase) exhibited a smaller average RMS
difference than in the 3PDM sequence and 4PD sequence. In the
Bland–Atlman plots in Figure 4, there are no consistent differences
between the two 3PD sequences and the 4PD sequence.
All mDixon results produced a similar behaviour when com-
pared with MRS. Considering the sequences with 10° ﬂip angles,
all sequences exhibited the same pattern: increasing over-
estimation of the phantom fat content for the 0–20% sunﬂower
oil phantoms and underestimation of the 40% sunﬂower oil
phantom. Overestimation of the 0% sunﬂower oil phantom
highlights a misregistration between water and fat. This may be
caused by various factors, including spectral modelling simpli-
ﬁcation and magnetic ﬁeld homogeneity. An example phantom
spectrum given in Figure 1 shows that the phantom spectra are
dominated by single lipid peak at 1.3 ppm. Combined with the
overestimation of the 0% sunﬂower oil phantom, this suggests
that spectrum simpliﬁcation is unlikely to be the main cause
of this overestimation of fat content and that magnetic ﬁeld
inhomogeneities may have a more signiﬁcant affect.
The higher group average intramuscular fat measured using the
magnitude optimized sequence (3PDM) than in the phase
estimation–optimized sequence (3PDP) suggests that the phase
errors caused by magnetic ﬁeld inhomogeneities are one of the
limiting factors of the mDixon sequences investigated. The large
inhomogeneities in vivo would therefore signiﬁcantly affect the
accuracy of the mDixon sequences. Again, differences in spectral
modelling may contribute to the difference in fat content
measured between the two techniques. A two-lipid peak spectral
model for MRS, corresponding to IMCL and EMCL, was
employed in this study, as this is commonly performed in the
literature, whereas more complex models have been described
for Dixon.34 However, the lipid peaks at 1.3 and 1.2 ppm
dominate the muscle spectra, and any underestimation of the
lipid content by utilizing a two-lipid peak model for the MRS is
likely to be minimal. The use of T2 values in the literature for T2
correction may also contribute to the disagreement between the
MRS and mDixon techniques, although measuring the T2 values
of the metabolites in vivo for each individual volunteer is time
consuming and not representative of clinical practice.
In vivo, a signiﬁcant difference was observed between all
techniques with the exception of 3PDP and 4PD, which were
not signiﬁcantly different from each other. However, these
sequences also had the largest mean difference compared with
MRS, with the 2PD sequence having the best agreement with
MRS. The standard deviations of the subject group percentage
intramuscular fat measurements were similar across the
mDixon sequences, ranging from 1.25% (4PD) to 1.94%
(3PDP).
CONCLUSION
This study has compared two-point, three-point and four-point
mDixon techniques with MRS in test phantoms over a range of
physiologically expected fat–water ratios and in vivo for intra-
muscular fat quantiﬁcation. In vitro, all sequences tested corre-
lated strongly with MRS, with the 2PD in closest agreement. The
ﬂip angle was observed to have a more signiﬁcant effect on
agreement between mDixon and MRS than sequence type, with
increasing ﬂip angle resulting in an increasing overestimation of
the fat content of the phantoms. In vivo, a signiﬁcant difference
was observed between MRS and all mDixon sequences in-
vestigated with the 2PD sequence in closest agreement with MRS
and with comparable variability in the measured intramuscular
fat across the subject group. The results of this study suggest that
the two-point Dixon sequence provides the most accurate
measurement of intramuscular fat and highlights the need for
small ﬂip angles to reduce fat overestimation due to T1 effects
when a short TR is utilized.
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The objective of this study is to determine whether adults with bilateral spastic cerebral 
palsy (BSCP) have greater adiposity in and around their skeletal muscles than their 
typically developing (TD) peers as this may have significant functional and cardio-
metabolic implications for this patient group. 10 young adults with BSCP (7 male, mean 
age 22.5 years, Gross Motor Function Classification System (GMFCS) levels I-III), and 
10 TD young adults (6 male, mean age 22.8 years) took part in this study. 11 cm 
sections of the left leg of all subjects were imaged using multi-echo gradient echo 
chemical shift imaging (mDixon). Percentage intermuscular fat (IMAT), intramuscular 
fat (IntraMF) and a subcutaneous fat to muscle volume ratio (SF/M) were calculated. 
IntraMF was higher with BSCP for all muscles (p=0.001-0.013) and was significantly 
different between GMFCS levels (p<0.001), with GMFCS level III having the highest 
IntraMF content. IMAT was also higher with BSCP p<0.001). No significant difference 
was observed in SF/M between groups. Young adults with BSCP have increased 
intermuscular and intramuscular fat compared to their TD peers. The relationship 
between these findings and potential cardio-metabolic and functional sequelae are yet to 
be investigated.  
 
The work in this chapter has been published in BMC Musculoskeletal Disorders (Noble 
et al. BMC Musculoskeletal Disorders 2014 15:236). 
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8.1	  	   Background	  
The mechanical potential of muscle depends on gross morphology (cross sectional area, 
fibre length118), muscle fibre type, and muscle composition (fraction of intramuscular 
fat and connective tissue). Anatomical magnetic resonance imaging (MRI) and 
ultrasound imaging have demonstrated that the skeletal muscles of the lower limbs of 
individuals with bilateral spastic cerebral palsy (BSCP) are reduced in size by up to 
50% compared to the muscles of their typically developing (TD) peers56,57,278. However, 
studies of microstructure and composition have been limited to a small number of 
biopsy studies119,120. In the lower limb, these have demonstrated increases in the 
connective tissue fraction, reduced muscle fibre diameter, and altered muscle fascicle 
stiffness119,120. 
 
Decreased physical activity is associated with increased intermuscular fat63-66. Due to 
the typically sedentary behaviour observed in this group71,72, one aspect of muscle 
composition that may be altered in BSCP is the level of intra- and intermuscular fat. 
Fatty infiltration into muscle results in a reduced proportion of contractile tissue per unit 
muscle volume. Intramuscular fat also may secrete inflammatory cytokines that can 
reduce the myofibrillar force even in the absence of muscle atrophy62. If present in this 
group, raised intramuscular fat may have important consequences for physical 
performance, and implications for exercise regimes employed in their physical 
management142.  
 
Heightened levels of inter- and intra- muscular fat are associated with cardiovascular 
risk44,121. Adults with cerebral palsy may have a 2-3 times greater risk of dying from 
ischemic heart disease than their typically developing peers13. However, there are few 
studies in the literature that have attempted to document body or muscle composition in 
this group. Since individuals with cerebral palsy have reduced muscle mass, even those 
with body mass index (BMI) in the normal range may have relatively increased levels 
of adipose tissue. Previous studies in children with CP have suggested raised levels of 
fat76,77. In an MRI study of the lower limbs in children with quadriplegic cerebral palsy 
(Gross Motor Function Classification System (GMFCS) levels III-V), Johnson et al76 
found increased levels of intermuscular and subcutaneous fat76.  To date, there have 
been no studies of intramuscular fat in adults or children with BSCP even though this 
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non-invasively quantified parameter appears to be one of those most associated with 
cardio-metabolic disease122.  
 
T1-weighted image segmentation is primarily used to quantify IMAT, with IMAT 
defined as the MRI-visible fat within the muscles (intramuscular fat) and between the 
muscles beneath the fascia (intermuscular fat). Although this method is effective for 
assessing intermuscular and subcutaneous fat volumes, it is not an accurate method for 
measuring fat distribution within individual muscles. Chemical shift magnetic 
resonance imaging-based water/fat separation techniques based on that first proposed by 
Dixon217 have been developed which utilise the chemical shift difference between fat 
and water to enable reconstruction of separate water and fat images. These techniques 
utilise the predictable difference in phase evolution between water and fat signals due to 
their chemical shift difference to enable the calculation of separate water and fat 
images, permitting the calculation of the fat fraction. The fat fraction is the signal 
intensity attributable to fat, normalised by the total signal from all mobile proton 
species. These techniques have been widely used in studies quantifying the degree of 
liver fat in hepatic steatosis (for review see Reeder220): although, to date, Dixon imaging 
has only been used in a small number of clinical intramuscular fat quantification 
studies121,221,222.  
 
The aim of this study was to investigate the intermuscular fat (IMAT), subcutaneous fat 
(SF) and intramuscular fat (IntraMF) content in five major muscles of the leg (medial 
and lateral gastrocnemius, soleus, tibialis posterior and tibialis anterior) in 10 subjects 
with BSCP and 10 TD subjects using multi-echo gradient echo chemical shift imaging 
(mDixon). We hypothesised that the subjects with BSCP would exhibit increased fat 
content compared to their TD peers. 
8.2	  	   Methods	  
Ethical approval for this study was granted by Hampstead Research Ethics Committee 
London (09/H0720/120). All subjects gave informed consent before they participated.  
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8.2.1	  	  Subjects	  
Individuals aged 16 – 30 years, with a diagnosis of BSCP, Gross Motor Function 
Classification System (GMFCS) levels I-III, who met the safety requirements of MRI 
were included in this study. Patients who had undergone surgery, serial casting or 
botulinum toxin injections to the lower limbs within the previous year were excluded 
from the study. This was a convenience sample of individuals attending our hospital 
department, with consecutive patients that met the inclusion criteria invited to 
participate in the study.  
 
10 adults with a diagnosis of BSCP (7 male, 3 female, mean age 22.5 years, range 18-
27, GMFCS levels I-III from clinics in our university hospital and a convenience 
sample of 10 TD young adults (6 male, 4 female, mean age 22.8 years, range 18-27) 
recruited from individuals known to the research team participated in this study. None 
of the BSCP subjects had undergone surgery, serial casting or botulinum toxin 
injections to the lower limbs within the previous year. All TD subjects had no prior 
significant musculoskeletal trauma or disorders.  
8.2.2	  	  Data	  collection	  
MR data were acquired on a 3.0T Achieva system (Philips Healthcare, Best, The 
Netherlands) running software version 2.6.3, using an 8-channel receive-only phased 
array knee coil. One subject had a 30o knee fixed flexion deformity; instead a 32-
channel cardiac coil was used. An 11cm section of the left leg was scanned, centred at 
the largest circumference of the calf with the subject prone. Four point gradient echo 
mDixon images were acquired with TE/TR= 2.3/7.1ms, 35o flip angle, 2.0 x 2.0 mm in-
plane resolution, 4.0 mm slice thickness, echo-time shift = 1.0ms. Utilising the known 
chemical shift between water and fat signal constituents, separate water and fat images 
were calculated within the scanner software. Subject height and body mass were 
measured in standing before the MRI scan using a stadiometer and calibrated weighing 
scales. Patients at our centre are routine classified according the GMFCS in their 
medical record by their consulting physician or surgeon. 
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8.2.3	  	  Data	  Processing	  
Regions of interest (ROIs) were manually drawn around the SF, muscle compartment 
(Figure 8.1B), and five individual muscles; the soleus, medial gastrocnemius, lateral 
gastrocnemius, tibialis anterior, and tibialis posterior (Figure 8.1C), on the mDixon 
water images using Osirix version 3.7.1280. SF volume was normalised to muscle 
volume (Equation 8.1), creating a SF to muscle volume ratio (SF/M). The ROIs around 
the entire musculature and individual muscles were eroded with a structuring element 
size of 2 pixels (4.0 mm) to remove any potential edge effects with surrounding 
subcutaneous fat (or intermuscular fat for IntraMF quantification). IMAT and IntraMF 
were calculated using a ratio of the water and fat signal intensities within the eroded 
ROIs (Equation 8.2). The reproducibility of the Dixon technique employed was 
measured using 5 acquisitions of one TD subject imaged over 3 visits, with the scan 
repeated twice during 2 of these visits. Reproducibility was defined as the average 
standard deviation of the measured percentage fat, i.e. the standard deviation averaged 
across all muscles investigated.  
 
 Equation 8.1 
 Equation 8.2 
Where I = Signal intensity 
 
	  
Figure 8.1 (A) Example mDixon water image; (B) manually drawn region of interest (white) for the 
muscle compartment for IMAT segmentation; and (C) the 5 muscles analysed drawn around tibialis 
anterior (TA), tibialis posterior (TP), soleus (SOL), medial gastrocnemius (MG) and lateral 
gastrocnemius (LG) for IntraMF segmentation. 
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8.2.4	  	  Data	  analysis	  
Following application of the Kolmogorov-Smirnov test for normality and Levene’s test 
for equality of variance, independent samples t-tests were performed to investigate 
physical characteristic differences between the two subject groups for all measured 
parameters. Two-way ANOVA was performed on IntraMF with GMFCS level and 
muscle identity as fixed factors with a Tukey post-hoc test. Non-parametric independent 
samples median tests compared SF/M and IMAT between groups. The Kruskal-Wallis 
Test was used to investigate differences in SF/M and IMAT with GMFCS level. 
Pearson’s correlations were used to investigate relationships between measured 
parameters. All statistical tests were performed using SPSS (Version 20.0; IBM SPSS) 
with significance set to p≤0.05.  
8.3	  	   Results	  
Physical characteristics of subjects in the BSCP and TD groups are summarised in 
Table 8.1. There were no group differences in age, body mass, height, or BMI (p>0.05). 
The GMFCS level of the BSCP subjects are also presented in Table 8.1. The BSCP 
subjects had undergone a range of previous interventions (see Table 8.2), although none 
of these were performed in the last year. The average standard deviation representing 
reproducibility of intramuscular fat averaged across all muscles was 0.33%. Example 
images for a case and age-matched control are given in Figure 8.4. 
 
 BSCP group TD group 
Number of subjects 10 10 
Age (years) 22.5 ± 2.9 22.8  ± 3.0 
Sex (m,f) 7, 3 6, 4 
Body mass (kg) 64.0  ± 11.5 71.2 ± 11.8 
Height (m) 1.69  ± 0.08 1.76 ± 0.12 
BMI (kg/m2) 22.4  ± 3.6 22.9 ± 1.7 
GMFCS level I 2 N/A 
GMFCS level II 5 N/A 
GMFCS level III 3 N/A 
Table 8.1 Physical characteristics (mean ± standard deviation) of BSCP and 
TD groups and number of BSCP subjects in each GMFCS levels (I-III) 
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BSCP Subject Intervention 
1 None 
2 Gastrocnemius lengthening 
3 Gastrocnemius lengthening 
4 None 
5 Gastrocnemius lengthening 
6 Gastrocnemius lengthening 
7 Gastrocnemius lengthening 
8 None 
9 Gastrocnemius and Achilles tendon lengthening 
10 None 





Figure 8.2 Example water (A and C) and fat (B and D) for one subject 
with BSCP (A and B), and an age matched TD subject (C and D). 
 
Figure 8.3 shows a bar chart of group-averaged percentage IntraMF and IMAT. The 
BSCP group had a significantly higher average percentage IMAT (p<0.001) and 
IntraMF compared to the TD group for all muscles investigated (p<0.001), with the 
soleus having the largest percentage fat difference (12.9% greater in BSCP group). In 
the BSCP group, IntraMF was significantly correlated between all muscles measured 
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(r=0.697 to 0.947, p<0.001 to p=0.025) except for the soleus, which did not correlate 
with any other muscle (r= 0.437 to 0.587, p=0.074 to 0.206). Figure 8.4 shows a bar 
chart of group-averaged SF/M ratio. The mean SF/M ratio was 1.9 times greater in the 
BSCP group compared to the TD group; however, this difference was not statistically 
significant (p=0.179). Group means and 95% confidence intervals for intramuscular fat, 
IMAT, and SF/M are given in Table 8.3. 
 
95% Confidence 
Interval for Mean 
 









CP 7.61 5.31 9.90 3.21 1.02 MG 
TD 3.70 2.99 4.41 0.99 0.31 
CP 7.75 4.64 10.86 4.35 1.38 LG 
TD 3.24 2.85 3.64 0.55 0.17 
CP 16.56 9.42 23.69 9.97 3.15 SOL 
TD 3.66 3.15 4.16 0.71 0.22 
CP 6.07 4.40 7.74 2.33 0.74 TA 
TD 2.36 2.08 2.65 0.39 0.12 





TD 2.30 1.89 2.70 0.56 0.18 
CP 13.91 9.73 18.09 5.84 1.85 IMAT (%) 
TD 4.60 4.08 5.11 0.72 0.23 
CP 0.76 0.45 1.06 0.43 0.14 SF/M 
TD 0.40 0.25 0.54 0.21 0.07 
Table 8.3 Group mean, 95% confidence interval, standard deviation and standard error for the CP 
and TD groups. MG = medial gastrocnemius; LG = lateral gastrocnemius; SOL= soleus; TA = 
tibialis anterior; TP = tibialis posterior; IMAT = inter- + intramuscular fat; SF/M = subcutaneous fat 
to muscle volume ratio. 
 
One-way ANOVA and post hoc analysis revealed significant differences in IntraMF 
levels by GMFCS level (p<0.001), with GMFCS level III significantly higher compared 
to GMFCS levels I and II (p<0.001 and p=0.001 respectively). No significant difference 
was observed in IMAT or SF/M with GMFCS level (p=0.131). In the TD group, SF/M 
was correlated with IMAT (r=0.81, p=0.005) but not with IntraMF (r=0.182, p=0.206), 
and no correlation was observed between IMAT and IntraMF (r=0.251, p=0.079). In the 
BSCP group, no correlations were observed between SF/M and IMAT (r=0.392, 
p=0.262) or IntraMF (r=0.134, p=0.353); IMAT and IntraMF were significantly 
correlated (r=0.529, p<0.001).  
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Figure	   8.3	   Percentage IntraMF and IMAT in the medial 
gastrocnemius (MG), lateral gastrocnemius (LG), soleus (SOL), 
tibialis anterior (TA), tibialis posterior (TP) and in the BSCP 
group (white) and TD group (grey). IMAT and IntraMF in all 
muscles were significantly different between groups (p < 0.05). 

































Figure 8.4 Subcutaneous fat to 
muscle volume ratio in the BSCP 
group (white) and TD group (grey). 
Error bars represent the standard 
error of each group. 
 
8.4	  	   Discussion	  
We conducted MRI measurements of IMAT, SF/M ratio, and IntraMF on 10 young 
adults with BSCP and 10 of their TD peers. This is the first study to show that ambulant 
adults with BSCP have raised levels of IntraMF, ranging from 2.3 to 34.4%. Percentage 
IntraMF was also found to be significantly different between GMFCS levels, with those 
at GMFCS III having greater fatty infiltration. These differences in IntraMF by GMFCS 
level suggest IntraMF may be related to the degree of mobility impairment. This may be 
due to decreased physical activity with increasing mobility impairments. 
 
The 1.9 fold greater SF/M ratio in the BSCP group is comparable to the results of 
Johnson et al76, who reported 2 fold greater SF/M ratio in the mid thigh of children with 
quadriplegic cerebral palsy GMFCS levels III-V76. This is surprising due to the higher 
functional ability of the subjects in this study (GMFCS levels I-III). IMAT values 
cannot be compared between these studies due to the separation by Johnson et al of 
IMAT into intermuscular and sub-fascial fat and the different imaging and analysis 
techniques employed. 
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8.4.1	  	  Clinical	  Implications	  
Children and young adults with cerebral palsy have been shown to have reduced muscle 
volumes in their lower limbs53,56-61,278 and increased IMAT76. This study demonstrates 
that these muscles also have greater levels of intramuscular fat that is independent of 
subcutaneous fat levels. This combination of morphological and compositional changes 
may have implications both for the mechanical performance of these skeletal muscles 
and also for the predisposition of the adult with BSCP to cardio-metabolic disease122.  
 
Muscle weakness is a prevalent feature of individuals with cerebral palsy53-55. Muscle 
weakness, in this group, is in part caused by an inability to fully activate available 
muscular resources75, increased co-activation105 and by reduced muscle volume53,56-
61,278. For a given muscle volume, a higher intramuscular fat content will correspond to 
reduced contractile tissue content, resulting in a weaker muscle than predicted from 
muscle mass alone. Furthermore, inflammatory cytokines produced by intramuscular fat 
may interfere with the action of myofibrillar proteins reducing specific force 
production62. These secondary pathologies may contribute to a deficit in the “functional 
reserve” of adults with BSCP, and may expose these individuals to a heightened risk of 
immobility with increasing age60. 
 
Greater intramuscular fat content in BSCP may expose these individuals to a greater 
risk of developing cardio-metabolic disease122. There is a strong relationship between 
intramuscular fat content, insulin resistance and type-II diabetes44-46. Within skeletal 
muscle, fat is stored in two separate compartments: Intramyocellular lipid (IMCL) and 
extramyocellular lipid (EMCL). EMCL is found within adipose cells adjacent to the 
muscle fibres, and IMCL is located along with enzymes involved in fatty acid 
esterification, hydrolysis, and transport into the mitochondria47. Enhanced storage of 
IMCL occurs due to the combined effects of high concentration of serum insulin and 
free fatty acids48.  In particular, greater IMCL in the soleus correlates with glucose-
insulin-lipid metabolism and insulin sensitivity49-52, with soleus IMCL content being the 
only differentiating feature in a study of lean insulin-resistant subjects and their TD 
peers matched for BMI, body fat distribution, percentage body fat and physical 
fitness52. However, IntraMF quantification using Dixon imaging techniques measure 
IMCL and EMCL as a composite. IMCL has been shown to be unrelated to measures of 
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adiposity283,49. In this study IntraMF did not correlate with SF/M. This suggests that the 
raised IntraMF measured in BSCP may be due to greater IMCL content. However, 
although the mDixon scans showed raised IntraMF with BSCP, whether this is due to 
raised IMCL, EMCL, or both is not yet known. Therefore, further investigations are 
required using magnetic resonance spectroscopy to determine to contributions of IMCL 
and EMCL to the raised IntraMF.  
 
Greater intramuscular fat may also be a marker of impaired mitochondrial content 
and/or function41. The increased intramuscular fat content observed in this study, 
particularly in the soleus, indicates that patients with cerebral palsy may have a greater 
risk of developing obesity related diseases, particularly type-II diabetes. Since IntraMF 
was observed to be greater with increasing GMFCS level, this risk of obesity-related 
disease may increase with decreasing functional ability. However, intramuscular fat is 
only one factor associated with the risk of developing obesity related diseases. Future 
studies of activity levels, fat levels, and glucose tolerance, are required to investigate the 
risk developing cardio-metabolic diseases in this patient group. 
  
Greater intramuscular fat can be caused by a chronic mismatch between energy intake 
and expenditure53,284. Such a mismatch would also result in greater subcutaneous fat 
levels. In this study, however, despite SF/M being greater in the BSCP group, this was 
not statistically significant. This suggests that other factors as well as any potential 
energy mismatch are adversely affecting the intramuscular fat content in BSCP.  
 
IntraMF has been correlated with deficits in central muscle activation67, increased risk 
of future mobility loss68,69, and insulin resistance70 in the elderly population. 
Preliminary studies have also shown that particular exercise regimes in older adults may 
prevent and decrease intramuscular fat66. Since skeletal muscle in cerebral palsy has 
similarities with muscles in the elderly, including reduced muscle volume73, increased 
stiffness74 and reduced voluntary muscle activation75, these exercise studies could have 
important implications for the physical management of this group as suggested by 
Peterson et al142.  
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8.4.2	  	  Limitations	  
The number of subjects recruited may limit the scope and power of this study. However, 
the differences in intramuscular fat between the TD and BSCP groups were large and 
statistically significant. The group differences were also were much larger than the 
reproducibility of the mDixon technique used in this study, defined as the average 
standard deviation of measured percentage fat across all muscles (0.33%).  
 
Despite having good accuracy and reproducibility, fat-fractions measured using multi-
echo techniques are not standardised and platform-independent. The precision of the 
quantified fat fraction depends on five confounding factors; T1 bias, T2* decay, spectral 
complexity of fat, noise bias, and eddy currents220. The T1 bias and the assumption that 
fat has a single frequency peak, results in an inadvertent misidentification of some 
signal from fat as arising from water, and hence to quantification errors285. The T1 bias 
is due to the T1 weighting of the mDixon sequence, in order to reduce scan time. When 
there is partial-volume mixing of fat and muscle tissue within pixels, signal from fat, 
which has a shorter T1 than water, is overestimated. Therefore, despite being suitable 
for comparisons within single site studies, comparison of absolute values of 
intramuscular fat quantified in this study across sites where different techniques and 
sequence designs have been employed will be more difficult. 
 
Six of the ten BSCP subjects had undertaken gastrocnemius recessions to the left leg; 
with one of these six subjects also having had Achilles tendon lengthening. Since 
muscle injury can lead to fatty degradation of muscle tissue286-289, it is possible that the 
histories of surgical intervention received by the individuals with BSCP in this study 
may have influenced the development of particular muscles. A bar chart comparing the 
percentage intramuscular fat between the TD group, BSCP subjects with no 
intervention, and BSCP subjects who have previously received gastrocnemius 
lengthening is given in Figure 8.5. Percentage intramuscular fat was significantly 
dependent on intervention and muscle (p=0.048 and p=0.009 respectively).  Despite not 
being operated on directly, the soleus had significantly higher intramuscular fat content 
compared to MG and LG (p=0.006 and p=0.007 respectively). This data suggests that 
gastrocnemius lengthening may result in damage to the soleus causing fatty 
accumulation. It has previously been shown that following tendo-­‐Achilles	  lengthening	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and	   gastrocnemius	   recession	   surgeries	   in	   a	   rabbit	   model,	   the	   gastroc-­‐soleus	  undergoes	   atrophy	   and	   fat	   infiltration	   with	   immobilisation	   not	   contributing	   to	  either	  of	  these	  processes290.	  However,	  longitudinal studies are required to determine 
whether surgery results in greater accumulation of intramuscular fat, or conversely 
whether those with heightened levels of intramuscular fat are more likely to have 
surgery in this patient group. 
 
The subjects groups were not age, BMI, and sex matched: however, the physical 
characteristic differences between the two groups were minimal with no significant 
difference in age, body mass, height, or BMI observed between the groups. It is possible 
that the large differences in fat levels in BSCP are due to large differences in life style, 
including activity levels and diet. Alternatively, the greater fat levels observed in this 
study may be due to an inherent predisposition with BSCP. To assess the contribution 
of the factors, further research is required to identify the cause of the increased 























Figure	  8.5	  Percentage	  intramuscular	  fat	  in	  the	  medial	  gastrocnemius	  (MG),	  lateral	  gastrocnemius	  (LG)	  and	  soleus	  (SOL)	  for	  the	  TD	  group	  (grey),	  the	  no	  intervention	  BSCP	  subjects	  (white)	  and	  the	  gastrocnemius	  recession	  BSCP	  subjects	  (striped). 
 
8.5	  	   Conclusion	  
Greater intramuscular fat and IMAT is found in BSCP compared to their TD peers; with 
the amount of intramuscular fat related to GMFCS level. Despite normal BMIs, the 
patients in this group may have an increased risk of developing obesity-related diseases, 
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with risk increasing with decreasing functional ability. Furthermore, the increasing 
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9. Spinal	  cord	  white	  matter	  
organisation	  in	  bilateral	  
spastic	  cerebral	  palsy	  
The aim of this chapter is to investigate white matter organisation in the spinal cord at 
the C6/7 and T10/11 spinal levels in individuals with bilateral spastic cerebral palsy 
(BSCP) and their typically developing (TD) peers. 11 individuals with bilateral spastic 
cerebral palsy (BSCP) (mean age: 16.4 years ± 4.2; GMFCS level I: n=1, level II: n=4, 
level III n=5, level IV: n=1) and 10 of their TD peers (mean age: 16.9 years ± 3.9) took 
part in this study. T2-weighted and reduced field of view DTI data was acquired at the 
T10/11 and C6/C7 spinal levels and the mean ADC and FA values of the total white 
matter and left and right lateral spinal cord white matter were measured in each subject. 
The functional ability (GMFM-66), selective motor control (SCALE) and spasticity 
(Modified Ashworth) were assessed by a physiotherapist and relationships between 
these clinical measures and white matter ADC and FA values investigated.   
 
Spinal cord white matter cross-sectional area was significantly smaller in the BSCP 
group compared to their TD peers at both C6/7 (p=0.047) and T10/11 (p=0.027) spinal 
levels. No significant difference was observed in grey matter cross-sectional area at 
C6/7 and T10/11 spinal levels. A significant lower ADC (p=0.012) was observed at 
C6/7 in the BSCP group, no difference in FA value was observed at this level. No 
significant difference was observed in ADC or FA between subject groups at T10/11. 
No relationships were observed with the clinical measures (GMFM-66, SCALE, and 
Modified Ashworth). These results suggest that there is no difference in spinal cord 
white matter microstructure in individuals with BSCP compared to their TD peers. 
However, the sensitivity of these results to alterations in white matter microstructure, 
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particularly at the T10/11 level, is limited by image quality at data acquisition and low 
subject numbers. 
9.1	  Introduction	   	  
Periventricular leucomalacia (PVL) is the most common brain injury in bilateral spastic 
cerebral palsy (BSCP) and is caused by a primary arterial ischemic injury to the white 
matter, including damage to the corticospinal tract. The corticospinal system has 
multiple functions including inhibition and excitation of motor neurones, and the 
control of spinal reflexes. The corticospinal tract conducts impulses from the brain, 
originating at the primary motor cortex, the supplementary motor area, and the pre-
motor cortex to the spinal cord grey matter via axonal projections of the neurons in the 
motor cortex. These axonal projections form the corticospinal tract that descends the 
spinal cord.  
 
As the corticospinal tract develops, a course network of connections between the 
corticospinal tract and spinal motor neurons are initially formed which are then refined 
by neuronal activity causing the elimination of transient corticospinal connections, and 
by the growth of axon terminal branches and synaptic boutons21,22. There is also 
evidence that there are interactions between the developing corticospinal and afferent 
muscle systems23. The elimination of transient corticospinal terminals may leave more 
space in the spinal grey matter reducing the competition and thereby reducing the 
pruning of muscle afferent fibre branches24. This refined connectivity ultimately 
determines the specific functional network required to perform precise voluntary 
movements14. 
 
PVL tends to occur between 24 and 33 PCW, before the transient spinal terminations of 
the corticospinal tract in the spinal cord grey matter have been eliminated and mature 
projections onto the cells of the spinal grey matter have formed. As a result of this 
injury, intrinsic cord networks may not mature and muscle development may be 
delayed30. An injury to the developing corticospinal tract results in the loss of fine 
selective voluntary muscle control in distal limb muscles. Spinal cord and subsequent 
muscle development is likely to be affected by the extent, severity and timing of the 
original brain injury. 
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As well as damaging the corticospinal tract, PVL can also damage the reticulospinal and 
vestibulospinal tracts that facilitate the control of muscle tone. The vestibulospinal 
tracts originate from the vestibulospinal nuclei and are involved in balance and support 
with the vestibulospinal tracts exciting the motor neurons in the spinal cord causing 
contractions of the extensor muscles in the lower limbs. The reticulospinal tracts 
originate from the reticular nuclei and form the medial and lateral reticulospinal tracts. 
The medial reticulospinal tract stimulates the extensor muscles and inhibiting the flexor 
muscles of the proximal limb musculature and the lateral reticulospinal tract has the 
complementary effect, having an inhibitory effect on the extensors muscle and an 
excitatory effect on the flexor muscles of proximal limb musculature. Therefore, altered 
muscle tone may be caused by damage to the reticulospinal and vestibulospinal systems. 
PVL is an upper motor neuron lesion and as a result can have both negative and positive 
effects. The negative effects include loss of power, decrease in fine motor control. The 
positive effects include spasticity, involuntary movements, and co-contractions. It is 
possible that damage to the reticulospinal and vestibulospinal tracts in PVL may alter 
the structure or organisation of these tracts in the spinal cord white matter. 
 
In the literature, DTI has been used successfully in the brain to investigate white matter 
injuries in individuals with cerebral palsy, often correlating their findings with motor 
function239-245. Spinal cord DTI techniques have only recently started to be applied to 
the spinal cord, with recently published studies investigating a range of pathology 
including spinal cord compressions248, inflammatory diseases249 and arteriovenous 
malformations251. Diffusion parameters, the Apparent Diffusion Coefficient (ADC), a 
measure of the magnitude of diffusion, and Fractional Anisotropy (FA), a measure of 
the degree of isotropy in diffusion, have been shown in histological studies to be 
sensitive to the underlying axon microstructure246,247. However, it is important to note 
that a measured change in FA or ADC does not differentiate between specific changes 
in axon dimensions or packing parameters. Therefore, DTI parameters can only detect a 
change in an underlying microstructure but cannot identify how this microstructure has 
changed. 
 
The aim of this study is to investigate white matter organisation in the spinal cord at the 
C6/7 and T10/11 spinal levels in individuals with BSCP and their typically developing 
(TD) peers using DTI. Spinal cord grey and white matter areas are also measured. We 
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hypothesise that at the T10/11 spinal level, compared to their TD peers, individuals with 
BSCP will have decreased FA and increased ADC values associated with increased 
transient connections between the grey and white matter in the spinal cord. These FA 
and ADC values will be correlated to their functional ability. At the C6/7 spinal level, 
we hypothesise that, considering the lesser involvement of the upper limbs in BSCP, no 
significant difference will be observed in FA or ADC values in the spinal cord white 
matter between subject groups. Considering the reduced cerebral white matter volume 
following PVL291,292, we hypothesise that the damage to the white matter tracks in the 
PLIC will result in reduced white matter volume in the spinal cord and that this will be 
related to their functional level (GMFM-66). 
9.2	  	   Methods	  
9.2.1	  	  Participants	  
West London National Research Ethics committee granted ethical approval for this 
study. Individuals aged 12 – 25 years, with a diagnosis of BSCP, Gross Motor Function 
Classification System (GMFCS) levels I-III, who met the safety requirements of MRI 
were included in this study. Patients who had undergone surgery, serial casting or 
botulinum toxin injections to the lower limbs within the previous year were excluded 
from the study. This was a convenience sample of individuals attending our hospital 
department, with consecutive patients that met the inclusion criteria invited to 
participate in the study. 11 participants with BSCP were recruited to the study (mean 
age: 16.4 years ± 4.2; age range: 12.1 – 25.5 years; GMFCS level I: n=1, level II: n=4, 
level III n=5, level IV: n=1; 11 male) and ten TD subjects were included in this study 
(mean age: 16.9 years ± 3.9; age range: 12.3 – 23.2 years, 12 male). The TD subjects 
had no previous surgery to their lower limbs and had no known neurological or 
musculoskeletal conditions.  
9.2.2	  	  Data	  collection	  
All MR data were acquired on a 3.0T Achieva system (Philips Medical Systems. Best, 
Netherlands) using a 16-channel neurovascular coil for C6/7 and a 16-channel posterior 
cardiac coil for T10/11. Imaging protocol: At each spinal level, anatomical images of 
the spinal cord were acquired with an accumulated T2*-weighted gradient echo 
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sequence with TR= 1000 ms, TE= 6.5, 15.2, 23.8, 32.4, and 41.0 ms, flip angle=28o, 0.5 
x 0.5 mm in plane voxel size, 5.0 mm slice thickness, 4 signal averages, 224 x 203 
matrix size. The accumulated T2*-weighted gradient echo sequence improves the image 
contrast between grey and white matter in the spinal cord compared to images acquired 
with a single TE. Cardiac gated reduced field of view EPI DTI images were acquired of 
the cervical and thoracic spinal cord with b=0 and 750 s/mm2, 6 directions, 5.0 mm 
slice thickness, TE = 55 ms, TR ≃ 2000 ms (dependent on subject heart rate), 90° flip 
angle, 0.5 x 0.5 mm in plane voxel size, 64 x 64 acquisition matrix, 40 x 40 x 30 mm 
FOV, acquisition time ≃ 8 minutes (depending on the subject’s heart rate), small FOV 
option - slab thickness 120 mm, 3 NSA.  ADC and FA maps were calculated on the 
scanner. 
 
Functional ability (Gross Motor Function Measure 66 (GMFM-66)184), selective 
voluntary motor control (Selective Control Assessment of the Lower Extremity 
(SCALE)188), and spasticity (modified Ashworth293) of the lower limbs of the subjects 
with BSCP was assessed by a physiotherapist on the same day as the MRI scan. 
9.2.3	  	  Data	  analysis	  
The ADC and FA maps were calculated from the acquired DTI data on the Philips 
Achieva scanner after each scan and exported to Matlab (R2013b, Natwick, USA). The 
FA and ADC maps from the DTI data sets were registered to the T2-weighted image 
series and the spinal cord white matter manually segmented on the T2-weighted images 
and the grey and white matter areas calculated (Figure 9.1b).  Regions of interest were 
manually drawn around the lateral spinal cords defined by a line from the postero-lateral 
sulcus to the junction of the anterior and posterior horn and on to the antero-lateral 
sulcus (Figure 9.1c). This enabled the spinal cord white matter to be segmented into left 
and right lateral spinal cord regions as shown in Figure 9.1d. The mean and standard 
deviations of the FA and ADC maps were then calculated for the total spinal cord white 
matter and separately for the left and right lateral spinal cord segments. The mean FA 
and ADC values were compared between subject groups and between spinal cord levels 
within each group using independent samples t-tests. The relationships of FA and ADC 
values with functional clinical tests (GMFM-66, SCALE, and modified Ashworth) were 
investigated using Pearson’s correlation tests. To assess the test-retest repeatability of 
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the grey and white matter segmentation method in 18 subjects at the T10 spinal level 
was examined using a one-way intra-class correlation coefficient (ICC) reporting single 
measure reliability. The benchmarks for ICC proposed by Landis and Koch (1977)294: 
0-0.2 ‘poor’; 0.21-0.40 ‘fair’; 0.41-0.60 ‘moderate’; 0.61-0.80 ‘substantial’; and 0.81-
1.00 ‘almost perfect’. The standard error of measurement (SEM) was calculated using 
Equation 9.1. The smallest detectable difference (SDD) with 95% confidence interval 
was calculated using Equation 9.2 to estimate the minimal difference between muscles 
to exceed measurement error. All statistical tests were performed using SPSS (Version 
22.0; IBM SPSS, Chicago, USA). 
 
   Equation 9.1 
Where SDdiff is the standard deviation of the differences between the repeated 
measures. 
   Equation 9.2 
 
 
Figure 9.1(A) Cervical spinal cord at C6/7 of one volunteer; (B) Segmented 
white matter (green) and grey matter (blue; (C) Lateral spinal cord white 
matter defined by lines from the postero-lateral sulcus to the junction of the 
anterior and posterior horn and on to the antero-lateral sulcus (red); (D) 
Lateral spinal cord regions (red). 
 
9.3	  	   Results	  
Table 9.1 summarises the physical characteristics of each group. No significant 
difference was observed in age (p = 0.787), subject height (p = 0.218), body mass (p = 
0.378) or body mass index (BMI) (p = 0.888) between the two subject groups. The 
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T10/11 data from one TD subject was excluded from analysis due to significant subject 
movement during image acquisition. The repeatability of the grey and white matter 
segmentation technique is summarised in Table 9.2. ‘Almost perfect’ ICC was observed 
for the grey and white matter segmentation technique. 
 
 CP group TD Group 
Age (years) 16.4 ± 4.2 16.9  ± 3.9 
Height (m) 1.64 ± 0.13  1.73  ± 0.13 
Body mass (kg) 59.7  ± 17.1 65.5 ± 11.2 
BMI (kg/m2) 21.6  ± 4.6 21.8  ± 1.7 
GMFCS level I N = 1 N/A 
GMFCS level II N = 4 N/A 
GMFCS level III N = 5 N/A 
GMFCS level IV N = 1 N/A 














SEM	   SDD	  
Grey	  Matter	   33.5	  (29.9)	   0.819	   0.454	   0.941	   12.74	   35.31	  
White	  Matter	   -­‐63.9	  (53.2)	   0.845	   0.533	   0.95	   20.93	   58.02	  
Table 9.2 Mean difference in initial and repeated measure of white matter and grey 
matter area at the T10/11 spinal level with the corresponding intraclass correlation 
coefficient (ICC) values. The standard error of measurement (SEM) and smallest 
detectable difference (SDD) and the paired-test p-value for bias are also given. 
Significance was set at p≤0.05. 
 
Group mean ADC and FA values, and grey and white matter areas are given in Tables 
9.3 and 9.4 for C6/7 and T10/11 spinal levels respectively. Example ADC and FA maps 
from one CP subject at the cervical and thoracic spinal levels are shown in Figures 9.2. 
Figures 9.3 and 9.4 show bar charts of ADC and FA values for each group at the C6/7 
and T10/11 spinal levels respectively. No significant difference was observed between 
the TD and BSCP groups at T10/11 spinal level white matter mean group ADC values 
(all white matter p=0.581; left lateral cord p = 0.418; right lateral cord p = 0.564) or FA 
values (all white matter p=0.597; left lateral cord p = 0.990; right lateral cord p = 
0.485). A significant difference was observed between TD and BSCP groups at C6/7 
spinal level white matter ADC values (all white matter p = 0.012; left lateral cord p = 
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0.011; right lateral cord p = 0.04). No significant difference was observed in FA at C6/7 
between groups (all white matter p=0.495; left lateral cord p = 0.634; right lateral cord p 
= 0.127). No significant relationships were observed between any of the measured ADC 
(r2<0.19, p>0.05) or FA (r2<0.25, p>0.05) parameters with GMFM-66, SCALE, or 
modified Ashworth tests. Figure 9.5 shows a bar chart of the grey and white matter 
areas at each spinal level investigated for the BSCP and TD groups. The white matter 
area was significantly lower in the BSCP group for both the C6/7 (p=0.047) and T10/11 
(p=0.027) spinal levels. However, white matter area did not correlate with GMFM-66, 
SCALE, or Modified Ashworth scale at either C6/7 or T10/11 spinal levels (r2=0.01-
0.16). No significant difference was observed in the grey matter areas between the two 
groups at the C6/7 (p=0.223) and T10/11 (p=0.537) and grey matter area did not 
correlate with GMFM-66, SCALE, or Modified Ashworth scale at either C6/7 or 













CP 301 260 343 62 19 Grey matter area 
(mm2) TD 333 295 372 50 17 
CP 1125 1023 1228 153 46 White matter 
area (mm2) TD 1297 1137 1456 207 69 
CP 437 358 517 119 36 White matter 
ADC (mm2/s) TD 562 509 616 69 23 
CP 0.817 0.801 0.834 0.024 0.007 White matter FA 
TD 0.827 0.793 0.86 0.044 0.015 
CP 432 349 516 124 38 
Left lateral WM 
ADC (mm2/s) 
TD 570 507 633 82 27 
CP 0.822 0.801 0.843 0.031 0.009 Left lateral WM 
FA TD 0.812 0.774 0.851 0.05 0.017 
CP 432 356 508 113 34 
Right lateral WM 
ADC (mm2/s) 
TD 530 472 587 74 25 
CP 0.811 0.784 0.838 0.04 0.012 Right lateral WM 
FA TD 0.842 0.807 0.878 0.046 0.015 
Table 9.3 Mean, 95% confidence interval of the mean, standard deviation and standard error for 
the CP and TD groups at the C6/7 spinal level. ADC = apparent diffusion coefficient; FA = 
fractional anisotropy; WM = white matter; GM = grey matter. 
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95% Confidence 









CP 237 204 269 48 14 Grey matter area 
(mm2) TD 269 224 315 59 20 
CP 744 696 792 71 21 White matter 
area (mm2) TD 833 761 904 93 31 
CP 510 345 676 246 74 White matter 
ADC (mm2/s) TD 490 349 631 183 61 
CP 0.813 0.761 0.866 0.078 0.024 White matter FA 
TD 0.805 0.77 0.84 0.046 0.015 
CP 534 356 713 265 80 
Left lateral WM 
ADC (mm2/s) 
TD 491 352 629 180 60 
CP 0.779 0.726 0.832 0.079 0.024 Left lateral WM 
FA TD 0.77 0.723 0.817 0.061 0.02 
CP 449 302 597 220 66 
Right lateral WM 
ADC (mm2/s) 
TD 434 299 569 176 59 
CP 0.805 0.759 0.851 0.069 0.021 Right lateral WM 
FA TD 0.797 0.756 0.839 0.054 0.018 
Table 9.4 Mean, 95% confidence interval of the mean, standard deviation and standard error for 
the CP and TD groups at the T10/11 spinal level. ADC = apparent diffusion coefficient; FA = 
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Figure 9.3 Mean (A) ADC and (B) FA values for the CP (white) and TD (grey) subject groups at the 
C6/7 spinal level. Error bars represent ± one standard error for each group. * Denotes a significant 
difference between subjects groups (p≤0.05). 
 
  
Figure 9.4 Mean (A) ADC and (B) FA values for the CP (white) and TD (grey) subject groups at the 
T10/11 spinal level. Error bars represent ± one standard error for each group. 
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Figure 9.5 (A) Grey and white matter spinal cord areas at the C6/7 and T10/11 spinal 
levels in the CP (white) and TD (grey) groups. B) The ratio of grey and white matter 
cross-sectional areas in the CP (white) and TD (grey) groups. Error bars represent ± one 
standard error for each group. * Denotes a significant difference between subjects groups 
(p≤0.05). 
9.4	  	   Discussion	  
This study has found a reduced white matter cross-sectional area at both T10/11 and 
C6/7 spinal levels in individuals with BSCP compared to their TD peers.	  As there was 
no significant difference in body size (height or body mass) between the two subject 
groups, this suggests that body size does not account for the differences in white matter 
area between the two groups. This suggests that there may be reduced numbers of axons 
descending the spinal cord, reduced axon diameter, increased axon density, reduced 
myelination, or a combination of these factors in subjects with BSCP. The reduced 
spinal white matter area in BSCP observed in this study matches the reduced cerebral 
white matter volumes reported in individuals with PVL291,292.  This suggests that PVL 
may adversely affect the development of white matter in the spinal cord, however the 
white matter area did not correlate with any of the outcome measures investigated. 
 
Despite the difference in white matter cross-sectional area between the groups, no 
significant differences in ADC and FA values in the spinal cord white matter were 
observed in individuals with BSCP compared to their TD peers at the T10/11 spinal 
level. This is in disagreement with the original hypothesis. Due to the timing and 
location of the injury to the posterior limb of the internal capsule in PVL, and the 
clinical presentation of individuals with PVL (increased muscle tone, reduced voluntary 
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selective motor control, and reduced function ability) we hypothesised that the 
corticospinal tract will abnormally develop resulting in altered microstructure in the 
spinal cord. However, reduced ADC values were measured at C6/7 spinal levels. This 
suggests that there is restricted diffusion in the cervical cord white matter. This may be 
related to alternations in white matter organisation including axon number and axon 
diameter246. However, no significant differences in FA values were observed between 
the subject groups. 
 
Although a reduced ADC was observed in the cervical spinal cord, the insignificant 
finding for FA at this level and for both ADC and FA in the thoracic spinal cord 
suggests that spinal cord microstructure may not be significantly altered in BSCP. 
However, the difference between the two groups may be masked by two limiting 
factors: the contrast and resolution of the T2-weighted anatomical image series and the 
image quality of the DTI protocol. The image contrast and in-plane resolution of the T2-
weighted scans enables the cross section of the spinal cord to be coarsely segmented 
into grey and white matter. The individual tracts of the spinal cord cannot be 
distinguished. It is possible that the local microstructure of the corticospinal tract may 
be altered in subjects with PVL; however, the regions of interest in this study are much 
larger than the size of the tracts. The inclusion of the different tracts of the spinal cord 
may limit the sensitivity of the technique to detect a change in structure that is restricted 
to the local region of the corticospinal tract. The limited resolution of the regions of 
interest employed in this study may also explain the insignificant relationships found 
between the ADC and FA parameters and the functional measures GMFM-66, SCALE, 
and modified Ashworth, as only particular regions of the spinal cord, such as the 
regions of the vestibulospinal and reticulospinal tracts in the white matter may correlate 
with one of the measures. The ‘noise’ acquired by including other white matter regions 
not related to muscle inhibition or excitation may limit the sensitivity of this study to 
detect subtle changes in microstructure of the individual white matter tracts, resulting in 
an insignificant result. The resolution and image contrast also limits the accuracy with 
which grey and white matter can be segmented. This may inadvertently result in the 
inclusion of cerebrospinal fluid or grey matter in the white matter regions of interest. 
This would artificially increase the variability in the measured parameters due to the 
significantly different structure and therefore ADC and FA of the cerebrospinal fluid 
and grey matter compared to the white matter. 
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Figure 9.6 Example axial b0 images of the spinal cord at the T10/11 spinal level of two volunteers 
with (A) high SNR, and (B) low SNR 
 
The DTI acquisition protocol may be a serious limitation to the sensitivity of the study 
to detect any potential difference in white matter organisation compared to their TD 
peers. Image quality, including distortion and SNR of the T10/11 DTI datasets are 
variable between individuals in this study. Example variation in SNR between two 
subjects is shown in Figure 9.5. If the variability of the DTI parameters is less than the 
variability due to noise in the DTI dataset, no difference between the subject groups will 
be detected. FA is SNR dependent: low SNR regions results in a higher FA being 
measured295-297. When the SNR is high, FA is stable since the small difference in FA 
due to SNR variation is low. If the SNR varies significantly between subjects, the 
difference in FA due to the change in SNR will be dominant compared to the small 
difference in FA due to the underlying tissue microstructure. The SNR of the acquired 
DTI datasets cannot be calculated; however, the coefficient of variation (CoV) of the 
cerebral spinal fluid signal intensity in the b=0 images of each dataset can provide an 
indication of the image quality. The CoV of the C6/7 datasets were significantly higher 
(p<0.001) than the T10/11 datasets (Figure 9.6). No significant difference in CoV was 
observed between subject groups at the T10/11 (p=0.351) or C6/7 (p=0.873) spinal 
levels. The low image quality of the T10/11 datasets limits the sensitivity of the 
sequence to detect small differences in underlying tissue microstructure. Therefore, it is 
possible that this study has a false negative result.  
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Figure 9.7 Coefficient of variation of the cerebrospinal fluid in the b=0 
images at C6/7 and T10/11 spinal levels in the CP (white) and TD (grey) 
subject groups. Error bars represent the standard error of the coefficient of 
variation of signal intensity 
 
The ADC and FA values of white matter in the cervical spinal cord have previously 
been published in TD subjects by Wilm et al272 using reduced-field-of-view DTI on a 
Philips Achieva 3T system. Wilm et al272  reported an average FA values of 0.75 ± 0.07 
and ADC values of 910 ± 100 mm2/sec from four TD subjects. This FA value is lower 
compared to the mean FA of the TD subjects in this study (FA = 0.83 ± 0.04), and the 
ADC is higher than those measured in the cervical spinal cord of TD subjects in this 
study (ADC = 562 ± 70 mm2/sec). This difference in ADC is much larger compared to 
the reproducibility of brain ADC measured across centres298	  and is indicative of motion 
during data collection. This further suggests that the DTI results in this study are 
compromised by low SNR, which results in artefactually low ADC values and high FA 
values.  
 
One factor that may be contributing to the low image quality is the shimming of the 
magnetic field in the region of interest, resulting in image distortion. Qualitatively, the 
SNR also appears to vary between subjects at the T10/11 spinal level. The influence of 
noise on the DTI results could be improved by increasing the number of diffusion 
directions and removing cardiac gating to enable a greater number of gradient directions 
to be acquired for the same scan time. Further investigation of the apparent subject 
dependency of the SNR is required. 
 
Limiting this study to the analysis of spinal cord white matter microstructure may also 
be a limiting factor. It is possible that the microstructure of the spinal cord grey matter 
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is altered in BSCP, potentially to a greater extent than the white matter tracts. During 
corticospinal tract development, the elimination of transient corticospinal terminals in 
the spinal cord grey matter may result in greater changes to the grey matter 
microstructure than the white matter. As a result, an injury to the developing 
corticospinal tract would result in greater abnormalities in the grey matter compared to 
the white matter. Therefore, the spinal cord grey matter may be a more sensitive target 
to altered spinal cord development than imaging the corticospinal tract itself. However, 
in this study the grey matter cannot be reliably and accurately identified in the acquired 
data sets due to the resolution of the acquisition protocol. In a future study this could be 
addressed by acquiring images with a higher resolution and increased SNR by 
increasing the TR and increasing the number of diffusion gradient directions acquired. 
9.5	  	   Conclusion	  
This study has found that individuals with BSCP have a reduced white matter cross-
sectional area compared to their TD peers. However, except for a significantly reduced 
ADC of the cervical cord white matter, no significant difference in diffusion parameters 
were observed, suggesting that the white matter microstructure is not significantly 
different in individuals with BSCP compared to their TD peers. Small subject groups 
and poor image quality of the DTI protocol, particularly at the T10/11 spinal level, may 
limit the sensitivity of this study to detect any potential alterations in white matter 
microstructure. A future study with increased SNR, reduced distortion, and increased in 
plane resolution is required to establish the validity of the results of this study. This 
would also enable the spinal cord grey matter microstructure to also be investigated 
simultaneously with the white matter analysis. 
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10. Summary	  
	  
10.1	  	  	  Review	  of	  aims	  
This programme of work set out the following set of aims: 
1. To compare lower limb muscle volumes of subjects with bilateral spastic 
cerebral palsy (BSCP) to their typically developing (TD) peers using MRI. 
2. To investigate if there is a relationship between muscle volume and bone 
strength in the lower limb. 
3. To compare muscle adiposity in subjects with BSCP and compare with their TD 
peers. 
4. To investigate white matter organisation in the cervical and thoracic spines of 
adolescents and young adults with BSCP and compare with their TD peers using 
diffusion tensor imaging (DTI) MRI. 
5. To investigate any relationships between white matter organisation in the 
thoracic spine and gross motor function, selective motor control. 
The major findings of this programme of work are: 
10.1.1	  	  Lower	  limb	  muscle	  volume	  
Seven of the nine lower limb muscles investigated in this study (medial gastrocnemius 
(MG), lateral gastrocnemius (LG), soleus (SOL), tibialis anterior (TA), rectus femoris 
(RF), semimembranosus (SM), semtiendinosus (ST)) were smaller in subjects with 
BSCP compared to their TD peers. Gluteus maximus (GMax) and the vastus 
intermedius and lateralis composite (VI+VL) were also reduced in the BSCP group: 
however, this was not statistically significantly. The average muscle volume deficit in 
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the BSCP group compared to the TD group mean muscle volume was 27.9%. Muscle 
volume deficits were significantly greater for distal muscles than proximal muscles 
(p<0.001). 
 
Reduced lower limb muscle volume in BSCP is an important finding. Although lower 
limb muscle volumes have previously been investigated in cerebral palsy53,56-60, few 
studies include measurements of muscle size for the whole lower limb116,299,57, and are 
limited to studies of hemiplegic subjects116,299, or do not compare muscle volumes to 
TD subjects116,299. This is the first study investigating muscle volumes with all subjects 
diagnosed with BSCP, with the muscle volumes compared to their TD peers. This study 
also has greater subject numbers (19 subjects in each group) than currently published in 
the literature. Although only nine of the major lower limb muscles have been measured 
in this study, the greater muscle volume deficits of the distal muscles provides a general 
guide for strength training interventions in ambulant individuals with BSCP.  
 
10.1.2	  	  Bone	  strength	  and	  muscle	  volume	  in	  ambulant	  individuals	  with	  
BSCP	  
In the distal femur, the polar section modulus (Zp), a measure of bone bending and 
torsional strength, was significantly positively related to thigh muscle volume and 
height, independent of body mass and diagnosis. The buckling ratio (BR), a measure of 
bone buckling stability was not significantly different between groups and was not 
related to any of the variables tested. Cortical bone CSA, related to bone compressional 
strength, was significantly dependent on diagnosis and positively associated with thigh 
muscle volume in the distal femur, and to diagnosis and subject height in the proximal 
tibia. 
 
Tibial cortical bone cross-sectional area, an indicator of compressional bone strength 
was observed to be dependent on diagnosis and independent on muscle volume. This is 
a surprising result that may be explained by the irregular cross-section of the proximal 
tibia and uneven distribution of muscle around it.  The uneven distribution of muscle 
around the tibia results in an uneven distribution of load applied to the tibia by the 
surrounding musculature. Therefore, any adaptations to muscle induced stress and strain 
may be location dependent. Therefore, the relationship between the muscle volume and 
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cortical thickness needs to be investigated considering the loading direction of the 
muscle groups. 
 
This is the first study investigating the relationship between bone geometry and strength 
with muscle volume in individuals with cerebral palsy. These results suggest that bone 
growth in BSCP show the same adaptation to mechanical loading as their TD peers, a 
process known as Wolf’s law, a finding supported by a recently published study 
showing bone adaptation following low-magnitude vibration training282, with the stress 
and strain mediated by muscle action having significant influence over bone 
remodelling and, therefore, bone strength Although predominantly prescribed for non-
ambulant individuals with cerebral palsy, weight-bearing exercises and drug therapies 
are often utilised to improve bone strength. However, the associations between femoral 
bone strength and thigh muscle volume in this study suggest that weak bones may not 
be a direct consequence of having cerebral palsy, but may be related to muscle size. 
This suggests that strength training to increase muscle size, that in turn exposes the 
bones to greater stress and strain, may increase bone strength and cortical bone CSA, 
decreasing the risk of fractures in this patient group. Future work is required to 
determine whether the relationship between bone strength and muscle volume is also 
present in non-ambulant individuals with cerebral palsy and whether bone strength can 
be increased through muscle strength training. Directly loading the bones may also 
produce a similar remodelling affect to those mediated by muscle action, which may 
provide an alternative treatment on the bones 
 
Study limitations 
Muscle volume has been used as a surrogate of muscle strength in this study. In 
typically developing individuals directly measuring muscle strength may improve the 
relationship between muscle and bone. However, measurement of muscle strength in 
cerebral palsy is unreliable and may underestimate the maximum force generating 
capacity of muscle due to poor selective voluntary motor control and co-activation of 
antagonist muscle groups53,105,106. However, muscle volume is reflective of the total 
number of sarcomeres and is linearly related to muscle power118. Therefore, it is 
reasonable to use muscle volume as a surrogate measure of maximal muscle force 
potential in BSCP. Similarly, Zp, Br, and cortical bone CSA are not direct 
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measurements of bone strength and assume uniform material properties of bone, 
including cortical bone density, across all subjects in this study. 
 
The MRI data was collected using three MRI protocols on two different MRI scanners. 
Although the bone and muscle geometries for each individual were measured from a 
single scan, the use of two different scanners may result in a systematic error in the 
measured muscle and bone geometries between the subjects. This systematic error is 
likely to be small due to required geometric reproducibility of clinical imaging across 
different MRI machines. However, the reproducibility of the geometric measures across 
scanners should be investigated to ensure that any potential systematic error is small 
compared to the differences in muscle and bone geometries between the subject groups. 
 
10.1.3	  	  Muscle	  adiposity	  in	  BSCP	  
Intramuscular fat was higher in subjects with BSCP for all muscles tested (MG, LG, 
SOL, TA) compared to their TD peers. Intramuscular fat was significantly related to 
GMFCS level (p<0.001). Intermuscular fat (IMAT) was also higher in subjects with 
BSCP p<0.001). No significant difference was observed in subcutaneous fat normalised 
to muscle volume (SF/M) between groups. 
 
The number of subjects recruited may limit the scope and power of this study. However, 
the differences in intramuscular fat between the TD and BSCP groups were large and 
statistically significant. The group differences were also were much larger than the 
reproducibility of the mDixon technique used in this study, defined as the average 
standard deviation of measured percentage fat across all muscles (0.33%).  
 
Surgical intervention may also have an effect on the results of this study. Six of the ten 
BSCP subjects had undertaken gastrocnemius recessions to the left leg; with one of 
these six subjects also having had Achilles tendon lengthening. It is possible that the 
histories of surgical intervention received by the individuals with BSCP in this study 
may have influenced the development of particular muscles, with percentage 
intramuscular fat significantly dependent on intervention and muscle (p=0.048 and 
p=0.009 respectively). Despite not being operated on directly, the soleus had 
significantly higher intramuscular fat content compared to MG and LG (p=0.006 and 
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p=0.007 respectively). This data suggests that gastrocnemius lengthening may result in 
damage to the soleus causing fatty accumulation. This is an interesting finding as the 
lengthening intervention is performed on the gastrocnemius muscles, not the soleus. 
This suggests that gastrocnemius lengthening may expose the soleus to much greater 
forces in the post-operative period, resulting in muscle damage. The degree of soleus 
injury may be related to the size and strength of the soleus pre-operatively, with larger 
muscles more likely to be able to withstand greater forces without suffering a muscle 
injury leading to fatty degradation. Alternatively, the muscle injury caused by the 
surgery may lead to fatty degradation of the muscle tissue. There are currently no 
studies investigating the effect of surgical intramuscular lengthening on intramuscular 
fat. However, a rabbit model of gastrocnemius lengthening and Achilles tendon 
lengthening surgeries found increased intramuscular fat and reduced volume after 
surgery290. Longitudinal studies are required to determine whether surgery influences 
intramuscular fat, or whether those individuals with heightened levels of intramuscular 
fat are more likely to have surgery. 
 
Increased adiposity in BSCP may help to explain deficits in muscle performance in this 
group: however, increased adiposity may also have further physiological implications. 
This study suggests that despite having a body mass index (BMI) within the healthy 
range (18-25), the patients in this group may have an increased risk of developing 
obesity-related diseases, with risk increasing with decreasing functional ability. 
However, to date there are no reports of glucose intolerance or diabetes in adolescents 
and young adults with cerebral palsy. It is possible that the prevalence of metabolic 
conditions in cerebral palsy have not been investigated. Alternatively, increased 
adiposity in this population may have a different aetiology or implication or metabolic 
function.  Future studies are required to investigate the physiological implications of 
raised intramuscular fat in BSCP.  
10.1.4	  	  Spinal	  cord	  white	  matter	  imaging	  in	  BSCP	  
No significant difference was observed in grey matter cross-sectional area at C6/7 and 
T10/11 spinal levels. No significant difference was observed in ADC or FA between 
subject groups. No relationships were observed for ADC or FA of spinal cord white 
matter with the clinical measures (GMFM-66, SCALE, and Modified Ashworth) at both 
T10/11 and C6/7 spinal levels. Spinal cord white matter cross-sectional area was 
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significantly smaller in the BSCP group compared to their TD peers at both C6/7 
(p=0.047) and T10/11 (p=0.027) spinal levels.  
 
These results suggest that despite the presence of a reduced white matter cross-sectional 
area, there is no difference in spinal cord white matter microstructure in individuals 
with BSCP compared to their TD peers. However, this study is limited by image quality 
in the DTI datasets. The sensitivity of these results to alterations in white matter 
microstructure, particularly at the T10/11 level, appears to be limited by poor image 
quality at data acquisition. Image quality, including distortion and the signal-to-noise 
ratio (SNR) of the T10/11 DTI datasets are variable between individuals of both groups 
in this study. ADC and FA are SNR dependent: low SNR results in a higher FA and 
lower ADC values. When the SNR is high, FA is stable since the small difference in FA 
due to SNR variation is low295-297. When the SNR is low and variable between subjects, 
the difference in FA due to the change in SNR will mask a small difference in FA due 
to the underlying tissue microstructure. Compared to previously published ADC and FA 
values acquired with a similar acquisition protocol in TD subjects272, this study 
measured lower ADC and higher FA values, further suggesting that the DTI results in 
this study are compromised by low SNR. 
 
Preliminary tests have established that image distortion is related to subject dependency 
of the magnetic field shimming, resulting in image translation or wrap artefacts in the 
image. Increasing the shim region and changing from a pencil beam to a volume-based 
approach has reduced the prevalence of the wrap artefact.  The low and variable SNR 
has also been investigated, however, this has not been resolved. In the acquired datasets 
the SNR has only been a limiting factor in the reduced-field-of-view DTI datasets. This 
has been investigated through increasing the number of diffusion directions, using a 15-
channel spine coil, and by removing cardiac gating to remove the heart rate dependency 
of the repetition time (TR). Despite these modifications, the SNR remains subject 
dependant and, therefore, this study has been suspended until the issue has been 
resolved with the assistance of the manufacturer. A future study is required to confirm 
the results of this study once the study limitations have been addressed. 
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10.2	  	  	  Clinical	  implications	  
The results of the musculoskeletal imaging sections of this programme of work have 
important clinical implications. This programme of work has found that adolescents and 
young adults with BSCP have reduced lower limb muscle volumes compared to their 
typically developing peers, with the distal muscle more greatly reduced. Muscle volume 
together with selective motor control is a strong predictor of functional ability, with 
lower limb muscle volume and Selective Control Assessment of the Lower Extremity 
(SCALE) explaining 90.3% of the variation in Gross Motor Function Measure (GMFM-
66) (Appendix F). Since selective motor control in individuals with BSCP is static, with 
limited changes to muscle activation patterns in gait following surgery300,301, 
maximising muscle volume through strength training may be an important factor for an 
individual to maximise their functional ability. The relatively greater reduction in distal 
muscle volume suggests that strength-training exercises should include, and perhaps 
focus on, the distal muscles in these individuals, as these muscles are comparatively 
more affected than the proximal musculature. However, exercise prescription should 
still be patient specific, taking into account the degree of involvement of specific 
muscles, the patient’s functional ability, and goals. 
 
As well as having reduced muscle size, these muscles also have greater intramuscular 
fat than their typically developing peers. Reduced muscle volumes and increased 
adiposity may further explain the reduced muscle strength and functional ability in this 
patient group. The increased intra- and intermuscular fat in cerebral palsy observed in 
this programme of work may have important implications for the metabolic health of 
these patients. Raised intramuscular fat levels are strongly associated with insulin 
resistance and type-II diabetes44-46. These morphological and compositional changes 
may have implications both for the mechanical performance of these skeletal muscles 
and also for the predisposition of the adult with cerebral palsy to cardio-metabolic 
disease122. This data suggests that individuals with cerebral palsy may benefit from an 
exercise intervention targeting both the strength and metabolic function of their lower 
limb muscles through strength and cardio-vascular training with the aim to both 
decrease their intramuscular far content and their muscle size and strength. However, 
the cause and implications of increased intramuscular fat requires investigation to fully 
in form the clinical management of this patient population. 
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This programme of work has also observed that muscle volume has an important role in 
bone strength in ambulant individuals with BSCP. Muscle volume and height are 
significantly related to femoral bone strength estimated from bony geometry, 
independent of diagnosis and body mass. This may have important implications for the 
clinical management of fracture risk in this population and in non-ambulatory 
individuals with cerebral palsy. Traditionally these individuals receive weight bearing 
therapies, medication to increase bone mass, or a combination of these. The 
insignificant relationship between body mass and bone strength in the ambulant 
individuals with cerebral palsy suggests that weight bearing therapies are unlikely to 
improve bone strength. Therapies where the direction of loading is not aligned with the 
long axis of the bone imparts greater bending forces, and therefore, may cause greater 
bone remodelling to occur. These forces can be mediated by muscle action, however, 
the bones may also remodel in response to passive loading, which may be more 
applicable therapy for a non-ambulant population. However, this is a cross-sectional 
study and longitudinal studies are required to determine whether the long bones of 
individuals with cerebral palsy increase in strength following a loading mediated by 
muscle action or by passive loading.  
10.3	  	  	  Methodological	  findings	  
In this programme of work, MRI has been used successfully to image the lower limbs of 
individuals with BSCP, facilitating the measurement of muscle and bone morphology, 
and intramuscular fat quantification. Two main methodological findings have been 
made during this programme of work that can be applied to both future studies of 
cerebral palsy, and other conditions. 
10.3.1	  	  Intramuscular	  fat	  quantification	  
In the literature, T1-weighted image segmentation is primarily used to quantify IMAT, 
with IMAT defined as the MRI-visible fat within the muscles (intramuscular fat) and 
between the muscles beneath the fascia (intermuscular fat). Although this method is 
effective for assessing intermuscular and subcutaneous fat volumes, it is not an accurate 
method for measuring fat distribution within individual muscles.  
 
Multi-echo imaging techniques for fat quantification have been evaluated against 
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magnetic resonance spectroscopy (MRS) in vitro with fat-water phantoms and in vivo in 
vastus medialis of TD subjects. Although multi-echo techniques have been widely used 
and evaluated for hepatic fat quantification, this is the first study published study 
investigating Dixon imaging, specifically mDixon imaging, for in vivo intramuscular fat 
quantification. This study investigated the dependence of the mDixon technique on the 
flip angle of the excitation radio-frequency pulse, and on the selection of the number of 
data points acquired and their timing, informing sequence design for future 
intramuscular fat quantification studies. However, it is important to note that fat 
quantification measured using multi-echo techniques are not standardised and platform-
independent. The precision of the quantified fat fraction depends on five confounding 
factors; T1 bias, T2* decay, spectral complexity of fat, noise bias, and eddy currents220. 
This work is discussed in detail in Chapter 7 and has been published in the British 
Journal of Radiology302. 
10.3.2	  	  Drawing	  regions	  of	  interest	  
This programme of work has involved the manual identification of muscle boundaries 
throughout the lower limbs of over 50 individuals. Although automatic segmentation 
algorithms can successfully segment MRI images by tissue type based on pixel 
intensity, pixel intensity based segmentation techniques are currently not successful at 
indentifying complex boundaries between neighbouring muscles. Therefore, all muscle 
regions of interest in this programme of work were performed manually. In order to 
minimise the processing time of these images, a novel method was employed where the 
input of an iPad was used to facilitate the direct tracing of muscle boundaries on MRI 
images using a touch screen pen. 
10.4	  	  Future	  work	  
10.4.1  Do	  patients	  with	  bilateral	  spastic	  cerebral	  palsy	  have	  an	  
increased	  risk	  of	  developing	  obesity-­‐related	  diseases?	  
Adults with cerebral palsy may have a 2-3 times greater risk of dying from ischemic 
heart disease than their typically developing peers13. Chronic sedentary behaviour, 
which is often prevalent in cerebral palsy, is generally accepted as the predominant 
cause of cardio-metabolic decline and sarcopenia in the general population303, with 
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sedentary behaviour strongly associated with disease, disability and shortened lifespan 
among all adults304.  
 
An atherogenic lipid profile has been widely reported in persons with chronic spinal 
cord injuries (SCI)305-309. Subjects with a SCI have similar functional difficulties and 
sedentary behaviour patients with BSCP. Both patient groups exhibit reduced muscle 
size, reduced muscle activation, and reduced activity levels. In SCI, the most consistent 
lipid profile alteration is a depressed blood plasma concentration of high-density 
lipoprotein cholesterol (HDL-C)305,306,310-312. HDL-C has a range of functions including 
protection against the development of vascular disease313. Altered lipid profiles, 
including low HDL-C, have also been linked with insulin resistance in non-disabled 
clinical populations314,315. Due to the strong relationship of cardiovascular disease with 
altered blood lipid profiles and similar activity levels with SCI patients, measuring the 
lipid profiles of BSCP subjects is an important step in assessing their risk of developing 
cardiovascular diseases.  
 
The increased inter and intramuscular fat in BSCP observed in this programme of work 
(Chapter 8) may expose patients with cerebral palsy to a greater risk of developing 
cardiovascular44,121 and cardio-metabolic disease122. However, the cardio-metabolic 
implications of this are unknown. There is a strong relationship between intramuscular 
fat content, insulin resistance and type-II diabetes44,46,45. In particular, increased 
intramyocellular lipid in the soleus correlates with glucose-insulin-lipid metabolism and 
insulin sensitivity49-52,41. Since individuals with BSCP have reduced muscle mass, even 
individuals with body mass index in the normal range may have relatively increased 
levels of adipose tissue compared to their typically developing peers. As discussed in 
Chapter 8, young adults with BSCP have significantly higher intramuscular fat content 
compared to their typically developing peers, with the soleus the most adversely 
affected. The level of intramuscular fat also appears to be dependent on the degree of 
their mobility impairment (GMFCS level). Previous studies in children with CP have 
also suggested raised levels of fat76,77. Therefore, investigating the risk factors including 
blood lipid profiles, glucose tolerance, and adiposity is important to assess the risk of 
adults with BSCP to developing cardio-metabolic disease. 
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10.4.2	  	  The	  relationship	  between	  surgical	  intervention	  and	  muscle	  
quality	  
Surgical muscle lengthening is a common intervention performed on individuals with 
cerebral palsy with the aim to correct the joint range of movement following the 
development of muscle contractures. In Chapter 8, the intramuscular fat content of the 
plantarflexor muscle group in individuals with BSCP was found to be significantly 
dependent on whether an individual had received a surgical gastrocnemius lengthening, 
with the soleus having higher intramuscular fat content compared to the medial and 
lateral gastrocnemius muscles. As this study was cross-sectional, the relationship 
between surgical intervention and intramuscular fat accumulation cannot be elucidated: 
1. Surgical intramuscular lengthening may lead to intramuscular fat accumulation 
through the same mechanism of fatty degradation following muscle injuries286-
289. 
2. Heightened intramuscular fat levels may be associated with the development of 
muscle contracture, with the raised intramuscular fat levels measured in Chapter 
8 being present prior to surgery. If the intramuscular fat is present prior to the 
intervention, the degree of fatty infiltration into the muscles may be related to 
surgical outcome. 
A longitudinal study, with intramuscular far measurements performed pre- and post-
intervention, to determine whether surgery results in greater accumulation of 
intramuscular fat, whether individuals with heightened levels of intramuscular fat are 
more likely to have surgery, and whether intramuscular fat content prior to surgery 
predicts surgical outcome. 
10.4.3	  	  Measurement	  of	  bony	  morphology	  using	  MRI	  	  
Bony morphology is often investigated using computed tomography (CT). Although CT 
produces high quality images of the skeletal system, it is associated with a high dose of 
ionising radiation (X-rays). MRI does not use involve ionising radiation and has been 
increasingly used in the literature for measurements of bony geometry. Despite having 
lower water content and very short relaxation times, cortical bone can be identified on 
MRI images due to the very low MR signal acquired compared to the surround fat and 
muscular tissue. 
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Femoral anteversion is the inclination of the axis of the femoral neck with respect to the 
knee joint axis in the transverse plane. The angle at which the femoral neck is inclined 
is the anteversion angle. At birth a child has approximately 30-50° of femoral 
anteversion316. As the child matures and develops they progress through several key 
motor milestones including crawling, standing and walking. These activities induce 
stress on the proximal end of the femur. In response to the applied stress, the proximal 
end of the femur remodels with femoral anteversion decreasing rapidly in the first three 
to four years of life to approximately 15° at skeletal maturity316,317. The delay of motor 
milestone acquisitions which often occurs with cerebral palsy results in the degree of 
anteversion remodelling in early life being reduced316, with increased femoral 
anteversion persisting into adulthood318,319. The number of years spent walking 
independently may be a significant factor influencing the remodelling of femoral 
anteversion in ambulant individuals with BSCP (Appendix G). 
 
Internal foot progression is a common gait abnormality in ambulant children with 
cerebral palsy320. Internal foot progression can be caused by deformity of femur, tibia, 
and/or foot in the transverse plane, with internal hip rotation commonly related to 
excessive femoral anteversion angle321. The primary treatment for excessive femoral 
anteversion is a femoral derotation osteotomy (FDRO). During an FDRO, the femur is 
cut and the distal segment of the femur is externally rotated and then fixed to the 
proximal segment. However, excessive femoral anteversion is not the only cause of 
internal hip rotation321 and FDRO does not consistently correct internal hip rotation in 
gait322,323, with one study reporting that internal hip rotation persisted in 33.3% of cases 
at a mean post FDRO follow-up of 22 months with a reoccurrence of internal hip 
rotation at 53 months post surgery in 9.5% of the individuals that reported with 
corrected internal hip rotation at 22 months323. Three dimensional gait analysis and 
clinical examination of femoral anteversion improve the surgical outcomes of 
FDRO322,324,325; however, the clinical test of femoral anteversion, the greater trochanter 
prominence test (GTPT), is problematic. 
 
The GTPT is performed with the patient in prone with the hip in a neutral coronal 
position and knee flexed to 90°, the hip was rotated internally and externally while 
palpating the most prominent part of the greater trochanter. Femoral anteversion is the 
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angle of the tibia to vertical when the greater trochanter is at its most prominent lateral 
position. However, in a study comparing the GTPT with MRI, there was only moderate 
agreement, with the true femoral anteversion value being within 11.8° of GTPT (95% 
confidence limit)326.  	  
Seventeen of the individuals with BSCP volunteering for studies in this programme of 
work also attended the One Small Step Gait Laboratory at Guy’s Hospital for clinical 
3D gait analysis within four months of their MRI scan, during which their femoral 
anteversion is measured using the GTPT and mean internal hip rotation in gait is 
measured. A weak but significant positive linear relationship (r=0.379, p=0.030) was 
observed between the femoral anteversion angle measured using the GTPT and from 
MRI using the Murphy method327, with the GTPT underestimating the femoral 
anteversion angle by 20°(p ≤ 0.001).  However, the passive internal hip rotation range 
of the lower limb also limits the applicability of the GTPT. When the maximum passive 
internal hip rotation is less than the femoral anteversion angle, it is not possible to 
measure the femoral anteversion angle by the GTPT, instead an erroneous measure is 
made on the palpation of a false lateral prominence of the greater trochanter. In this 
subject group, 24% (8 lower limbs) exhibited femoral anteversion angles measured by 
MRI outside the maximum internal range of movement of the hip. 
 
Setting the upper limit of the normal range to the 95% confidence limit (mean plus two 
standard deviations of the TD subjects) for femoral anteversion (31.3°) and mean 
internal hip rotation in gait (10.6°) enables the interaction between femoral anteversion 
and internal hip rotation to be investigated. Of the lower limbs of the BSCP subjects 
that volunteered for studies in this programme of work, 33.3% exhibited excessive 
femoral anteversion and excessive internal hip rotation compared to the normal range, 
48.5% had excessive femoral anteversion without excessive internal hip rotation in gait, 
18.2% had both femoral anteversion and internal hip rotation within the normal range, 
and 3% had excessive internal hip rotation without excessive femoral anteversion. 
These results demonstrate that the cause of internal hip rotation in gait is multi-factorial 
and improving selection of patients who may benefit from a FDRO by measuring 
femoral geometry from MRI may improve surgical outcome. 
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A weak but significant relationship was observed between femoral anteversion angle 
and mean internal hip rotation during gait for both the GTPT (r=0.415, p=0.026) and 
MRI method (r=0.545, p=0.001).  However, when only the lower limbs that presented 
with both excessive femoral anteversion and excessive mean internal hip rotation 
(Figure 10.1), a strong positive correlation is observed between MRI measured femoral 
anteversion and mean internal hip rotation (r=0.650), but no correlation is observed 
between the GTPT and mean internal hip rotation (r=0.127). This means that 65% of the 
variability in internal hip rotation in individuals with excessive femoral anteversion and 
mean internal hip rotation can be explained by their femoral anteversion angle when 
measured by MRI. These results suggest that measuring femoral anteversion by MRI 
instead of the GTPT when indentifying individuals who may suitable for a FDRO may 
improve surgical outcome. Therefore, a future study is required to investigate whether 
MRI based femoral anteversion measures improve patient outcome (correction of 
internal hip rotation in gait) following FDRO.                                                                                
                                                                                                                                  
 
Figure 10.1 Scatter plot of femoral anteversion angle measured by MRI (black) (r=0.650) 
and GTPT (white) (r=0.127) versus mean internal hip rotation in gait for lower limbs 
exhibiting both excessive femoral anteversion and excessive internal hip rotation. 
 
10.4.4	  	  The	  effect	  of	  strength	  training	  on	  the	  muscle	  bone	  unit	  
The relationships observed between bone strength and muscle volume, independent of 
body mass, in Chapter 6 have important implications for the physical management of 
the cerebral palsy patient group. This suggests that muscle weakness, which is prevalent 
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in cerebral palsy55, may be a significant factor in bone growth and development in this 
group. Low functioning individuals with cerebral palsy are often prescribed weight-
bearing activities to improve bone strength and reduce their risk of fractures. The results 
of the study in Chapter 6 suggests that strength training to increase muscle size and 
strength may be more likely to result in increased bone strength compared to traditional 
weight bearing therapies. Although it should be noted that the relationship between 
bone strength and muscle volume was not observed in the tibia, possibly due to the 
irregular shape of the tibia and distribution of musculature around it. Lower limb 
muscle strength training may enable individuals to maximise the mechanical forces 
experienced by the bones and thereby maximise the potential for bone development.  
 
It is known that muscle strength in cerebral palsy can be improved through strength 
training328-330, resulting in an improved functional ability328-330. Bones in adolescents 
and young adults with cerebral palsy also show the same adaptation to mechanical 
loading due to muscle contractions as their TD peers282.  Therefore, the effect of muscle 
strength training on bone strength requires further investigation. This could be achieved 
by a 12-week strength training interventional study in which subjects have their lower 
limb muscle strength measured and undergo an MRI scan of their lower limbs at the 
start of the strength training programme (0 weeks), 6 weeks, at completion of the 
strength training programme (12 weeks), and 3 months after completing the programme.  
10.4.5	  	  Spinal	  cord	  DTI	  
Significantly reduced spinal cord white matter cross sectional area was observed in 
individuals with BSCP compared to their TD peers in Chapter 9. This is comparable to 
the reduced cerebral white matter volume reported in studies of PVL291,292. However, as 
discussed in section 9.1.4, the study failed to determine whether there is altered white 
matter microstructure organisation in BSCP due to poor image quality of the DTI 
datasets. Therefore, the potential difference in white matter organisation suggested by 
the reduced white matter cross-sectional area observed in this study, requires further 
investigation. The inclusion of spinal cord grey matter DTI in a future study is also 
advisable as this may prove to be a more sensitive region to altered corticospinal tract 
development than the white matter as damage to the developing corticospinal tract may 
affect the elimination of transient spinal terminations of the corticospinal tract in the 
spinal cord grey matter and the development mature projections onto the cells of the 
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spinal grey matter. The image quality can be improved in future studies by dedicating 
more acquisition time to the DTI acquisition protocol, with a greater number of 
diffusion directs acquired at a higher resolution. The effect of cardiac gating on image 
quality could be investigated. The removal of cardiac gating would enable a 
standardised TR to be used across patients to reduce the T1 weighting and SNR 
variability between patients,  
10.5	  	  	  Conclusion	  
This programme of work has found that the lower limb muscles of adolescents and 
young adults with bilateral spastic cerebral palsy have reduced have reduced volume 
and increased intramuscular fat compared to their typically developing peers.  These 
reduced muscle volumes are related to altered bony geometry and reduced strength of 
the distal femur and proximal tibia. These findings suggest that individuals with 
cerebral palsy may benefit from strength training programmes to improve their muscle 
and bone strength, and that they may be exposed to greater cardio-metabolic risk due to 
increased intramuscular fat content, particularly in the soleus.  
 
This programme of work has also observed reduced white matter volume in the thoracic 
and cervical spinal cord of individuals with cerebral palsy compared to their typically 
developing peers. This result indicates that spinal cord as well as cerebral development 
may be affected in these individuals. Future work is required to elucidate any micro-
structural changes in the spinal cord that make relate to the severity of the condition.
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Appendices	  
A.	  Magnetic	  resonance	  
imaging	  
MRI relies on the interactions of nuclei with an external applied magnetic field to 
produce images. The nuclei predominantly used are those of hydrogen, where each 
nucleus consists of a single proton. Hydrogen is abundant within the body within all 
water and fat molecules. A fundamental property of a proton is spin. Protons can have a 
spin of ± 1/2. Particles with a net spin can absorb and are, therefore, excited by 
radiowaves at a frequency ω0 whilst in an applied magnetic field B. This frequency, the 
Larmor frequency, is dependent on the gyro-magnetic ratio, γ of the particle and the 
external field strength (B) (Equation A.1).  
ω0=γB Equation A.1 
 
The spin of the proton gives it two properties: angular momentum (J) and a magnetic 
moment (µs). The angular momentum is due to the net spin and odd mass number, 
which together with the electrical charge of the proton produce the magnetic moment. 
The interactions of spin with a magnetic field can be considered from both a classical 
and quantum mechanical approach. Classically, the angular momentum of a proton is 
given in Equation A.2. In an applied magnetic field, the magnetic moment of the proton 
changes the angular momentum since γ where I is the moment of inertia and ħ is the 
reduced Planck’s constant. This causes the magnetic moment to precess around the 
direction of the applied magnetic field. This precession frequency is the Larmor 
frequency. Quantum mechanically, in an applied magnetic field a proton has energy 
given by Equation A.3. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   Equation	  A.2	  
Appendix	  A	  
J.J.	  Noble	   Musculoskeletal	  and	  spinal	  cord	  imaging	   185	  
 
                  E = -µs.B Equation A.3 
 
Since a proton can have a spin of +/- ½, the protons can occupy two distinct energy 
states: 
E = +µsB   or    E = - µsB Equation A.4 
 
If energy is supplied equal to the gap between the two energy states, proton transition 
will take place between the two states. This can be achieved by applying a Radio 
Frequency pulse at the Larmor frequency. Therefore, a proton in an applied magnetic 
field can have a magnetic moment in one of these two states, aligned parallel or anti-
parallel to the applied field. These are described as ‘spin up’ and ‘spin down’ 
respectively. There is a small difference in the spin populations of these two states; this 
causes a net magnetisation vector (M) parallel to the applied magnetic field. 
A.1	  Excitation	  
At equilibrium, the net magnetisation vector lies along the direction of the applied 
magnetic field Bo and is called the equilibrium magnetisation Mo. Therefore, the Z 
component of magnetisation MZ, the longitudinal magnetisation, is equal to Mo. Since 
MZ is equal to Mo there is no transverse magnetisation. Excitation of the spins is caused 
by the application of a radiofrequency (RF) pulse at the Larmor frequency of the proton. 
Quantum mechanically, the effect of the RF pulse is to alter the relative populations of 
the two spin states changing the direction of the net magnetisation vector. Classically, 
the magnetic field of the RF field interacts with the net magnetisation vector, causing 
the net magnetisation vector to nutate from the z-axis towards the transverse plane. 
Equation A.5 gives the ‘flip angle’ of the net magnetisation vector from the longitudinal 
axis, where t is the length of time the RF field is applied. For example, a 90o pulse will 
flip the net magnetisation vector from the Z direction into the transverse xy-plane. Any 
flip angle is possible, although the most common used are 90o and 180o. 
 
θ = γB1t Equation A.5 
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A.2	  Relaxation	  
Relaxation is the return of the net magnetization vector to its equilibrium state 
following a perturbation event by an applied RF field. There are two types of relaxation: 
spin-lattice and spin-spin. Spin- lattice relaxation is the longitudinal relaxation caused 
by spins losing energy to the bulk structure and realigning back along the longitudinal 
axis with MZ, returning to M0 exponentially with a time constant T1. Spin- Spin 
relaxation is transverse relaxation of MXY to zero. Spin-spin relaxation is due to 
exchanges of energy between adjacent spins. MXY decays exponentially, with a time 
constant T2. T2 is always less than or equal to T1. Transverse and longitudinal 
relaxations occur simultaneously after the application of an excitation RF pulse. 
 	   Equation	  A.6	  
	   Equation	  A.7	  
 
Since the signal acquired is due to oscillations in the transverse magnetic field, i.e. when 
the net magnetisation vector is in the transverse plane, the decay of the signal measured, 
known as the Free Induction Decay (FID), is characterised by T2. However, in practice 
the actual decay constant of the FID is characterised by T2*, which takes into account 
the additional dephasing caused by microscopic inhomogeneities in B0.  
 	   Equation	  A.8	  
A.3	  Image	  contrast	  
The basic MR image signal strength depends on the proton density and mobility. 
Therefore, for example, air and bone appear inherently dark due to their negligible 
hydrogen content. Proton mobility also affects the image contrast; immobile protons, 
such as those contained in large molecules, produce a small signal with free water 
producing the highest signal. This will, therefore, cause Cerebral Spinal Fluid (CSF) 
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and urine to appear bright. This inherent contrast is called proton-density weighted, as it 
fundamentally depends on the number of protons in a given region.  Proton density, 
however, is not the only source of image contrast. Relaxation times of protons strongly 
depend on their physicochemical environment. Therefore, different tissues have 
different relaxation parameters T1 and T2 introduced in Section A.2 This means that the 
amount of signal received from prospective tissue types can be manipulated to alter 
image contrast and obtain various degrees of T1 or T2 weighting. Table A.1 shows 
example T1 and T2 values for some tissue types at 1.5T.  
 
Tissue T1 T2 
White matter 560 82 
Grey matter 1100 92 
CSF 2060 160 
Muscle 1075 33 
Table A.1 Summary of approximate relaxation times for the three main tissue types331 
 
The relative T1 and T2 weighting of the resultant image is dependent on the relative 
timings of the acquisition sequence; the repetition time of the excitation pulses (TR) and 
the echo time between excitation and the middle of signal acquisition (TE). Generally, 
the shorter the TR the stronger the T1 weighting: the longer the TE, the stronger the T2 
weighting.  For example in a T2 weighted, to maximise the contrast between two tissues 
the TE is chosen when there is the largest difference in their relative signal intensities. 
Another method for controlling image contrast other than TR and TE manipulation is by 
varying the flip angle of the excitation pulse. A flip angle of less than 90o only transfers 
part of the net magnetisation vector into the transverse plane, leaving part in the 
longitudinal plane. This means that T1 recovery is much quicker so that a shorter TR 
can be used without any T1 weighting. 
A.4	  Spatial	  localisation	  
As explained in above, the Larmor frequency of spin depends on the strength of the 
external magnetic field. Applying a magnetic field gradient will cause the magnetic 
field and Larmor frequency to vary with respect to position. MRI utilises linear 
magnetic gradients to achieve this. One-dimensional gradients vary along only one 
direction, e.g. the x direction. Therefore, in order to accurately locate the origin point of 
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a signal in space the magnetic field needs to be varied along three orthogonal axes. The 
gradients along the x,y and z directions (Gx Gy Gz) are switched on and off to achieve 
signal localization in the following ways: 
A.4.1	  Slice	  selection	  
Slice selection is achieved by applying a linear magnetic field gradient during the period 
that the RF pulse is applied. This gradient is known as the slice-select gradient Gs or Gz 
(if the slice select gradient is applied in the z-direction, e.g. for axial or transverse 
slices). This causes the Larmor frequency of spins within the object to vary along z 
through the object (Equation A.1). A 90o pulse is applied in conjunction with a 
magnetic field gradient to rotate spins into the transverse plane that are located in a 
particular slice. The applied 90o pulse contains a band of frequencies equal to the 
frequency band of the slice of interest through the object as determined by the slice 
select gradient. Therefore, only the spins in the slice of interest will be excited by the 
pulse and rotated 90o into the transverse plane. A schematic diagram showing slice 












Figure A. 1 Slice select schematic diagram through application of a 
linear magnetic field gradient and an excitatory RF pulse of centre 
frequency and bandwidth to define slice position and slice thickness 
respectively through the object to be imaged 
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A.4.2	  Phase	  encoding	  
Phase encoding utilises the application of a second gradient orthogonal to the slice 
select gradient, known as the phase encoding gradient Gp. This gradient enables the 
signal to be located in the y direction. The phase encoding gradient is applied between 
the excitation pulse and signal acquisition (read-out) and changes the phase of the spins 
according to their y position.  
A.4.3	  	  Frequency	  encoding	  
Frequency encoding involves the application of a gradient orthogonal to the slice select 
and phase encoding gradients during signal acquisition, known as the read-out gradient 
Gr. This allows the signal to be located in the x direction within the slice defined by the 
slice select gradient. The application of the gradient changes the Larmor frequency for 
each x co-ordinate allowing the total signal to be decomposed from each location using 
Fourier analysis. Applying these three localisation methods in a pulse sequence enable 
the signal to be located within 3D voxels within the subject. Once the signal has been 
acquired the whole process is repeated but with a different phase encoding gradient to 
enable the whole signal for the area of interest to be acquired. This is best-understood 
using k-space.  
A.4.4	  	  K-­‐space	  
The simplest description of K-space is that it is a ‘raw data’ matrix that stores the 
encoded MR signal. K-space contains the frequency rather than spatial information of 
the image from which the image can be obtained by applying a Fourier Transform. The 
frequency and phase encoding matrix, i.e. how many steps of phase and frequency for 
which the signal is read, controls the size of both K-space and the final image in terms 
of the number of data points. For example, if a 256-matrix size is chosen for phase 
encoding, the signal needs to be acquired 256 times to fill k-space, filling 256 columns. 
However, it is important to note that each voxel in k-space does not correspond to the 
respective voxel in the final image due to the Fourier Transform process used. The 
middle of k-space contains the low frequency and, therefore, the contrast information of 
the image. The outer edges contain the high frequency information, which includes the 
image resolution data such as edges. There is, therefore, a relationship between the field 
of view (FOV) in k-space and image space. Gradients applied during a sequence control 
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the location in k-space at which the signal is acquired. The phase encoding gradient 
controls the position in kPE, and the read out gradient controls the location along kFE 
with the initial excitation pulse enters k-space at its centre (0,0). Sequences are, 
therefore, designed to traverse k-space in different ways, the most common of which are 
explained in the next section. 
A.5	  Basic	  sequences	  
It is important to note that the raw FID is not acquired; this would require the readout 
gradient to be switched on instantaneously following the excitation pulse, which would 
not enable 3D signal location techniques to be employed. Therefore, all sequences 
actually acquire an echo of the raw FID utilising either spin or gradient echo techniques.  
A.5.1	  Gradient	  Echo	  
Gradient Echo (GE) sequences use a read gradient to rephase spins into a FID echo. A 
GE sequence is shown in Figure A.2. GE sequences can be used to produce T1, T2* or 
proton density weighted images. The negative portion of the read gradient is used to 
control the position in k-space from which the signal will start to be acquired. The 
positive gradient then enables the MR signal to be sampled across the frequency 
encoding direction in k-space. It is important to note that the production of a signal echo 
using a gradient rephases the dephasing caused by the first gradient but does not correct 
for the dephasing caused by inhomogeneities in B0. Consequently, the images can only 
be T2* or T1 weighted. It is also important to note that the negative ‘blip’ of the read 
gradient also repositions the observer in k-space to the far left of kFE. The readout 
gradient then moves the observer across the width of k space acquiring the signal at 
various points defined by the readout matrix. As explained in Section A.1.4, the phase 
encoding gradient is then altered between each acquisition to obtain data in the 
consecutive lines of k-space. 
A.5.2	  Spin	  Echo	  
Spin Echo (SE) sequences are very similar to GE sequences but have a 180o RF pulse to 
refocus the spins instead of the application of a negative read gradient (see Figure A.3). 
This RF pulse flips the spins in the transverse plane. Therefore, any dephasing 
occurring due to magnetic field inhomogeneities now cause rephasing to produce an 
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echo of the FID, with the signal only having decayed by T2 processes. SE sequences can 

















Figure A. 2 Gradient Echo sequence diagram Figure A. 3 Spin Echo sequence diagram 
A.6	  Fast	  imaging	  sequences	  and	  techniques	  
Various techniques have been developed to speed up the imaging process to reduce 
patient time within the scanner. This also reduces the chance of patient movement 
during sequential image slice acquisitions and to permit the imaging of moving body 
parts such as the heart. The most common techniques are presented in this section. 
These techniques can also be used together to further decrease the scan duration. 
A.6.1	  Fast/Turbo	  Spin	  Echo	  (FSE/TSE)	  
Fast spin echo (FSE) is a SE technique that utilises a chain of multiple 180o RF pulses 
to form an echo train. These echoes are used to acquire multiple lines of k-space 
following a single excitation pulse. Therefore, each refocusing pulse has a different 
phase encoding gradient. The 180o pulses are equally spaced in time. The number of 
180o pulses and, therefore, acquired echoes, is known at the echo train length (ETL).  
A.6.2	  Echo	  Planar	  Imaging	  (EPI)	  
Echo Planar Imaging (EPI) is a readout technique that acquires an entire slice per 
excitation pulse. EPI can be single shot or multi-shot, SE or GE. In ‘blipped’ EPI 
readout, k-space is traversed through the application of a chain of frequency encoding 
gradients of opposite sign, between which small phase encoding gradients are applied to 
change between different lines of k-space. A GE EPI sequence is shown in Figure A.4.  
‘Blipped’ EPI produces regular paths through k-space as shown in Figure A.5. This also 
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speeds up image reconstruction. Large readout gradient amplitudes are required to 
enable the fast sampling of the points in kFE and the whole kPE following a single 
excitation pulse. Due to the FID, EPI is limited to acquisition times of approximately 
100 ms after which the FID has become too small to acquire. EPI readout is very useful 















Figure A. 4 Spin echo sequence with EPI readout Figure A. 5 EPI movement through k-space 
A.6.3	  Half	  Fourier	  
In Half Fourier acquisitions just over half of k-space is acquired. The half that is not 
acquired is estimated from the other half using complex conjugate synthesis. This 
reduces scan time by nearly 50% without significant drop in spatial resolution, but it 
does reduce SNR by approximately 30% since the noise is effectively copied to the non 
acquired half of k-space resulting in the noise no longer being uncorrelated 331. 
A.6.4	  Multi-­‐slice	  imaging	  
In single slice imaging, a single slice is excited and one line of k-space is read, then 
after a time (TR) the slice is excited again to read another line of k-space. This clearly 
results in a lot of time within each repetition for which the scanner is idle waiting to 
commence the next repetition unless a sequence with a short TR is used. For example, 
for a TE/TR of 20/600 ms, it takes approximately 30 ms to excite and acquire the data 
leaving 570 ms in which the scanner is idle. Multi-slice imaging takes advantages of the 
idle time by acquiring lines of k-space within other slices during the TR. Therefore; 
within a single TR the scanner excites and collects data from multiple slices within the 
object. The excitation of other slices during the TR does not interfere with the relaxation 
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processes occurring in that slice due small gaps between imaging slice through the 
object, which ensure no cross-excitation between the slices occurs. 
A.6.5	  Parallel	  imaging	  
Parallel imaging techniques, such as Sensitivity Encoding (SENSE), are methods of 
combining simultaneous images from multiple coils (phased array coils) around an 
object. SENSE utilises knowledge of the sensitivity of each coil element, to calculate 
the aliased signal component at each point. This technique can be used to improve SNR, 
improve spatial resolution or to reduce overall scan time. SNR increases because the 
signal between each element is correlated and, therefore, will combine to increase the 
resultant image signal, whereas the noise is uncorrelated and will combine destructively. 
The number of individual coil elements in the phase encoding direction determines the 
maximum time reduction factor. Time reduction is possible by under sampling k-space 
and recording images simultaneously from multiple imaging coils (phased array coils). 
Under sampling reduces the acquisition time and the use of multiple RF coils eliminates 
the wrap artefact, where part of the imaged anatomy located outside of the field of view 
appears inside of the field of view, caused by the under sampling. 
 
SENSE reconstruction is a post Fourier Transform process applied to the images from 
each coil of the phased array. In SENSE, reduced k-space is acquired by acquiring 
fewer points in the phase encoding direction of k-space. If, for example, an image is 
acquired in a conventional acquisition process with half the number of phase encoding 
steps, the scan time would be halved but the resultant image would be aliased due to the 
under sampling. However, the position of the aliased information in the resultant image 
can be predicted through knowledge of the field of view 331. SENSE utilises knowledge 
of the sensitivity of each coil element, to calculate the aliased signal component at each 
point. Therefore, each acquisition with SENSE requires a short, low resolution, 
calibration scan from which sensitivity maps are calculated. Figure A.6 shows how 
under sampling k-space affects the resultant image and how parallel imaging enables 
under sampling of k-space without seriously affecting the image. Figure A.6 (B) shows 
that by reducing the matrix size by half in the phase encoding direction by sampling on 
the centre of k-space the resolution of the image is reduced since the high frequency 
data is around the edges of k-space. However, the matrix size can be reduced but 
maintaining resolution by reducing the number of lines in k-space but still acquiring 
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over the same range. This however, results in aliasing of the image since field of view 
(FOV) is dependent on the sample spacing in k-space. Parallel imaging corrects for this 
aliased signal by using knowledge of the element sensitivities to interpolate between the 


















Figure A. 6 K-space and image matrix behaviour and parallel imaging. (A) 
256x256 matrix (B) 256x128 matrix resulting in low image resolution (C) 256x128 
matrix resulting in aliased signal wrapping back onto image (D) Parallel imaging 
corrects for aliasing for the matrix used in (C) 
A.7	  Diffusion	  tensor	  imaging	  (DTI)	  
Diffusion Weighted (DW) images are sensitive to small microscopic movements of 
Hydrogen nuclei within the body, such that regions with free water diffusion are dark 
and areas of restricted diffusion are bright. This is achieved by applying two 
symmetrical gradients either side of an 180o pulse as shown in Figure A.7. The first 
gradient gives a phase to the spins dependant on their position within the slice. If the 
spins are in the same position after the 180o pulse the identical gradient will now 
produce the opposite phase change since the spins have been flipped in the transverse 
plane between the applications of the two gradients by the 180o pulse. This causes the 
spins to be rephased, resulting in a strong signal. For spins that have moved between the 
applications of the two gradients, different and unique phase changes will be 
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experienced, causing the spins to be out of phase reducing the net transverse 
magnetisation, resulting in a smaller signal. The degree of dephasing and signal 
intensity of the spins will be dependent on the difference between the two phase 
changes experienced and, therefore, dependant on the motion of the spins. 
 
 
Figure A. 7 Basic Pulsed Gradient Spin Echo (PGSE) sequence with 
EPI read-out 
The b-value is defined for the PGSE sequence shown in Figure A.8 in Equation A.9, 
where G is the gradient amplitude is the gradient duration, and ∆ is the separation of 
the two gradients. The b-value determines the amount of diffusion weighting in the 
resultant image. Increasing the b-value increases the diffusion weighting; this results in 
a higher sensitivity to diffusion but with an increase in overall signal loss and, therefore, 
reduction in SNR. 
 Equation A.9 
 
The ADC calculation removes influences on signal from image weighting and other 
sources including bulk flow and bulk motion. The ADC can be calculated from two or 
more images with different b-values enabling the image to be displayed as ADC map. 
The calculation of the ADC map is shown in Equation A.10, where the TE is equal in 
both the DW and T2 weighted images.  
 
 Equation A.10 
 
The b-value in Equation A.10 is a user-prescribed DTI parameter dependant on the 
amplitude, duration, and timing of the diffusion-sensitising gradient-pulse waveform 
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and is a primary determinant of the molecular water diffusion sensitivity. As the b-value 
is increased, the amount of diffusion weighting in the acquisition increases. 
 
The diffusion weighting can only be applied in one direction at a time. In order to model 
diffusion as a tensor, a minimum of six diffusion directions are required, this technique 
is known as diffusion tensor imaging (DTI). Each voxel in DTI is a measure of the 
diffusion magnitude and direction at that location. Diffusion can be visualised as 
ellipsoids, with the eigenvectors of the Diffusion tensor representing the three 
orthogonal axes. For example, in skeletal muscle, it has been shown that the principal 
eigenvalue (λ1) corresponds to diffusion directed along the fibre’s length, with the other 
two eigenvalues (λ2 and λ3) in the cross-sectional plane 332.  Notably, DTI permits the 
calculation of Fractional Anisotropy (FA). FA is a scalar whose value, between 0 and 1, 
describes the degree of anisotropy of diffusion, where FA=0 describes isotropic 
diffusion. FA is calculated using Equation A.11, where D is the mean of the trace 
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Royal Free Hospital & Medical School 
 Research Ethics Committee 
Royal Free Hospital NHS Trust 
Royal Free Hospital 




07 January 2010 
 
Mr Jonathan Noble 
MEP, Faraday building 




Dear Mr Noble 
 
Study Title: Muscular assessment by magnetic resonance imaging 
and ultrasound of young people with cerebral palsy 
REC reference number: 09/H0720/120 
 
Thank you for your letter of 4th December, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair.  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see “Conditions of the favourable opinion” below). 
 
The Committee has not yet been notified of the outcome of any site-specific assessment 
(SSA) for the non-NHS research site(s) taking part in this study. The favourable opinion 
does not therefore apply to any non-NHS site at present. I will write to you again as soon as 
one Research Ethics Committee has notified the outcome of a SSA. In the meantime no 
study procedures should be initiated at non-NHS sites. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned. 
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For NHS research sites only, management permission for research (“R&D approval”) should 
be obtained from the relevant care organisation(s) in accordance with NHS research 
governance arrangements.  Guidance on applying for NHS permission for research is 
available in the Integrated Research Application System or at http://www.rdforum.nhs.uk.  
Where the only involvement of the NHS organisation is as a Participant Identification 
Centre, management permission for research is not required but the R&D office should be 
notified of the study. Guidance should be sought from the R&D office where necessary. 
 
Sponsors are not required to notify the Committee of approvals from host organisations. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 




The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date    
REC application       
Protocol  1  02 October 2009  
Investigator CV       
Participant Consent Form: Cases  1  02 October 2009  
Participant Consent Form: Control  1  02 October 2009  
Referees or other scientific critique report    02 October 2009  
Advertisement       
Participant Information Sheet: Patients  3  04 December 2009  
Participant Information Sheet: Controls  2  04 December 2009  
Response to Request for Further Information       
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Now that you have completed the application process please visit the National Research 
Ethics Service website > After Review 
 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views 
known please use the feedback form available on the website. 
 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Progress and safety reports 
• Notifying the end of the study 
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The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
 
We would also like to inform you that we consult regularly with stakeholders to improve our 
service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk.  
 










Enclosures: “After ethical review – guidance for researchers” [SL-AR1 for CTIMPs, 
SL- AR2 for other studies]  
Copy to: Karen Ignatian, Guy's & St Thomas'Foundation NHS Trust 
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Muscular fat infiltration of young people with Cerebral Palsy (PATIENTS)  




St Thomas’ Hospital 
Westminster Bridge Road 
London SE1 7EH 
 
Hospital No: 020 7188 7188 
Direct Line:  020 7188 2476 
Fax: 020 7188 2477 
E-mail: adam.shortland@gstt.nhs.uk 
 








You are invited to take part in a research study.  Before you decide whether you want to take 
part, it is important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it with friends, 
relatives and your GP if you wish.  Ask us if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you and your child wish to take part. 
   
WHAT IS THE PURPOSE OF THIS STUDY? 
 
In this study, we hope to learn about the differences in 
calf muscles of typically developing young adults and 
young adults with cerebral palsy. We think that 
individuals with cerebral palsy suffer from changes, 
primarily fat and connective tissue, of the muscle that 
causes their muscles to be weaker than their typically 
developing peers.  
 
We will compare the fat and connective tissue content of 
the calf muscles and their microstructure using 
ultrasound imaging and magnetic resonance imaging 
(MRI). A typical image we will obtain using MRI is 
shown in figure 1. We will use the same sort of 
ultrasound technology that is used to scan pregnant 
women to look at their unborn child. The MRI will 
involve lying in an MRI scanner for up to 1 hour. By comparing the MRI data and the ultrasound 
data of the two groups we will understand more about how muscles are affected for individuals 




Figure 1: A typical MRI image we 
will be acquiring through the calf 
muscles. 
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Version 3 04/12/2009 
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WHY HAVE YOU BEEN CHOSEN? 
 
You have cerebral palsy. We are asking 10 individuals who have cerebral palsy to participate. 
We hope to learn more about how the muscles of individuals with cerebral palsy differ from their 
typically developing peers by comparing the data from typically developing young adults and 
young adults with cerebral palsy. 
 
WHO DECIDES IF I WILL TAKE PART? 
 
Any typically young adult aged between 16 and 35 years of age diagnosed with cerebral palsy 
may be asked to take part. It is important that they have not received any orthopaedic surgery or 
treatment on their lower limbs in the last 12 months. The decision to take part is up to you. If you 
decide to take part, you will be asked to sign a consent form. 
 
WHAT IS BEING ASKED OF YOU? 
 
If you agree to take part in the study, you will need to attend St Thomas’ hospital. We will make 
some measurements of height and weight. We will then place an ultrasound probe (like those use 
to scan pregnant mothers) on the skin of your calf to obtain images of the calf muscles. You will 
then be accompanied by a member of staff to the MRI unit. You will be asked to lie in an MRI 
scanner for up to 1 hour. The position you will be asked to lie in is shown in figure 2 and 3 
below. During the MRI scan you can listen to the radio or you can bring along a CD to listen to. 
The whole process should take less than one and a half hours. 
 
" "
Figure 2: The position you will be required to lie in 
during the scan 
Figure 3: A member of the research team in the MRI 
scanner 
WHAT ARE THE POSSIBLE RISKS/BENEFITS? 
 
Ultrasound is considered a safe imaging technique. MRI is also considered safe and does not 
involve the use of ionising radiation. However, there are certain indirect hazards, primarily the 
presence of a strong magnetic field that will exert a force on magnetic materials near the scanner. 
Rigorous safety policies are in place to minimise these risks that meet the national and 
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international safety guidelines for MRI. MRI has been carried out on tens of thousands of 
patients and volunteers at Guy’s and St Thomas’ over more than 20 years without a serious 
adverse incident.  
 
There are no benefits from taking part in this study. 
 
WHAT IF YOU CHANGE YOUR MIND? 
 
If you wish to withdraw from the study, you can do so at any time and without giving any 
reason. 
 
WHAT ABOUT CONFIDENTIALITY? 
 
All information collected during the course of this study will be kept strictly confidential. Any 
information leaving the hospital will have your personal details removed so that you cannot be 
recognised from it. 
 
ARE THERE ANY COSTS? 
 
Yes. You may incur some travelling expenses for which you will be reimbursed. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THIS STUDY? 
 
We expect that the results of this study will be published in medical journals and presented at 
national and international meetings to other medical professionals. 
 
WHO HAS REVIEWED THIS STUDY? 
 
The research ethics committee at the Royal Free Hospital and Medical School has reviewed this 
study. 
 
WHAT SHOULD BE DONE WITH THIS INFORMATION SHEET? 
 
Please take your time to read this information carefully. Keep it for reference if you and your 
child decide to take part. 
 
WHEN YOU HAVE MADE A DECISION 
 
If you decide to participate, please contact Adam Shortland (telephone: 0208 7188 2476) and he 
will organise an appointment for you to come in to the gait laboratory. You will need to bring the 
consent form with you (at the back of this information pack). You should sign the consent form 
at the appointment. 
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If you would like any more information about the study or have any concerns please contact: 
 
Adam Shortland, Clinical Scientist on 020 7188 2476 
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A Research Ethics Committee established by the Health Research Authority 
 
NRES Committee London - West London  
Room 4W/12, 4th Floor 
Charing Cross Hospital 
Fulham Palace Road 
London 
W6 8RF 
 Telephone: 020 3311 7258  
Facsimile: 020 3311 7280 
Dr Adam Shortland 
Consultant Clinical Scientist and Manager 
Guy's & St Thomas' NHS Foundation Trust 
One Small Step Gait Laboratory 
Guy's Hospital, St Thomas' Street 
London SE1 9RT 
 
13 December 2011 
 
Dear Dr Shortland 
 
Study title: Are MRI diffusion parameters in the corticospinal tract 
related to abnormalities of motor control and muscle 
growth in bilateral spastic cerebral palsy? 
REC reference: 11/LO/1520 
 
Thank you for your letter of 28 October 2011,  responding  to  the  Committee’s request for 
further information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair.  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 




The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 




The Committee has not yet been notified of the outcome of any site-specific assessment 
(SSA) for the non-NHS research site(s) taking part in this study.  The favourable opinion 
does not therefore apply to any non-NHS site at present.  We will write to you again as soon 
as one Research Ethics Committee has notified the outcome of a SSA.  In the meantime no 
study procedures should be initiated at non-NHS sites. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
Management permission or approval must be obtained from each host organisation prior to 
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A Research Ethics Committee established by the Health Research Authority 
 
the start of the study at the site concerned. 
 
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk.   
 
Where  a  NHS  organisation’s  role  in  the  study  is  limited  to  identifying  and  referring  potential  
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of approvals from host organisations 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 




The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date    
Investigator CV  Adam 
Shortland  
02 September 2011  
Letter of invitation to participant  Adult v1  31 August 2011  
Other: Letter of invitation to participant  Parent/Guar
dian v1  
31 August 2011  
Other: Advert: Adults Under 25  2  28 October 2011  
Other: Advert: Parents/Guardians Of Children Over 12  2  28 October 2011  
Other: GSFM Score Sheet  1.0     
Other: LIFE-H  3.0     
Participant Information Sheet: Adult (Cases)  1  31 August 2011  
Participant Information Sheet: Parent/Guardian (Controls)  2  28 October 2011  
Participant Information Sheet: Parent/Guardian (Cases)  2  28 October 2011  
Participant Information Sheet: Child (Controls)  2  28 October 2011  
Participant Information Sheet: Child (Cases)  2  28 October 2011  
Participant Information Sheet: Adult (Controls)  2  28 October 2011  
Protocol  1  26 July 2011  
REC application    02 September 2011  
Referees or other scientific critique report  Action 
Medical 
Research  
   
Response to Request for Further Information       
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
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The attached document “After  ethical  review  – guidance  for  researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Notification of serious breaches of the protocol 
 Progress and safety reports 
 Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 




You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views 
known please use the feedback form available on the website. 
 
Further information is available at National Research Ethics Service website > After Review  
 
11/LO/1520 Please quote this number on all correspondence 
 









Enclosures: “After  ethical  review  – guidance for researchers” 
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Are MRI diffusion parameters in the corticospinal tract related to abnormalities of motor 
control and muscle growth in bilateral spastic cerebral palsy? 
 
INTRODUCTION 
You are invited to take part in a research study. Before you decide whether or not you 
would like to take part, it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following information carefully 
and discuss it with friends, relatives and your GP if you wish. Ask us if there is anything 
that is not clear or if you would like more information. Take time to decide whether or 
not you wish to take part. 
  
WHAT IS THE PURPOSE OF THIS STUDY? 
The central nervous system is organised into two parts: grey matter (where all the main 
bodies of the neurones are located) and white matter (consisting of long thin extensions 
of neurones that allow communication between the cells of the central nervous system). 
Many people with cerebral palsy have injuries that affect the development of the white 
matter and muscles.  
In this study we wish to investigate the organisation of the white matter in the spinal 
cord, and measure the volumes of the muscles of the leg. We hope to learn about 
whether there are differences in white matter organisation in people with cerebral palsy 
compared with their typically developing peers. We think that individuals with cerebral 
palsy suffer from decreased white matter organisation that would cause a reduction in 
selective motor control ability. We will also investigate how lower limb muscle volumes 
relate to white matter organisation in the spine. Changes in muscle volumes in cerebral 
palsy can cause their muscles to be weaker than their typically developing peers.  
 
We will take measurements of your spine, brain, and lower limb muscles using magnetic 
resonance imaging (MRI). We will also assess your ability to perform particular 
controlled movements and your overall functional ability through a clinical examination 
and questionnaire. We want to see if the altered development of the white matter is 
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associated with deficits in motor control and functional ability in a group of individuals 
with cerebral palsy. 
WHY HAVE YOU BEEN CHOSEN? 
You have cerebral palsy. We are asking 20 individuals who have cerebral palsy to 
participate. We hope to learn more about how the spinal cord and muscles of individuals 
with cerebral palsy differ from their typically developing peers by comparing the data 
from typically developing subjects and subjects with cerebral palsy. 
 
WHO DECIDES IF I WILL TAKE PART? 
Adults and children, aged between 12 and 25 years of age, with cerebral palsy may be 
asked to take part. It is important that you have not received any orthopaedic surgery on 
their your limbs in the last 12 months. The decision to take part is up to you. If you 
decide to you would like to take part then you will be asked to sign a consent form. 
 
WHAT IS BEING ASKED OF YOU? 
If you agree to take part in the study, you will need to attend St Thomas’ hospital. Once 
at the hospital we will check that you are still happy to take part in the study and if so 
ask you to sign the consent form. For the MRI scan you will need to remove any metal 
objects that you are wearing, which will be stored in a secure area, and you will be 
asked to lie in an MRI scanner for up to 1 hour. The inside of the scanner is shown in 
figure 1. For approximately 10 minutes of the scan you will be required to lie with your 
head inside of a special coil, which will give us better pictures of your brain as shown in 
figure 2. After scanning your brain, we will reposition you in the scanner without the 
plastic helmet and we will take imaged of your spinal cord and lower limb muscles.  
 
  
Figure 1: Inside the scanner Figure 2: Plastic helmet for part of the scan 
 
The scanner can be quite noisy and so we will give you ear-defenders to wear. These 
also contain speakers so you can still talk to the research team and listen to the radio or 
you can bring along a CD to listen to. The whole process should take less than one and 
three quarter hours. You are welcome to visit the MRI scanner in a separate visit to see 
what it will be like during the scan. 
 
After your MRI scan, a physiotherapist or a clinical scientist will perform a brief 
examination of the range of motion of your ankles knees and hips, and assess your 
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ability to control your lower limbs. They will also ask you to perform particular functional 
tasks (sitting kneeling etc.). These tests will require you to change into either shorts and 
a t-shirt, or swimwear, and will take about one hour and thirty minutes. 
  
This means that in total you will be with us for about 3 hours. 
 
WHAT ARE THE POSSIBLE RISKS/BENEFITS? 
MRI is considered safe and does not involve the use of ionising radiation. However, 
there are certain indirect hazards, primarily the presence of a strong magnetic field that 
will exert a force on magnetic materials near the scanner. Rigorous safety policies are in 
place to minimise these risks that meet the national and international safety guidelines 
for MRI. MRI has been carried out on tens of thousands of patients and volunteers at 
Guy’s and St Thomas’ Hospitals over more than 20 years without a serious adverse 
incident.  
 
There are no benefits from taking part in this study. 
 
WHAT IF YOU CHANGE YOUR MIND? 
If you wish, you can withdraw from the study at any time and without giving any reason. 
 
WHAT ABOUT CONFIDENTIALITY? 
All information collected during the course of this study will be kept confidential. Any 
information leaving the hospital will have your personal details removed. 
 
ARE THERE ANY COSTS? 
No, you will be reimbursed for travelling expenses. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THIS STUDY? 
We expect that the results of this study will be published in medical journals and 
presented at national and international meetings to other medical professionals. 
Participants will not be given any of their individual MRI results. 
 
We may use your anonymised study data in future research. If you are happy for us to 
use your data in another study please sign the relevant section of the consent form. 
 
WHO HAS REVIEWED THIS STUDY? 
This study has been reviewed by the West London Research Ethics Committee. 
 
WHAT SHOULD BE DONE WITH THIS INFORMATION SHEET? 
Please take your time to read this information carefully and keep it for reference if you 




WHEN YOU HAVE MADE A DECISION 
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If you decide that you would like to participate in this study then please contact Adam 
Shortland (see below) and he will organise an appointment for you to come to St 
Thomas’ Hospital. You will need to bring the consent form with you, which is located at 
the back of this information pack. You should sign the consent form at the appointment 
and you will receive a copy for your records. 
 
ANY QUESTIONS? 
If you would like any more information about the study or have any concerns please 
contact: Adam Shortland, Clinical Scientist on 020 7188 2476. 
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________________________, ________________, , ________________,
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D. Supplementary	  information	  for	  
Chapter	  5.	  
	  
D.1	  Repeatability	  of	  muscle	  volume	  measurement	  
The accurate measurement of muscle volume in this study is dependent on the manual 
delineation of muscles within the MRI images. This is a subjective process and the 
measured muscle volume is inter-observer and intra-observer dependent. A single 
person, the primary assessor, drew the majority of the muscle volume regions of interest 
drawn in this study. A second assessor drew the regions of muscle around the 
quadriceps and hamstring muscles of ten BSCP and ten TD subjects. To minimise the 
inter-observer error, the regions of interest drawn by the second assessor were checked 
and corrected if required by the primary assessor.  
 
To assess the test-retest repeatability of the muscle volume measurement of the primary 
assessor, muscle volume measurements were repeated 18 months apart on five muscles 
(MG, SOL, ST, RF, and GMax) of five subjects (three BSCP and two TD subjects) on 
the same data sets with the assessor blinded to the results. Inter-observer reliability was 
examined using a one-way intra-class correlation coefficient (ICC) reporting single 
measure reliability in SPSS ((Version 20.0; IBM SPSS, Chicago, USA). The ICC is a 
score from 0 to 1, The benchmarks for ICC proposed by Landis and Koch (1977)294: 0-
0.2 ‘poor’; 0.21-0.40 ‘fair’; 0.41-0.60 ‘moderate’; 0.61-0.80 ‘substantial’; and 0.81-1.00 
‘almost perfect’. The standard error of measurement (SEM) was calculated using 
Equation D.1. The smallest detectable difference (SDD) with 95% confidence interval 
was calculated using Equation D.2 to estimate the minimal difference between muscles 
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   Equation D.1 
Where SDdiff is the standard deviation of the differences between the repeated 
measures. 
 
   Equation D.2 
 
Table D.1 summarises the results of the test—re-test consistency of measuring muscle 
volume. ‘Almost perfect’ ICC coefficients were observed for all muscles investigated. 
The smallest detectable difference for each muscle is much lower than the difference 
between the muscle volumes of the two subject groups in this study.   
 
95% ICC  










Gmax -7.2 (9.3) 0.999 0.991 1 0.29 0.82 
RF -2.4 (6.4) 0.997 0.972 1 0.35 0.97 
ST -0.8 (4.7) 0.999 0.99 1 0.15 0.41 
SOL -2.6 (7.7) 0.998 0.98 1 0.34 0.95 
MG 2.8 (10.9) 0.988 0.883 0.999 1.19 3.31 
Table D.1 Mean difference in initial and repeated measure of muscle volume with the 
corresponding intraclass correlation coefficient (ICC) values for each muscle tested. The 
standard error of measurement (SEM) and smallest detectable difference (SDD) and the 
paired-test p-value for bias are also given. Significance was set at p≤0.05. GMax = 
Gluteus maximus; RF = Rectus Femoris; ST = Semtiendinosus; SOL = Soleus; MG = 
Medial Gastrocnemius). 
 
Although a very good agreement was observed between the repeated measurements, 
this repeatability only examines the repeatability of the measurement of the muscle 
volumes and does not include the repeatability of the acquisition of the MRI scan. The 
MRI data was collected using two different image acquisition protocols: T1-weighted 
and mDixon. This results in different image contrasts in the acquired data sets affecting 
the detection of muscle boundaries. This may result in a systematic error in the muscle 
volume measured between the two imaging techniques. This systematic error is likely to 
be comparable in size to the repeatability of the manual muscle volume measurement 
discussed above. However, a comparison of muscle volume measurements for the same 
subject acquired using both imaging protocols is required to investigate the validity of 
Appendix	  D	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the grouping of the two data sets in this study. However, it is likely that any systematic 
error between volume measurements for the two imaging protocols is much smaller 
than the large difference in muscle volume between the two subject groups and 
therefore should not significantly affect the results of this study.  
 
D.2	  Example	  images	  
Figure D.1 shows example transverse MRI images of the thigh (a and c) and shank (b 
and d) muscles of a CP and an age and sex matched TD subject respectively. 
 
 
Figure D.1 Example MRI traverse images of the thigh (a and c) and shank (b and d) 
muscles of a CP and an age and sex matched TD subject respectively 
 
D.3	  Rationale	  for	  normalisation	  of	  muscle	  volume	  to	  body	  mass	  
The strong linear relationship between muscle volume and body mass in the typically 
developing subjects in this study (r= 0.694-0.959, see Chapter 5 Table 3) and in our 
previous work59 demonstrates the body mass is a significant non-pathological factor 
influencing lower limb muscle volume. Therefore, in order to identify any pathological 
difference in muscle volume in cerebral palsy the significant non-pathological 
differences in muscle volume due to body size should be accounted for. Therefore, the 
lower limb muscle volumes of the subjects in this study were normalised to body mass 
to minimise the non-clinical variation between the subjects in this study 
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D.4	  Tables	  of	  results	  
 
Normalised muscle volume (cm3/kg) 
95% Confidence Interval for Median 
Muscle Group Median Lower Bound Upper Bound 
CP 9.1 8.24 10.27 GMax 
TD 11.835 9.21 12.98 
CP 2.53 2.17 2.81 RF 
TD 3.34 2.78 3.79 
CP 13.92 12.74 15.09 VI&VL 
TD 13.92 12.57 17.13 
CP 1.5 0.99 2.01 ST 
TD 2.07 1.74 2.88 
CP 1.88 1.66 2.28 SM 
TD 2.82 2.44 3.15 
CP 1.985 1.51 2.37 MG 
TD 3.11 2.77 3.58 
CP 1.015 0.93 1.24 LG 
TD 1.65 1.45 1.82 
CP 4.085 3.28 4.95 SOL 
TD 5.87 5.42 6.41 
CP 1.005 0.87 1.2 TA 
TD 1.57 1.35 1.72 
Table D.2 Median and 95% confidence intervals of the median of the normalised muscle 
volumes for the CP and TD groups for each muscle investigated. 
 
Percentage muscle volume deficits (%) 
95% Confidence Interval for Median  
Muscle Median Lower Bound Upper Bound 
GMax 20.30 10.0 27.8 
RF 26.25 17.9 33.6 
VI&VL 11.40 4.0 20.0 
ST 35.00 12.4 56.9 
SM 35.20 29.5 49.3 
MG 39.20 26.5 53.0 
LG 37.85 23.9 43.2 
SOL 35.80 18.7 52.9 
TA 35.05 22.3 43.7 
Proximal 26.75 20.0 30.0 
Distal 36.80 33.1 41.7 
Table D.3 Median and 95% confidence intervals of the median of the 
percentage muscle volume deficit for each muscle investigated and when 
grouped by location in the lower limb (proximal and distal) in the CP 
group compared to the TD group. 
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E. Supplementary	  information	  for	  
Chapter	  7.	  
	  	  	  
95%	  Confidence	  Interval	  for	  
Mean	  





MRS	   1.95	   1.39	   2.51	   0.73	   0.24	  
3PDp	   8.34	   6.96	   9.73	   1.80	   0.60	  
3PDm	   11.79	   10.29	   13.28	   1.94	   0.65	  
2PD	   5.06	   4.06	   6.05	   1.29	   0.43	  
4PD	   11.58	   10.62	   12.54	   1.25	   0.42	  
Table E.1 Median and 95% confidence intervals of the median of the percentage 
intramuscular fat measured by each method investigated.	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F. SCALE	  and	  muscle	  volume	  
predicts	  gross	  motor	  function	  
	  	  
AACPDM 2014 Free Papers 
Title: Selective motor control and muscle volume predicts gross motor function in bilateral 
spastic cerebral palsy 
Background/Objectives: Gross motor function in cerebral palsy is often considered to be 
dependent on spasticity, muscle size/strength, and selective motor control. However, limited 
studies have been performed investigating the contribution of these factors to gross motor 
function. In this study we investigate the predictive nature of these factors on gross motor 
function measure (GMFM-66) in bilateral spastic cerebral palsy (BSCP). 
Design: Cohort study 
Study participants & Setting: 10 adolescents and young adults with BSCP (10 male, 15.7±3.7 
years, Gross Motor Function Classification System levels I [n=1], II [n=4], III [n=4], and 
IV[n=1]). 
Materials and Methods: Magnetic resonance images were acquired on a 3.0T Achieva system 
(Philips Healthcare), with a quadrature body coil. Three point Dixon sequence 
(TE/TR=2.11/5.2 ms, echo time shift = 0.76 ms (120 o echo phase shift), 10o flip angle, 1.2 x 
1.2 mm in-plane voxel size, number of averages = 2, 5 mm slice thickness) were acquired of 
both lower limbs. Muscle volumes were manually segmented in Osirix (version 5.8.2) for 18 
muscles in both legs (medial gastrocnemius, lateral gastrocnemius, soleus, tibialis anterior, 
tibialis posterior, vastus medialis, rectus femoris, vastus intermedius and lateralis composite, 
semimembranosus, semtiendinosus, gracilis, sartorious, biceps femoris long and short head, 
adductors composite, gluteus maximus, gluteus medius, and gluteus minimus). Muscle 
volumes were normalised to body mass and averaged between legs for each individual. Gross 
motor function (GMFM), lower limb selective motor control (SCALE), and spasticity 
(Modified Ashworth) were assessed. Pearson’s correlations were used to investigate 
relationships between the measured parameters, and forward stepwise multiple linear 
regression analysis used to identify which clinically significant factors (SCALE, modified 
Ashworth, and normalised lower limb muscle volume) predicted gross motor function. All 
statistical tests were performed using SPSS (version 20.0; IBM SPSS) with significance set to 
p≤0.05. 
Results: GMFM-66 is significantly positively correlated to SCALE (r=0.915, p≤0.001) and 
total lower limb muscle volume (r=0.749, p=0.013). GMFM-66 was not related to modified 
Ashworth score. Forward stepwise multiple linear regression analysis showed that SCALE 
and lower limb muscle volume explained 90.3% of the variation in GMFM-66 (p≤ 0.001). 
Conclusions/Significance: Selective motor control and muscle volume, rather than spasticity, 
are the significant factors limiting gross motor function in ambulant individuals with bilateral 
spastic cerebral palsy. 
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Introduction 
At birth a child has approximately 30-50o of femoral 
anteversion (FA)1,2. As the child matures and develops 
they progress through several key motor milestones 
including crawling, standing and walking. These 
activities induce stress on the proximal end of the 
femur1. In response to the applied stress, the proximal 
end of the femur remodels with FA decreasing rapidly 
in the first three to four years of life1. The delay of 
motor milestone acquisitions which often occurs with 
cerebral palsy (CP) results in the degree of FA 
remodelling in early life being reduced2.  
 
This is a retrospective study analysing the degree of 
FA in patients with CP, who attended the One Small 
Step Gait Laboratory at Guy’s Hospital between 2007 
and 2009, to determine if there is a relationship 
between their age of first independent walking and the 
number of years spent walking independently, and the 
degree of FA.  
Materials and methods 
128 bilateral (aged 5-25; 81 male) and 51 unilateral 
CP patients (aged 4-24; 31 male) who walked 
independently and had not had a femoral de-rotation 
were reviewed. Patients were categorised by condition 
(bilateral or unilateral) and into 8 age categories 
according to when they first walked independently (6 
month intervals except for the first (6-18 months) and 
last (60+ months) intervals; parent reported). FA was 
measured with the patient in prone with the hip in a 
neutral coronal position and knee flexed to 90o, the hip 
was rotated internally and externally until the most 
prominent part of the greater trochanter was palpated 
(the trochanteric prominence test). The angle between 
the shank and the vertical was taken as the angle of 
FA. Data was analysed using univariate analysis of 
variance (ANCOVA) methods using patients grouped 
by age of first independent walk as the main factor and 
the number of years spent walking independently as 
the covariate. For each of the bilateral patients, FA 
was averaged between legs. For unilateral patients, 
only the measurements of the affected limb were 
considered. Significance was defined as p≤0.05. 
 
Results and discussion 
FA was found to exhibit a significant relationship only 
with number of years spent walking independently (p= 
0.038) for the bilateral patient group. Age of first 
independent walk was not significantly related to 
degree of FA. There was no significant relationship 
between FA and either of the independent factors for 
the unilateral group (Table 1). There was no significant 
difference in FA between bilateral and unilateral 
groups (p=0.428). 
 
Patient category Factor/Covariate P-value 
Age of first independent walk 0.281 
Bilateral 
Time walking independently 0.038 
Age of first independent walk 0.293 
Unilateral 
Time walking independently 0.297 
Table 1: Summary of statistical analysis results 
 
Figure 1: Femoral anteversion relationship with years of 
independent walking for bilateral patients 
 
These results suggest that FA is negatively correlated 
with the number of years spent walking independently 
in the case of bilaterally-affected patients. However, 
there was no such relationship for unilateral CP. 
Figure 1 suggests that FA decreases by 0.5o per year 
for bilateral CP patients on average. While this rate of 
remodelling may be considered clinically insignificant, 
it may be possible that a subgroup of subjects remodel 
at a greater rate. Further investigations on a larger 
sample may be required to distinguish these sub-
groups (e.g. GMFCS, gait pattern). Identifying 
individuals that remodel FA rapidly may help inform 
treatment decision making. Off-loading of the affected 
limb in unilateral CP may explain the lack of 
relationship between the number of years spent 
walking independently and the degree of FA.  
Conclusion 
This study has found that the femur remodels 
significantly with the number of years spent walking 
independently for bilateral CP patients and is not 
dependent on age of acquisition of independent 
walking. Remodelling of the femur does not appear to 
be dependent on years spent walking independently or 
timing of acquisition of motor skills for unilaterally-
affected patients with CP. 
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